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l)CONFIGURATIONS OF INTER-FIRM RELATIONS IN MANAGEMENT INNOVATION
A STUDY IN CHINA’S BIOPHARMACEUTICAL INDUSTRY
This dissertation proposes a configurational approach to the study of inter-firm relations
facilitating management innovation. Previous research conceptualizes management innovation
as either the outcome of determinants of individual firms or a complex process of conjunc -
tural factors between firms. In contrast, this thesis attempts to reconcile the two camps by
examining the conditions under which the management innovation process within inter-
firm relations takes place. The empirical analysis employs data from 56 firm partnerships in
China’s biopharmaceutical industry collected during field research in 2008. The population of
firms in China’s biopharmaceutical industry is young, highly diverse and strongly relies on ties
to other organizations. Operating under volatile conditions requires constant development
of new managerial instruments. Methodologically, this dissertation employs a technique
new in the study of management innovation. Fuzzy Set Qualitative Comparative Analysis
(fsQCA) has been chosen for its ability to properly translate complex theories into models
and its suitability for configurational analyses. 
The results identify four configurations of inter-firm relations differing in their combi -
nations of relational, structural and environmental conditions. Each is equally effective in
facilitating management innovation yet employs internal and external knowledge differently
to develop and implement new management instruments. The results provide a simple and
well arranged decision-making tool for drafting intelligible managerial strategies and
indicate that firms in China’s biopharmaceutical industry swiftly develop and introduce
management instruments which soon may serve as templates for the global biopharma -
ceutical industry as a whole.
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1. Introduction 
Some five thousand years ago around 3000 BC in Babylon, 80 kilometres south of 
Baghdad, the first concentration of settlers emerged as what is nowadays referred to as a 
city (Bragg, 2004).1 With more than one hundred thousand people, Babylon did not differ 
from other, smaller settlements solely from the number of its inhabitants. More 
importantly, it constituted a highly complex social organism. Aside from people producing 
food and farming the fields, Babylon featured an administrative system of trade, law and 
order. Babylon ultimately became too complex to be managed merely by words and 
memories. Around this time, temple bureaucrats developed and implemented systems of 
numbers, known today as the Babylonian Numerals. These helped to predict, manage and 
control the land, the assets and the people working in the fields. This first use of numbers 
to administer complex organizations essentially represented nothing more than a new 
management tool. 
Nowadays, the phenomenon of developing and implementing new managerial 
practices, processes and structures is referred to as management innovation (Birkinshaw, 
Hamel, & Mol, 2008). Yet while currently there is only little research on this subject, 
recent history has seen similarly revolutionary management innovations that have 
substantively affected the way organizations are managed. One of the first management 
innovations commonly associated with firms is the moving assembly line implemented at 
the Ford Motor Company in the beginning of the 20th century (Chandler, 1977). Instead of 
having workers move from one station to another assembling parts of each car 
individually, Ford introduced a system in which the product, not the producers, would 
move. This management innovation modularized the production process, allowed for 
specialization among operators and significantly improved the efficiency of the plant. 
Other management innovations followed and, especially between the 1960s and the 1980s, 
Japan’s economy developed some of the most prominent examples. For instance, the 
concept of Quality Circles, self-administered teams that meet regularly under the 
supervision of a team leader, were first introduced in the Nippon Corporation in the late 
1960s to develop solutions to work related problems (Hutchins, 1985). Another example 
can be found in Toyota’s Lean manufacturing concept introduced during the 1980s, a 
bundle of practices aimed at eliminating, or at least reducing, wasteful efficiencies during 
the production process (Krafcik, 1988). Similar management concepts emerged shortly 
afterwards, such as Total Quality Management or Six Sigma, introduced by Motorola in 
the late 1980s and aligning business activities to improve the overall quality of goods and 
services (Cua, McKone, & Schroeder, 2001).  
Practitioners and researchers alike are increasingly becoming aware of the crucial 
role of management innovation (Hamel, 2006) and are trying to understand when and how 
management innovation takes place, why some organizations innovate while others do not 
and what characterizes more innovative organizations (Baldridge & Burnham, 1975). 
Management innovation is believed to enhance a firm’s overall efficiency by improving its 
competitive position, enabling rapid adaptation to new situations and ultimately increasing 
                                                 
1
  This first paragraph largely draws on the radio program ‘Babylon’ in BBC Radio 4’s series ‘In our Time’, 
broadcasted on June 4, 2004. It is available in the online archive of the program series.  
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a firm’s performance (Birkinshaw et al., 2008). It thereby creates sustainable advantages 
and dramatically shifts a firm’s competitive position.  
To avoid confusions, management innovation is not innovation management or the 
management of innovation. These terms relate to technological innovations that concern 
products, technical processes, and other technologies used to produce goods or “… render 
services directly related to the basic work activities of organizations.” (Crossan & 
Apaydin, 2010: 1168-69). Instead management innovation, put simply “… changes how 
managers do what they do” (Hamel, 2006: 4) and is necessary to reap the benefits of 
technological innovation. It is intangible and directly relates to management aspects of an 
organization: its structure, processes and practices.  
1.1. What we know about Management Innovation so far?  
Currently, the literature on management innovation conceptualizes the phenomenon 
from two rather different perspectives. While some scholars argue that management 
innovation is a complex process of events and activities driven by certain actors 
(Birkinshaw et al., 2008), others understand management innovation as an outcome of 
individual, organizational and environmental determinants (Kimberly & Evanisko, 1981). 
Outcome or variance theories consider the individual firm as the unit of analysis and 
provide us with theoretical explanations for the influence of a range of different 
independent variables.2 Process theories, in contrast, indicate how the management 
innovation process takes place within inter-firm relations and argue that merely the 
application of new management practices, processes and structures relies within individual 
firms. Furthermore, the process approach illustrates how conditions facilitating 
management innovation are interrelated and, in conjunction, explain when new 
management instruments are generated by the interaction between firms. The arguments of 
process models essentially render outcome models overly simplistic as the latter treat 
facilitating conditions as independent and competing explanations (Gopalakrishnan & 
Damanpour, 1994). However, the in-depth focus of process models leads this body of 
literature to neglect the organizational and environmental conditions under which inter-
firm relations operate. Also, propositions of process models are difficult to substantiate as 
they rely on complex conceptual models and individual case studies.  
A mediating approach is provided by contingency theories of management 
innovation. Scholars in this field, while in principle advocating an outcome perspective, 
suggest that the conditions under which management innovation takes place may be 
contingent on the appropriate alignment of individual, organizational and environmental 
factors (Burns & Stalker, 1961; Daft, 1978; Damanpour, 1996; Gopalakrishnan et al., 
1994). Contingency theories thereby emphasize the notion of ‘fit’ among variables, and the 
idea that there are alternative, equally effective organizational systems that facilitate 
management innovation processes (Nicholson, Rees, & Brooks-Rooney, 1990; Pennings, 
1975). These propositions are supported by illustrative evidence (Sapolsky, 1967), and by 
                                                 
2
  In many bodies of literature the term ‘variance theories’ is usually preferred over the term ‘outcome theories’. 
In the following, I continue using the term outcome theories as it seems to be more common in the innovation 
literature.  
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post-hoc and implicit theorization in outcome and process studies respectively (Birkinshaw 
et al., 2008; Corwin, 1972). Contingency theories provide an alternative to outcome and 
process approaches by acknowledging complexities among the contextual antecedents of 
management innovation while remaining sufficiently systematic to formulate testable 
hypotheses. However, they have so far not been used in management innovation research, 
as translating their hypotheses poses severe methodological difficulties (Fiss, 2007; 
Longenecker & Pringle, 1978; Parker & van Witteloostuijn, 2010).  
1.2. Research Approach and Objectives 
In this thesis, I take a holistic approach to contribute to the current literature on 
management innovation. I acknowledge the insights of process theories of management 
innovation and take the inter-firm relation as the unit of analysis (Birkinshaw et al., 2008). 
Inter-firm relations are essentially social action systems similar to individual firms. Both 
represent organizational systems that are subject to the same contextual influences (van de 
Ven, 1976). Subsequently, I adopt insights provided by outcome theories of management 
innovation and apply relational, structural and environmental variables to the inter-firm 
relation (Baldridge et al., 1975; Damanpour, Szabat, & Evan, 1989; Mol & Birkinshaw, 
2009). Furthermore, I adopt theoretical arguments put forward by contingency theories 
aiming at substantiating the theoretically complex antecedents of management innovation. 
Instead of specifying what actors within inter-firm relations do to develop and implement 
new management instruments, I thereby ask under what conditions the management 
innovation process within inter-firm relations takes place. This thesis therefore aims at 
providing an answer to the following question: 
What configurations of relational, structural, and environmental conditions of inter-
firm relations facilitate management innovation processes? 
To answer this question, I use a method that is relatively new to organization studies. 
Fuzzy set Qualitative Comparative Analysis (fsQCA) builds on set theory to holistically 
examine and compare the complex configurations of cases, instead of analyzing the net-
effect of individual determinants (Ragin, 2008b). It uses Boolean logic, similar to queries 
in online search engines, to minimize data and to identify configurations, i.e. combinations 
of conditions, that explain a certain outcome. Thereby, fsQCA properly translates complex 
theoretical assumptions and is hence well suited for the analysis of configurations of inter-
firm relations that facilitate the management innovation process (Grandori & Furnari, 
2008; Ragin, 2008b).  
1.3. The Biopharmaceutical Industry in China 
The empirical study in this thesis takes place in China’s biopharmaceutical industry. 
Between 2007 and 2008, I conducted 56 interviews with Chinese biopharmaceutical firms 
to examine the role of inter-firm relations in management innovation. Due to substantial 
unpredictability regarding the ultimate marketability of biopharmaceutical products and 
the complex nature of the industry’s knowledge domains, biopharmaceutical firms operate 
under high degrees of uncertainty and strongly rely on ties to other organizations (Powell, 
Koput, & Smith-Doerr, 1996). The industry is known of its lack of appropriate managerial 
techniques to fully reap the benefit of the large number of technological innovations so 
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characteristic for the industry (Pisano, 2006). In China, the biopharmaceutical industry is 
relatively young, the market for biopharmaceutical products is growing and the 
institutional framework is rapidly changing (Frew et al., 2008; Lakhan, 2006). In addition, 
the industry contains a highly diverse population of firms. Inter-firm relations 
consequently operate under volatile conditions that require the constant development of 
new managerial instruments to address these dynamics. 
The background of the study, during China’s emergence as an economic powerhouse, 
adds to its relevance. During the last two decades, the world has witnessed the rise of large 
Chinese corporations, which have become global leaders in their industries. And while 
Chinese high technology firms have certainly begun competing with technology leaders in 
the West (Greeven, 2009; Greeven, 2007), these advancements do not, in and by 
themselves, explain why Chinese firms outperform larger, more mature and 
technologically more innovative companies. Clearly, political factors play a substantial 
role (Child & Rodrigues, 2005; Dickson, 2003; Krug, 2004; Schueler-Zhou, Brod, & 
Schueller, 2010). A growing body of management literature, however, suggests that the 
most successful innovation employed by Chinese firms pertains to innovations in the way 
business is conducted, i.e. management innovation (Krug & Hendrischke, 2008; Zeng & 
Peter, 2003; Zeng & Williamson, 2007). Chinese entrepreneurship in high technology 
industries is directly and successfully competing with Western counterparts, and there is 
much reason to believe that Chinese biopharmaceutical firms will soon play a prominent 
role among Western industries, too (Chervenak, 2009; Ernst & Young, 2005; Langer, 
2007a; Zhou, 2007). In light of significant recent economic developments taking place in 
rapidly developing countries understanding management innovation in China is 
increasingly urgent.  
1.4. Contributions  
The results of this study will identify four distinctive configurations of relational, 
organizational and environmental conditions of inter-firm relations that facilitate 
management innovation processes. Operating under strong environmental uncertainties, 
decentralized decision-making systems paired with flat hierarchically structured firms 
unleash internal knowledge resources distributed across cooperating firms. This 
configuration enables organizational systems to develop new management instruments in 
reaction to new situations. Similarly, the second configuration feeds of on decentralized 
structures yet requires a high degree of heterogeneity among interacting firms. The results 
indicate that such organizational systems spread sensing devices that allow them to access 
resources available in their broader environment. The third configuration of inter-firm 
relations generates new management instruments on the basis of internal knowledge. Here, 
between mutually dependent and homogeneous partners, the formalization of rules and 
regulations provides for the necessary preconditions to establish trust within the inter-firm 
relation, subsequently enabling the exchange and recombination of knowledge to 
managerially innovate. Finally, in the absence of environmental uncertainties, inter-firm 
relations engage in management innovation when they are hierarchically designed. In this 
configuration, the role of top management and administrative cores is pertinent in 
developing and implementing new management instruments.  
Introduction 
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From a theoretical perspective, the results provide substantial support for 
configurational theories in management innovation. There is not a single determinant, a 
‘one-size fits’ all solution, that satisfactorily explains when inter-firm relations trigger 
management innovation processes. To be clear, this is not merely a matter of how close 
one takes a look. fsQCA maintains distinct model coefficients that deem overall solutions 
as sufficiently consistent, or not. Consequently, by identifying equifinal configurations that 
exhibit multiple, conjunctural and asymmetric relationships among variables, this thesis 
uncovers substantial degrees of complexity among the contextual antecedents of 
management innovation. The results call for a stronger focus in theory development and 
suggest future research directions.  
Moreover, I introduce a new methodological approach, fsQCA. This approach is 
relatively new to management and organization research (Fiss, 2010; Fiss, 2007; 
Greckhamer, Misangyi, Elms, & Lacey, 2008), and has so far not been used in the study of 
management innovation. A holistic approach is taken by fsQCA, systematically comparing 
entire cases with each other (Ragin, 1987, 2008b). It refrains from disaggregating cases 
into (seemingly) independent variables and thereby represents an alternative analytical 
technique that improves the alignment of management innovation theories with methods, 
by better translating theoretical propositions into models (Doty & Glick, 1994; 
Venkatraman, 1989). However, as with every method, fsQCA bears risks and limitations 
and, as the method is relatively young, it is subject to constant methodological 
developments.  
Finally, configurational analyses ultimately develop taxonomies of viable, alternative 
design choices. These reduce complex phenomena to commonly shared elements and 
allow comparisons between alternative, equally effective organizational systems (Fiss, 
2010; Martin-Pena & Diaz-Garrido, 2008). The taxonomy developed in this thesis 
provides managers with a simple and well-arranged instrument to optimize and re-design 
inter-firm relations according to their management innovation strategy. It thereby drafts 
intelligible and practical managerial implications. In particular it provides answers to 
questions such as how inter-firm relations need to be designed (or configured) to enable 
management innovation? Or how can inter-firm relations be changed in order to facilitate 
or obstruct management innovation processes? 
Throughout this thesis, I provide empirical evidence and use short case studies from 
China’s biopharmaceutical industry to illustrate management innovation phenomena, and 
the functioning and mechanisms of inter-firm relations in the development and 
implementation of these instruments. The thesis thereby depicts China’s biopharmaceutical 
industry as a diverse population of organizations that, in interaction, creates new 
management instruments. The overarching picture that emerges is one of an industry that, 
as a whole, will soon take a prominent position among the dominant biopharmaceutical 
industries in the world.  
1.5. Overview of the Dissertation 
This thesis proceeds as follows. Chapter 2 summarizes previous literature on 
management innovation. The chapter first discusses conceptual issues that pertain to the 
study of innovation in general. It then provides an overview of theoretical perspectives on 
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management innovation and discusses their corresponding methodological approaches. 
Chapter 3 introduces the two major deviations from earlier research on management 
innovation proposed in this thesis. Firstly, a theoretical shift that combines insights from 
outcome, process, and contingency theories alike to propose a configurational model of 
conditions of inter-firm relations that facilitate management innovation. Secondly, a 
methodological shift that introduces a new analytical technique, fsQCA, to the study of 
management innovation. These two elements provide the conceptual foundations of the 
empirical study presented in this thesis. Chapter 4 describes in detail the empirical 
background in the Chinese biopharmaceutical industry. It provides an overview of the 
biopharmaceuticals industry and illustrates the specific business environment of 
biopharmaceutical firms operating in China. In Chapter 5, I report the empirical study 
among inter-firm relations in China’s biopharmaceutical industry. I describe aspects 
pertaining to the collection and measurement of data, the calibration of membership scores 
and lead the reader through the analysis step by step. I subsequently report and discuss the 
results. Finally, Chapter 6 summarizes the implications of the thesis and concludes.  
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2. Previous Research on Management Innovation 
The purpose of this chapter is to summarize previous research on management 
innovation. Before illustrating literature specific to management innovation I introduce 
conceptual issues that pertain to the study of innovation in general. Understanding these 
conceptual issues is important as it facilitates capturing the complexity and subsequent 
variety of approaches used in the research of management innovation. I then proceed to 
theories of management innovation, discussing outcome, process and contingency theories 
separately. Finally, I illustrate corresponding modelling and methodological. The review 
serves to illustrate how a holistic, configurational approach contributes to our 
understanding of management innovation. 
2.1. Conceptual Issues in Innovation Studies  
Innovation has been the subject of enquiry in a variety of academic disciplines 
ranging from economics, sociology, and technology studies to organizational and 
management studies (Gopalakrishnan & Damanpour, 1997). However, the development of 
an integrative theory is challenged by a range of conceptual dimensions pertaining to 
innovation in general. First, two substantially different conceptualizations of innovation 
exist in the literature: in one, whereby innovation is understood as the outcome of 
contextual factors; in the other as a process of different events and activities. Second, the 
research distinguishes various stages of innovation. Outcome models of innovation 
commonly simplify innovation by considering none or only a few consecutive stages. In 
contrast, process models argue that innovation consists of “…complex, cumulative and 
conjunctural progressions of convergent, parallel, divergent activities” (Gopalakrishnan 
1997: 16). Third, the most fundamental attribute of innovation pertains to its ‘newness’ 
(Gopalakrishnan et al., 1997). Yet, despite the fact that all innovation research agrees that 
innovation is essentially something new, there is wide disagreement over the definition, 
conceptualization, and measurement of ‘newness’. This fundamental attribute deserves 
separate attention. Fourth, scholars have also examined other attributes specific to 
innovation that help to grasp the phenomena as a whole (Downs & Mohr, 1976; Fliegel & 
Kivlin, 1966). Fifth, partly by taking such attributes into consideration, various types of 
innovation can be distinguished. It is here where management innovation is contrasted 
against other forms of innovation, most notably technological innovation (Damanpour, 
1987; Gopalakrishnan et al., 1997). I will discuss these five conceptual issues in the study 
of innovation in more detail one after another in the following sections.  
2.1.1. Two Conceptualizations of Innovation 
Innovation has been described and defined from two different perspectives. Some 
scholars conceptualize innovation as an outcome, such as a product or idea (Damanpour & 
Evan, 1984; Kimberly et al., 1981). I will refer to these as ‘outcome models’. Others have 
conceptualized innovation as a process (Birkinshaw et al., 2008; van de Ven & Rogers, 
1988; Zaltman, Duncan, & Holbek, 1973). I will refer to these as ‘process models’. 
Underlying both conceptualizations are processes of knowledge production or knowledge 
re-combination that allow new ideas to be developed and introduced (Kogut & Zander, 
1992; Nickerson & Zenger, 2004; Powell et al., 1996; Thompson, 1967). 
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Outcome models aim to identify individual, organizational, and environmental factors 
that influence the ability of an organization to innovate. Individual factors relate to the 
attitudes, knowledge, experiences, or affiliations of decision-makers who facilitate the 
sharing of knowledge and the development of shared ‘languages’. Organizational factors 
relate to a firm’s human resources (HR), and demographic, structural and strategic factors 
(Baldridge et al., 1975; Damanpour, 1996; Ettlie, 1983; Hage, 1980). Organizational 
variables clearly dominate outcome model research and it has often been argued that 
structural variables are the primary determinants of organizational innovation (Kim, Oh, & 
Swaminathan, 2006; Kimberly et al., 1981; Wolfe, 1994). Environmental factors relate to 
institutional theories, suggesting that firms respond to specific exogenous influences 
(Child, 1973; Powell et al., 1996). Conflicting contextual forces or institutional 
uncertainties are commonly regarded as triggers for innovative activities (Guler, Guillén, 
& MacPherson, 2002; Mintzberg, 1979).  
In contrast, process models emphasize the complex interplay between actors, 
activities, events and stages as elements of the generative process that leads to innovation 
(Birkinshaw et al., 2008; Kline, 1985). Models in this tradition aim to identify types of 
events and sequences central to the innovation process. Emphasis is placed upon activities 
such as idea initiation and idea proposal, and events such as project definition, problem 
solving, prototype solutions, development of feasible solutions and implementation (Kline, 
1985; Thompson, 1967). These models highlight the role of interaction between change 
agents and serve to describe and explain in detail the complex interdependencies within the 
innovation process (Gopalakrishnan et al., 1997). Scholars advocating a processual 
understanding of innovation critizise outcome approaches for simplifying and mis-
specifying the nature and direction of causal factors (Anderson & Tushman, 1990; Kline & 
Rosenberg, 1986; Schroeder, van de Ven, Scudder, & Polley, 1989).  
The distinction between outcome and process models of innovation carries significant 
consequences for the theorizing and modelling as well as the choice of methodological 
techniques. As a result, I will retain this distinction both in the section on theories of 
management innovation and in the section on modelling and methods.  
2.1.2. Stages of Innovation  
Outcome and process models differ in the emphasis they place upon their 
examination of innovation stages. Outcome models only consider either the generation or 
the adoption of a new idea (Roberston, 1974; Zaltman et al., 1973). This simplification of 
the innovation process allows researchers to develop empirical markers and to identify 
moments when a new idea or product is developed from an initial stage. Such models thus 
allow the researcher to distinguish the stage of ‘generation’ from subsequent stages such as 
‘implementation’ (Kline et al., 1986).  
Process models differ from outcome models in two ways. First, they take a holistic 
perspective and consider the entire innovation process. Pierce and Delbecq (1977), for 
instance, distinguish between the initiation, adoption, and implementation of innovation as 
well as between the corresponding activities of project definition, problem solving, design 
and development, and marketing and commercialization. Second, process models do not 
assume a linear and consecutive sequence of stages. Indeed, process model scholars 
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question the existence of discrete stages (Pelz, 1983; Rogers, 1983) and presume that even 
if such stages exist they should be conceptualized as interrelated, parallel, converging, 
diverging or overlapping (Kline, 1985; Schroeder et al., 1989).  
2.1.3. Newness of Innovation 
Because of its central role in innovation research, the notion of newness has received 
a lot of attention. While all scholars agree that innovation most fundamentally pertains to 
something new, there is wide disagreement over what level of adoption determines such 
newness. Consequently, one can find a variety of measurements for newness (Downs et al., 
1976). In general, in-depth process models examine innovations that are new to a single 
organization, whereas larger studies use a stricter definition of newness. These definitions 
range from new to its ‘local context or industry’ (Sapolsky, 1967; Teece, 1980), or its ‘first 
use ever’ (Mansfield, 1963; Thompson, 1965) to more restrictive criteria such as ‘new to 
the state of the art’ (Birkinshaw et al., 2008; Gordon, Kimberly, & MacEachron, 1975; 
Kimberly et al., 1981).  
In addition to these definitional differences, innovations by their very nature 
exacerbate the task of assessing ‘newness’. They are transient, i.e. their classification 
changes over time so that one and the same innovation is rarely the same thing in two 
organizations (Downs et al., 1976; Winter, 1968). Moreover, the perception of newness by 
the relevant unit of adoption plays a crucial role (Dewar & Dutton, 1986; Zaltman et al., 
1973). The relevance of perception in assessing ‘newness’ involves practical challenges. 
The more ‘new’ an idea or product is perceived to be, the stronger the resistance it faces 
during adoption (Kimberly et al., 1981). Similarly, for data collection purposes, managers 
tend to overstate the novelty of newly introduced instruments so that the use of self-
reported newness is likely to contain measurement biases (Downs et al., 1976). To avoid 
these biases, the use of expert groups is a preferred method to validly determine newness 
in innovation studies (Dewar et al., 1986; Kelley, 1976).  
2.1.4. Attributes of Innovation 
Aside from this fundamental attribute of newness, scholars have examined other 
attributes of innovation. Instead of focusing on contextual variables, events or activities 
that affect innovation, some have argued that understanding the attributes of innovation 
itself is fundamental to employing typologies and relationships in the context of theory 
building (Downs et al., 1976; Tornatzky & Klein, 1982). The most exhaustive collection of 
attributes of innovation is provided by Fliegel and Kivlin (1966), who develop a list of 
attributes grouped into the following categories: cost, efficiency, risk and compatibility. 
Cost attributes refer to initial and continuing costs as well as economic returns. Efficiency 
attributes, on the other hand, consider savings in time or reduction of discomfort. Risk and 
uncertainty attributes relate to the regularity of rewards, the divisibility of trials 
(modularity), or the communicability of an innovation. Finally, to assess the possibilities 
of integrating innovations, Fliegel and Kivlin distinguish compatibility attributes such as 
mechanisms of attraction and pervasiveness and less tangible attributes such as social 
approval (Fliegel et al., 1966). Following this research, Downs and Mohr (1976) proposed 
to distinguish primary attributes, i.e. those that “…can be confidently classified without 
reference to a specified organization” (Downs and Mohr, 1976: 702), from secondary, 
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context-specific attributes. A classification of the secondary attributes of an innovation 
essentially rests on assessing the organization that contemplates its adoption. The analysis 
of attributes remains a rather neglected field of research in innovation studies. 
Nevertheless, it facilitates understanding of the inherent uncertainties entailed in 
innovation processes and is necessary to essentially determine the economic effects of 
innovation activities, for instance on company performance.  
2.1.5. Types of Innovation 
The literature distinguishes between different types of innovation, partly based on 
various attributes. The term organizational innovation hereby captures all kinds of 
innovations generated by organizations. Within organizational innovation, scholars use 
various attributes to distinguish between material vs. non-material innovation (Ogburn, 
1922), radical vs. incremental innovation (Dewar et al., 1986), process vs. product 
innovation (Ettlie & Reza, 1992; Pisano, 1996), technical vs. non-technical innovation 
(Jangwoo & Miller, 1996; Whitley, 2000), or administrative vs. technological innovation 
(Daft, 1978; Evan, 1966). In addition, specific terms have been coined based on the 
ultimate objectives of innovation: ‘strategic innovation’, for instance, refers to the 
development of new strategies (Hamel, 1998; Markides, 1997); ‘cost innovation’ refers to 
combinations of innovations that reduce costs and increase efficiencies (Zeng et al., 2007); 
and ‘social innovation’ concerns sustainable organizational innovation that supports local 
communities, such as ethnic communities, cities or entire nations (Drucker, 1987; Westley, 
1991). Among these typologies, radical vs. incremental innovation and technological vs. 
administrative innovation have been most widely adopted (Baldridge et al., 1975; 
Damanpour, 1996). Technological innovations rather refer to the use of physical products, 
technical processes, and other technologies used to produce goods (Crossan & Apaydin, 
2010). 
2.1.6. Definitions of Management Innovation 
In contrast, management innovation is best considered as an offspring of 
administrative innovation (Damanpour, 1987; Evan, 1966; Teece, 1980). Hamel (2006) 
describes it as “…a marked departure from traditional principles, processes, and practices, 
or a departure from customary organizational forms that significantly alter the way the 
work of management is performed.” (Hamel, 2006: 4). He adds that, in contrast to 
technical or operational innovation, management innovation affects a firm’s management 
processes.  
While administrative innovation is confined to new administrative processes, 
organizational structures, and HR policies (Carroll, 1967; Damanpour, 1996; 
Gopalakrishnan et al., 1994), management innovation concerns a broader range of non-
technical innovation pertaining to managerial issues (Birkinshaw et al., 2008). These 
include innovations in marketing, strategy or operations management (Hamel, 2006; Mol 
et al., 2009; Vaccaro, Jansen, van Den Bosch, & Volberda, 2009). Both administrative and 
management innovation are directly related to the overarching management of an 
organization, and thus are only indirectly related to the day-to-day activities of staff (Evan, 
1966; Kimberly et al., 1981; Knight, 1967). Most scholars use the terms administrative and 
management innovation interchangeably as the differences between the two concepts are 
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marginal (Birkinshaw et al., 2008). In the remainder of this thesis, I use the term 
management innovation, yet when reviewing the literature, I include insights gained by 
research on administrative innovation. 
Hamel’s (2006) description points towards a number of peculiarities surrounding 
management innovation. Management innovation is assumed to involve significant set-up 
costs (Teece, 2007) due to necessary modifications in the structures and systems of 
organizations (Damanpour, 1996; Moon et al., 2004). Furthermore, the outcome of 
management innovation is subject to considerable uncertainty, is not necessarily successful 
or intentional (Baldridge et al., 1975). It is therefore difficult to directly relate its impact on 
organizational performance (Kimberly et al., 1981). Furthermore, management innovation 
is less tangible than for instance technological innovations, and consequently more 
difficult to implement (Damanpour, 1996). In contrast to technological innovation, its 
diffusion is not prevented by legal barriers (Teece, 1980). For these considerations, some 
researchers have suggested that incremental approaches to management innovation are 
unfeasible research directions (Damanpour, 1996). The distinction between radical and 
incremental innovation in fact appears rarely in the management innovation literature.  
The different definitions of management innovation reflect the various conceptual 
issues involved in innovation research. These are illustrated in the following examples. 
Birkinshaw et al. (2008) define management innovation as the “…invention and 
implementation of a management practice, process, structure, or technique that is new to 
the state of the art and is intended to further organizational goals.” (Birkinshaw et al., 
2008: 825). Menz (2009) defines it as “…the adoption of a management concept, idea, 
practice, process, structure, technique, or tool that is new to the organization and is 
intended to improve firm performance (Menz, 2009: 3). Finally, Vaccaro et al. (2010) 
define it as “…the implementation of a management practice, process, or structure that is 
new to the adopting organization.” (Vaccaro et al., 2010: 2).  
These three examples show how definitions differ in terms of the stages that are 
considered, the criteria used to determine newness, and whether or not management 
innovation is regarded as furthering organizational goals. The definition of Birkinshaw et 
al. (2008) covers two consecutive stages of management innovation, whereas the latter two 
examples focus respectively upon adoption (Menz, 2009) or implementation (Vaccaro et 
al., 2009) of management innovation. Most scholars agree that management innovation 
entails new managerial practices, processes, and structures. However definitions alter 
according to the particular research focus, as indicated in the differences in determining 
‘newness’ outlined in section 2.3, above. Whereas Menz (2009) and Vaccaro (2010) define 
‘newness’ as ‘new to the organization’, Birkinshaw et al. (2008) consider management 
innovation to occur only when the practice, process or structure is ‘new to the state of the 
art’ – ultimately a rather restrictive criteria. Lastly, scholars’ definitions of innovation also 
contain notable differences based upon the objectives of management innovation. These 
objectives are: those intended to further organizational goals (Birkinshaw et al., 2008); 
those used to improve firm performance (Menz, 2009); or those not used or intended to be 
used for any specific objective (Vaccaro, 2010). In the following, I maintain a preliminary 
definition of management innovation whereby:  
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Management innovation refers to the development (generation) and 
implementation (adoption) of a new management practice, process, or 
structure intended to further organizational goals. 
2.2. Theories of Management Innovation 
Management innovation has been theorized as either an outcome of contextual factors 
or as a process of interrelated activities and stages. In the following section, I discuss 
theoretical contributions in both fields. I begin by illustrating the theoretical arguments put 
forward by outcome models of management innovation, highlighting the various factors 
taken into account in this field of research. I then proceed to discuss process theories. Last, 
I describe systematic, multi-dimensional theories of management innovation, which 
predominantly rely on contingency arguments, and summarize the findings of this 
subsection. 
2.2.1. Outcome Theories of Management Innovation 
Between the 1960s and 1990s a remarkable number of theoretical contributions 
appeared which significantly shape todays understanding of management innovation. 
Research on innovation as the outcome of contextual factors is by now a large and 
established body of literature (Damanpour, 1991; Evan, 1966; Mol et al., 2009; Vaccaro et 
al., 2009). Its primary objective consists in analyzing the effects of individual, 
organizational, and environmental determinants of management innovation.  
Characteristics of Individual as Determinants of Management Innovation 
Some of the first theoretical contributions to the field of management innovation 
hypothesized that specific characteristics of individuals influence an organization’s ability 
to managerially innovate. Carlson (1967) for instance argued that better educated, more 
mature males of high social status are more able to introduce new managerial practices due 
to their perceived higher authority and legitimacy (Carlson, 1967). Others suggest that 
general attitudes and values, such as cosmopolitanism, provide individuals with the 
necessary range of ideas and experiences to devise new management instruments (Rogers, 
1983; Rogers & Cartano, 1962). Sapolsky, (1967) providing evidence from department 
stores, argues that the external communications of individuals outside their company 
promotes management innovation (Rogers & Shoemaker, 1971). However theories on the 
characteristics of individuals as determinants of management innovation have not been 
supported by empirical research (Baldridge et al., 1975). In fact most studies suggest that 
general characteristics of individuals are poor predictors of management innovation (Hage 
& Aiken, 1970). As an alternative, scholars have argued that, if one is to consider 
characteristics of individuals, one should also examine context-specific features of 
individuals (Baldridge et al., 1975).  
Organizational Determinants of Management Innovation  
The role of organizational factors has dominated research on management innovation, 
and essentially argues that organizational innovation is primarily an outcome to be 
explained by organizational determinants (Damanpour, 1991; Kim, 1980; Kimberly et al., 
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1981; Wolfe, 1994). In a continuation of theories on the role of individuals in management 
innovation, researchers have considered factors associated with an organization’s Human 
Resource (HR) system. In addition demographic, structural, and strategic factors have been 
within the focus of these analyses.  
Human Resource related Factors 
As indicated above, general characteristics of individuals have largely been dismissed 
as determinants of management innovation. Instead, theoretical focus has been directed 
onto context-dependent features of individuals (Aiken & Hage, 1968; Blau, 1970), i.e. 
factors that capture the role and function of individuals within organizations. First, scholars 
have examined the role of different leadership or administrative positions which are 
assumed to set, encourage, and approve the innovation process (Daft, 1978). Baldridge and 
Burnham (1975) for instance observe that administrative positions of individuals within an 
organization have an impact on innovation activities, and conclude that these positions are 
especially important to link “… demands and ideas from the outside and innovations 
adopted within the schools.” (Baldrige and Burnham, 1975: 167). Second, different 
attitudes and behavioural styles of an organization’s employees have been hypothesized to 
affect management innovation. As such, researchers examined employees’ attitudes 
towards change (Kimberly et al., 1981) or the internal resistance to change within the 
organization (Corwin, 1972; Daft, 1978; Dewar et al., 1986; Mintzberg, 1968). The third 
group of HR related factors pertains to the diversity of knowledge and experience available 
within an organization. Researchers argue that management innovation requires the re-
combination of existing expertise, and that a more diverse repository of knowledge 
increases the likelihood that a firm will develop and implement new managerial tools 
(Hage, 1980). Hence the distribution of knowledge within an organization is hypothesized 
to positively affect management innovation (Dewar et al., 1986). A similar line of thought 
is pursued by scholars who consider the degree of specialization, or the depth or intensity 
of organizational knowledge (Baldridge, 1971; Kimberly et al., 1981; Zaltman et al., 
1973). Others focus on the role of heterogeneity within management teams (Alexiev, 
Jansen, van den Bosch, & Volberda, 2010) or previous experience in different cultures 
(Chen, 2008). Finally, assuming that managers will be more inclined to introduce new 
instruments, scholars have argued that administrative intensity, i.e. the share of 
administrative staff in the total workforce, positively influences management innovation 
(Blackburn, 1982; Damanpour, 1991; Reinmann, 1973, 1974).  
Demographical Factor: Size 
A second group of factors hypothesized to affect management innovation relates to 
demographic features of organizations. Organizational size has been the most widely 
analyzed feature (Damanpour, 1992; Ettlie, 1983). Two rival hypotheses have been 
formulated. On the one hand, scholars argued that larger firms are more likely to innovate 
because they incorporate a larger span of role differentiation, problem solving experts, and 
supporting services to dedicate to innovative activities. On the other hand, it has been 
suggested that small firms are more likely to innovate because they are more flexible 
(Camisón-Zornoza, Lapiedra-Alcami, Segarra-Ciprés, & Boronat-Navarro, 2004; 
Damanpour, 1992; Moch & Morse, 1977).  
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Theories advocating a positive association between size and management innovation 
take a resource-based perspective (Feldman, 2004). This has led to refining the ‘size’ 
hypothesis by considering the amount of slack resources instead of size. The ‘slack’ 
resource hypothesis argues that firms with resources available for innovative activities are 
more likely to be managerially innovative (Baldridge et al., 1975). Similarly, researchers 
suggest that the change in output standards of organizations, and the resulting (and 
empirically observable) performance gap, are considered determinants of management 
innovation (Hage, 1980; March & Simon, 1958). Finally, heterogeneity has also been 
considered on the level of the organization. Researchers have further hypothesized a 
positive association between management innovation the geographical scope and diversity 
of larger organizations (Mol et al., 2009).  
Empirical results for both the size and the slack resource hypotheses have been 
inconclusive. As early as 1974, Utterbach (1974) found no evidence for any association 
between size and innovation, a result supported by later studies (Aiken, Bacharach, & 
French, 1980; Ettlie, 1983; Evan & Black, 1967; Jervis, 1975). At the same time, others 
found evidence for a positive relationship between the two variables (Blau & McKinley, 
1979; Dewar et al., 1986) while a third group provided evidence for negative relationships 
between the two variables (Hage, 1980). Motivated by inconclusive evidence, Damanpour 
(1992) conducted a series of meta-analyses on management innovation studies. He 
concluded that depending on the way size is measured a positive association can exist. He 
did not find that size affects different types of innovation, but rather identified different 
effects for different phases: size is more important during the implementation than during 
the initiation of an innovation. His results are confirmed by Camisón-Zornoza et al. (2004) 
even when applying advanced methods that allow distinguishing the size difference that 
result from different definitions of size.  
Structural Factors 
Structural factors of organizations have long been examined in theories of 
management innovation. Central to these arguments is the idea that structure needs to be 
designed to allow the unobstructed flow of knowledge and to encourage employees to 
freely communicate and participate in activities that promote management innovation 
(Thompson, 1967). Taxonomies commonly identify the following dimensions of 
organizational structure: specialization, administrative intensity, formalization, 
centralization, and vertical differentiation (Blackburn, 1982; Pugh, Hickson, & Hinings, 
1969). I have discussed the first two in the context of HR related factors as they primarily 
concern decision-makers and employees in organizations.  
Early research argued that formalization discourages managerial innovation because 
it prescribes expected behaviour and requires administrators to enforce rules by providing 
incentives for compliance while at the same time penalizing non-compliance (Hage, Aiken, 
& Marrett, 1971; Thompson, 1967). Subsequent research questioned this logic and instead 
argued that formalization may also enable employees to participate in certain activities by 
providing for sufficient certainty and defining specific rights (Adler & Borys, 1996; 
Aghion & Tirole, 1997; Vlaar, van Den Bosch, & Volberda, 2006). Empirical evidence for 
the role of formalization in management innovation remains inconclusive, and results from 
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a meta-analysis have not been able to identify a significant effect of formalization on 
management innovation (Damanpour, 1991).  
Similarly, it has been argued that a strong centralization of authority hinders 
innovation (Dewar et al., 1986; Thompson, 1967). In contrast, decentralized structures 
distribute responsibilities throughout the organization, thereby broadening the range of 
employees included in the decision making process (Becker, 1970; Normann, 1971). Zmud 
(1982), in his study on modern software practices, finds that centralization is positively 
related only for the initiation of management innovation. His results however are 
questioned by Damanpour’s meta-analysis (1991) which clearly shows that centralization 
negatively influences innovation across different types of organizations, types of 
innovation, and stages of adoption.  
Finally, researchers have considered the degree of vertical differentiation of an 
organization as an important determinant of management innovation (Blau et al., 1979; 
Hull & Hage, 1982). It has been argued that the more vertically differentiated a firm is, i.e. 
the larger number of hierarchical levels there are within an organization, the more difficult 
it is for crucial information to be communicated to the relevant change agents. However 
other scholars have theorized that vertical differentiation reflects the complexity of an 
organization supporting innovation. Empirical results support this latter view and indicate 
a positive association of vertical differentiation on management innovation (Damanpour, 
1991).  
Strategic and Organizational Boundary Factors 
Aside from structural factors, scholars have examined the role of a firm’s strategic 
orientation as a determinant of management innovation (Child, 1972; Ettlie & Bridges, 
1982). Once innovation as a strategic objective has been realized, it materializes in the 
form of innovation policies and thereby affects organizational innovativeness (Ettlie, 
1983). The realization of innovation as a strategic object is influenced by how effectively 
organizations communicate and exchange information with their environment (Tushman, 
1977). Particularly important in this respect are cognitive aspects such as awareness and 
perception of key decision-makers (Ferreira, 2010). Consequently, some have argued that 
the cognitive element between environmental dynamics and strategic decisions is decisive 
for management innovation (Becker, 1970). Researchers consider external sources of 
information available to managers or the managers’ use of local sources of information 
(Kaluzny, 1974; Kaplan, 1967; Mytinger, 1968); others have instead examined the roles of 
environmental scanning and other extra-organizational professional activities of top 
management teams as triggers for management innovations (Jervis, 1975; Miller & 
Friesen, 1982; Vaccaro et al., 2009).  
Environmental Determinants of Management Innovation 
Finally, a third group of factors associated with management innovation pertains to 
environmental conditions under which organizations operate. During the 1960s, scholars 
predominantly focused on environmental heterogeneity (Baldridge, 1971; Evan, 1965; 
Terreberry, 1968). Baldrige and Burnham (1975) for instance consider population density, 
urbanization and government expenses, and conclude that environmental heterogeneity is 
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“…likely to cause problems for organizations that promote the adoption of innovations.” 
(Baldrige and Burnham, 1975: 165). Mintzberg (1979) argues that organizations only 
adopt new organizational forms as a response to conflicting contextual forces. 
Consequently, environmental conditions were conceptualized along the two dimensions 
proposed earlier by Duncan (1972): simple vs. complex and stable vs. dynamic 
environmental conditions (Doty, Glick, & Huber, 1993; Duncan, 1972). In subsequent 
research, studies have predominantly considered an overall category representing 
environmental uncertainty (Damanpour, 1996; Ettlie, Bridges, & O'Keefe, 1984).  
Final Remarks on Outcome Theories of Management Innovation 
Outcome theories have considered a wide range of determinants to explain the 
conditions that enable organizations to managerially innovate. Their main contribution lies 
in compiling a range of individual, organizational and environmental determinants. 
Further, they contribute by specifying the underlying theoretical mechanisms. With few 
exceptions however, empirical evidence for the significance as well as the direction of 
their effect on management innovation have been widely inconclusive. The following 
Table 2.1 summarizes the findings of this section and provides an overview of the various 
determinants proposed in previous outcome research. 
Table 2.1: Factors in Outcome Theories of Management Innovation 
Characteristics of individuals 
 
• Level of education 
• Gender 
• Social status 
• Attitudes, values 
Insignificant 
Organizational factors  
  
 Human Resource Factors 
• Resistance to change 
• Leadership style 
• Specialization 
• Knowledge diversity  
• Administrative intensity 
Inconclusive 
 Demographical Factors 
• Size 
• Slack resources 
• Geographical heterogeneity 
• Cultural diversity 
Inconclusive 
 Structural Factors 
• Formalization  
• Centralization  
• Vertical differentiation 
Significant, direction 
unclear 
 Strategic and Boundary Factors 
• Strategic orientation 
• External communication 
• Environmental scanning 
• Extra-organizational activities 
Significant, direction 
unclear 
Environmental factors 
 • Environmental heterogeneity 
• Environmental change 
• Conflicting contextual forces 
• Environmental uncertainty 
 
Significant 
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2.2.2. Process Theories of Management Innovation 
In contrast to outcome studies, theories advocating a processual understanding of 
management innovation represent a much smaller body of literature. Instead of 
understanding management innovation as a linear sequence of stages, theories in this field 
conceptualize management innovation “… as a complex process with multiple, cumulative 
and conjunctural progressions of convergent, parallel and divergent activities” 
(Gopalakrishnan et al. 1997: 16; see also Kline, 1985; Rogers, 1978, 1983). Process 
theories of management innovation can broadly be distinguished between those focusing 
on the generation of management innovations and those focusing on the adoption of 
management innovations (Gopalakrishnan et al., 1994). Within each group, research 
examines the various actors and activities involved in facilitating the management 
innovation process.  
Theories of the generation of management innovation perceive innovation primarily 
as a problem-solving and decision-making process (Pinchot, 1985; Rothwell & Roberston, 
1973; Utterback, 1971). Scholars in this field examine how new ideas are generated. They 
focus on innovations that are new to industry as well as only new to an individual firm 
(Myers & Marquis, 1969; Utterback, 1971) and indicate how external change agents and 
linkages to other organizations decisively contribute to the generation of ideas (Birkinshaw 
et al., 2008). Innovations per se contain a high degree of uncertainty regarding their 
outcome. Generation theories examine activities that reduce ambiguities related to 
innovation (Tornatzky, Fergus, Avellar, Fairweather, & Fleischer, 1980). Stages such as 
idea generation, problem solving, design, production and commercialization are commonly 
considered (Cooper & Kleinschmidt, 1990; Rothwell et al., 1973). In addition, generation 
models show how activities between firms, such as agenda setting and idea linking, are 
important during the motivation and invention phase respectively (Birkinshaw et al., 
2008). Generation models regularly take into account distinctive attributes of innovations 
and their specificity to individual organizations (Gopalakrishnan et al., 1994).  
Theories focusing on the adoption stage examine how management innovations are 
implemented and affect the internal functioning of an organization (Hamel, 2006). 
Innovations are usually considered to be new to the firm but not necessarily new outside 
the firm. Adoption studies thereby represent an intermediate stage linking generation 
process models with diffusion models (Chatterjee & Eliashberg, 1990; Coleman, Katz, & 
Menzel, 1957; Teece, 1980). Adoption models primarily ask under what circumstances 
innovations can be integrated into an organization, and concur that complete assimilation 
is reached once innovations can no longer be identified as being different from other 
organizational practices (Tornatzky et al., 1980). The interaction between organizations 
plays a role in testing ideas and providing a theoretical framework for new management 
ideas from results of ‘in vivo’, i.e. practical trial and error, and ‘in vitro’, i.e. conceptual 
experiments (Birkinshaw et al., 2008).  
Process theories of management innovation emphasize the behaviour and activities of 
formal and informal, as well as internal and external, change agents (Ettlie, 1980; Pelz, 
1985; Poole, 1981; Saren, 1984). The in-depth focus serves to describe and explain in 
detail how various events, sequences, activities and stages in the innovation process are 
interrelated (Gopalakrishnan et al., 1994). In addition, by depicting management 
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innovation as a complex process, they show how these determinants interact to constitute 
new management instruments. Furthermore, process theories of management innovation 
provide substantial evidence for the role of inter-firm relations in management innovation. 
While outcome theories consider strategic boundary factors such as external 
communication or extra-organizational activities as alternative explanations, process 
theories in fact shift the focus of analysis to the inter-firm level. Most notably, the seminal 
contribution by Birkinshaw et al. (2008) explicitly conceptualizes management innovation 
as the result of the interaction between organizations.  
Despite the significant contributions of process theories, their degree of detail comes 
at an expense. Scholars disagree about the specific pattern of the innovation process 
(Schroeder et al., 1989); their models contain an unsystematic range of stages and 
activities. This makes it difficult to substantiate theoretical propositions with empirical 
studies using large datasets. Consequently, process theories usually examine only a very 
limited number of innovations in the form of single or comparative case studies. 
Furthermore, by emphasizing the developments within inter-firm relations process theories 
commonly lose sight of the role of organizational and environmental determinants 
(Anderson et al., 1990; Cooper, 1983; Zaltman et al., 1973) so that insights from outcome 
theories remain rather neglected.  
2.2.3. Contingency Theories of Management Innovation  
A third group of theoretical contributions to management innovation pertains to 
systematic, multi-dimensional theories. To some extent this group of theories constitutes a 
bridge between overly simplistic outcome theories and overly complex process theories 
(Gopalakrishnan et al., 1994)3. Confronted with difficulties of developing an integrative 
theory of management innovation, scholars turned to Penning’s (1975) structural 
contingency theory as a framework to explain differences in organizations and their 
deliberate changes in structure and strategy in response to environmental shocks (Child, 
1972; Pennings, 1975). In the centre of Penning’s (1975) theory lies the argument that, for 
firms to achieve superior performance, managers need to align organizational structure and 
practices to environmental changes. The most relevant contingency frameworks for 
management innovation are Evan’s (1966) dual core model, and Burns and Stalker’s 
(1961) distinction between organic and mechanistic organizational structures.  
Building on Evan’s (1966) dual core model, Daft (1978) argues that innovative ideas 
originate from different organizational cores and move in different directions through the 
organization. In particular, he hypothesizes that technical innovation emerges from an 
organization’s technical core located in the lower levels of an organization’s hierarchy. 
From there, technical innovation moves upwards towards a firm’s administrative core 
located in the upper echelons. Technical innovation therefore is best conceptualized as a 
bottom-up process. In contrast, management innovation emerges from the administrative 
                                                 
3
  As will be shown during the review of models and methods in management innovation research, contingency 
frameworks from a technical point of view belong to those approaches that implement management 
innovation as an outcome. From a theoretical stand however I consider them intermediate approaches between 
outcome and process theories as they acknowledge a considerable degree of complexity underlying the 
management innovation phenomenon.  
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core and from there ‘trickle down’ to lower hierarchical levels. It should thus be 
understood as a top-down process. These two organizational cores may only be loosely 
coupled, i.e. ties between the administrative and the technical core are weak and each locus 
of innovation retains a separate identity. In other cases, both cores might overlap, for 
instance in smaller, knowledge intensive organizations where administrative leaders are 
installed for their scientific expertise. Support for Daft’s (1978) dual core model of 
innovation exists in the form of illustrative evidence provided, for instance, by Sapolsky 
(1967) who observes that proposals for administrative changes usually originate from the 
executives in the central offices.  
The organizational contingency theory of Burns and Stalker (1961) stipulates that 
there are various combinations of structural elements. Distinguishing between organic and 
mechanistic configurations, they argue that organizations can be aligned along a 
continuum between these ideal types. These can be used to characterize organizational 
structures in terms of their ability to perform tasks such as maintaining constant quality 
levels during production, guaranteeing procedural consistency, responding to 
environmental shifts or cultivating the flow of innovative ideas within its boundaries 
(Burns et al., 1961; Damanpour et al., 1989).  
To distinguish ideal types, Burns and Stalker (1961) focus on a number of factors 
describing the structure of organizations. Mechanistic structures are characterized by 
specialization and task differentiation, high degrees of centralization, vertical 
differentiation, and formalization. They are hypothesized to be more appropriate in stable 
conditions. More attention is given to internal rather than external knowledge (Burns et al., 
1961). In contrast, organic structures feature shared responsibility, commitment and 
objectives, flat hierarchical structures and low degrees of vertical differentiation. They 
permit lateral, instead of vertical, communication flows and pay attention to external 
sources of knowledge, skills and experiences. Organic structures are more appropriate in 
unstable environmental conditions.  
In the context of management innovation it has been argued that mechanistic 
structures are less flexible and that they discourage both the development of new ideas by 
formalization and the underlying bureaucratic structures that penalize divergence from 
rules (Damanpour, 1996). In addition, centralization concentrates decision-making 
authority, and vertical differentiation hinders the flow of knowledge and ideas within the 
organization. In sum, mechanistic structures discourage innovation and are hence less 
likely to develop and introduce new managerial instruments (Gopalakrishnan et al., 1994). 
Conversely, organic configurations are characterized by antipodal structures and, 
consequently, are hypothesized to foster innovative activities within organizations.  
Structural contingency theory offers theoretical explanations that help to implement 
and substantiate propositions of management innovation theories. Its core theoretical 
paradigm argues for an alignment, ‘fit’ or consonance among various conditions as an 
explanatory approach to organizational phenomena (Doty et al., 1994). This coincides with 
the insights gained by process studies illustrating that variables in fact are not independent, 
but instead jointly exert their effect. Baldridge and Burnham (1975), for instance, assume 
that “… the various indicators of size, complexity, and environmental stability should 
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cluster together in meaningful groups.” (Baldridge and Burnham, 1975: 173) and note that 
it is important to examine their joint impact. This concept describing the inter-relatedness 
of variables is known as conjunctural causation and refers to the association of multiple 
variables with a given outcome (Donaldson, 2001; Ragin & Fiss, 2008). In addition, 
contingency theories suggest that there are different combinations of conditions, 
potentially explaining rivalling hypotheses and inconclusive results from empirical studies. 
This notion of equifinality refers to the idea that “… a system can reach the same final 
state from different initial conditions and by a variety of different paths.” (Katz & Kahn, 
1978: 30). In fact, a number of management innovation studies point to the possibility that 
there are different, equally effective, combinations of organizational determinants of 
management innovation (Birkinshaw & Mol, 2006; Damanpour, 1996; Hamel, 1998). 
Finally, contingency theories have been criticized for being overly vague about the 
direction and type of relationships among variables. Some – as will be shown in the 
following section – methodologically implement contingencies as interaction variables and 
thereby implicitly assume a unidirectional, linear and additive relationship between 
variables. While the criticisms of vagueness certainly are justified, contingency theories 
have ultimately triggered a discussion on the nature and the direction of relationships 
between variables (Damanpour, 1992; Lieberson, 1987; Longenecker et al., 1978). In 
particular, the idea of asymmetry among variables came to be discussed (Schoonhoven, 
1981), referring to “… the situation where the change in the causally produced 
phenomenon is not of the same order of magnitude or direction when the cause is added as 
when it is taken away.” (Lieberson, 1987: 174).  
Empirical support for multi-dimensional contingency theories is rare. Burns and 
Stalker’s (1961) model has been used on various occasions in innovation studies 
(Damanpour, 1996; Gopalakrishnan et al., 1994). Normann (1971), for instance, finds 
partial support for the model yet concludes that formalization and formal control 
instruments guiding the innovation process are not necessarily detrimental to innovation. 
This supports the ambiguous effect of formalization on organizational mechanisms. Zmud 
(1982), focusing on centralization and formalization, finds in his study of 49 software 
development groups that the interaction of the two determinants with innovation is partly 
supported. However, he too is required to qualify his conclusions, as comprehensively 
implementing the theoretical propositions put forward by contingency theories poses 
severe methodological challenges.  
2.2.4. Final Remarks 
This subsection has dealt with the various theoretical approaches to management 
innovation. Outcome theories contribute by providing a range of determinants and 
specifying causal mechanisms. Empirical support however has been inconclusive and it 
has been argued that outcome theories are too simplistic. In contrast, by taking an in-depth 
perspective process models describe how different interrelated factors determine 
management innovation. Furthermore, they emphasize inter-firm relations, instead of 
individual focal firms, as the appropriate locus of innovation. Process theories, however, 
are too complex and unsystematic to substantiate theoretical propositions. Finally, 
contingency theories constitute an alternative between simplistic outcome models and 
detailed process models by explicating complex theoretical propositions. These 
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specifically concern equifinality, conjunctural causation, and asymmetric relationships. At 
the same time, the increase in systematic complexity poses new challenges for 
substantiating theoretical propositions. Consequently, modelling and methodological 
issues are an important building block in the study of management innovation. These are 
subject of the following section.  
2.3. Modelling and Methods in Management Innovation Research  
During the last decades researchers have applied a variety of methodological 
approaches to substantiate management innovation theories. A particularly important 
aspect to testing and developing theories pertains to careful modelling by clarifying and 
refining underlying logics (Blablock, 1989a, 1989b). Inaccurate models that improperly 
translate the logical arguments neither validly represent, nor adequately test theory (Doty 
et al., 1994; Venkatraman, 1989).  
In this section, I describe modelling approaches used in management innovation 
research. Process theories have predominantly used conceptual models, circumstantial 
evidence and in-depth case studies. Outcome studies model management innovation as a 
series of competing explanations and use regression analysis to test hypotheses. The more 
complex contingency theories have been validated using different approaches to modelling 
ideal-types, forms of fit and equifinality (Doty & Glick, 1989). A particular focus of this 
section lies in the extent to which models are capable of reflecting the theoretical 
complexities among variables such as equifinality, conjunctural causation and asymmetric 
associations. My discussion of other methodological aspects pertaining to data format, 
sources or collection, is a secondary focus. 
2.3.1. Process Models 
Research focusing on the processes that lead to management innovation 
predominantly develops conceptual models. The aim of such models lies in identifying 
classes of events and sequences central to the innovation process. They strongly emphasize 
the role of agents in the development of new management instruments.  
One of the first case studies on the management innovation process was provided by 
Golightly (1968), in a study of innovation in airline management. Beginning with the 
introduction of new organizational forms, Golightly (1968) emphasizes the important, 
interconnecting function of marketing messages, the conversion of planning processes to 
operational management tools, and the role of chief executives. He observes in particular 
that there is not one unique, solely effective organizational format, and that the element of 
planning suffers from the over- or under-involvement of chief executives. Lillrank (1995), 
in a comparative case study, examines the process of transferring two management 
innovations, namely the Quality Control Cycle (QCC) and Time-Based Competition 
(TBC), from Japan to the United States. His model builds on the abstraction of 
management ideas which are transferred and re-applied within different cultural, social and 
historical environments. Despite the fact that Lillrank’s (1995) model takes place on a 
macro-level it points to the role of interaction between change agents and inter-firm ties 
deemed crucial for the development of innovative management instruments. In contrast, 
Carrero et al. (2000) contribute to management innovation literature with an in-depth, 
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comparative case study of four companies. Based on interview transcripts, they apply a 
grounded theory method (Glaser & Strauss, 1967) and explain management innovation 
alongside various stages of three parallel processes of adoption, experience and corporate 
historical development (Carrero, Peiro, & Salanova, 2000). In the centre of their model lie 
the activities, perceptions and reflections of actors in their cooperation with other private 
and public organizations.  
Finally, in a seminal contribution, Birkinshaw et al. (2008) develop a conceptual 
model supported by circumstantial evidence. Management innovation is modelled along 
interrelated phases, from motivation, invention and implementation, to theorization and 
labelling. These phases are linked in three ways. On the one hand, internal change agents 
engage in activities such as problem search, trial and error and reflection. On the other 
hand, external change agents contribute through activities such as contextualization, the 
refining of ideas and theorization. Most importantly, however, the activities between both 
are linked by agenda setting, idea linking and idea testing (Birkinshaw et al., 2008). The 
model combines the insights developed by previous process model and portrays 
management innovation as a phenomenon that results from activities that take place within 
inter-firm relations (Birkinshaw et al., 2008; Lounsbury & Crumley, 2007; Powell et al., 
1996).  
Characteristic in process models is the inclusion of multiple stages, events, activities 
and actors. The degree of detail within process models allows examination of the entire 
management innovation process and makes two contributions. First, it shows how different 
factors are interrelated in developing new managerial instruments. Second, in contrast to 
outcome theories that take individual firms as the unit of analysis, process models suggest 
that the development and implementation of new management instruments takes place 
within inter-firm relations. Ultimately, however, process models remain too complex to 
enable systematic testing of their theoretical implications (double arrows are common 
elements in conceptual models). Existing empirical work consists mainly of conceptual 
models, single or multiple case-studies (Birnbaum, 2000; Crompton, 1983; Lillrank, 1995) 
using qualitative data from interviews, questionnaires or archival data. The analysis of only 
a few cases limits the extrapolation of results. Process models implicitly acknowledge the 
existence of cases that function differently yet result in similar innovation. Also, the 
complexity of conceptual elements and the high degree of unspecified associations among 
them suggests that both conjunctural causation and asymmetry are taken into account.  
2.3.2. Outcome Models and Linear Regressions  
Most empirical research on management innovation has been conducted as outcome 
studies. During the past four decades a large variety of studies have measured the effect of 
individual, structural, organizational and environmental factors (Aiken et al., 1980; 
Damanpour, 1987; Kimberly et al., 1981; Nicholson et al., 1990; Ravichandran, 2000; 
Teece, 1980). In contrast to process models, outcome studies predominantly analyze large 
datasets using regression models to measure the net effect of a series of independent 
variables on the outcome.  
Two examples of studies using regression models to probe into the effects of 
variables on management innovation can be found in Kimberley and Evanisko (1981), and 
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Ravichandran (2000). Kimberley and Evanisko (1981) comprehensively study individual, 
organizational and environmental determinants of the adoption of technological and 
administrative innovations in hospitals. To identify innovation they use an independent 
expert panel to survey hospital administrators and chiefs of medicine. Running regression 
analysis, they find that variables better predict technical innovation than administrative 
innovation, and that size is the best predictor for both types of innovation. However, rather 
than identifying concrete determinants of innovation, they discuss conceptual differences 
in innovation types that may explain the inconclusive insights. A similar methodological 
approach has been used by Ravichandran (2000) in his study on the swiftness and intensity 
of adoption of administrative innovations using the example of Total Quality Management 
(TQM). On a sample of 123 information system departments in Fortune 1000 firms, he 
tests two environmental factors, four organizational and two task-related factors. The 
results indicate that the quality orientation of the host organization, management support 
for quality, functional differentiation, and structural complexity explain the intensity of 
TQM adoption (Ravichandran, 2000).  
Outcome models commonly rely on surveys to collect data. While the use of larger 
datasets seems attractive, especially regarding the extrapolation of results, there are 
problematic. Surveys commonly target senior managers of companies, such as CEOs, to 
fill out questionnaires. Especially in larger companies, these respondents are often not in 
possession of the necessary first-hand knowledge about their firm’s managerial innovation 
or information on the various determinants. Moreover, the use of only one respondent 
carries risks. Single response biases taint results from innovation studies when one and the 
same individual provides information on both the dependent as well as the independent 
variables. In addition, innovation, as a phenomenon, carries certain social desirability 
biases. Innovation in commonly perceived as positive, and therefore desirable. When 
asking CEOs whether their organizations managerially innovate, one will most likely get 
overly positive answers. Finally, the transient nature of management innovation questions 
‘closed questionnaire’ approaches with standardized items, as contextual specificities are 
hard to detect. 
Furthermore, the use of regression analysis seems questionable in its suitability for 
appropriately reflecting management innovation theories. Technically, by holding all 
variables constant, they are in fact being treated as competing explanations of management 
innovation. Regression analysis thus does not consider conjunctural causations among 
variables, and stands in opposition to the theoretical understanding of management 
innovation as being context-specific and differently achievable by different kinds of 
organizations. Also, the method does not allow the testing of alternative, equifinal 
explanations. By nature, variance based methods such as regressions imply linearity and 
additivity among variables; two notions that, similar to the misspecification of equifinality, 
stand in contrast to the theoretical arguments that lie in the core of more complex, 
multidimensional theories (Meyer, Tsui, & Hinings, 1993).  
2.3.3. Multi-dimensional, Contingency Models 
As a consequence of using contingency theory to conceptualize the complexities in 
management innovation, researchers applied more sophisticated techniques to substantiate 
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theoretical propositions. Methodologically, a contingency is “… any variable that 
moderates the effect of an organizational characteristic on organizational performance.” 
(Donaldson 2001: 7). While this seems straightforward, accurately implementing 
contingency models is in fact rather difficult (Longenecker et al., 1978; Luthans & 
Stewart, 1978; Schoonhoven, 1981). Three methodological challenges concern specifying 
the notion of ‘fit’, interpreting ideal types and conceptualizing equifinality (Doty et al., 
1993). 
Methodologically implementing ‘fit’ associations among variables lies at the core of 
any contingency model (Drazin & van de Ven, 1985). Although Donaldson refers to 
contingencies as moderating variables, there are alternative types of relationships between 
variables. As such, relationships among variables may as well be implemented as 
curvilinear, monotone increasing or decreasing, non-monotonic or asymmetric 
relationships (Lieberson, 1987; Moon et al., 2004). In fact most empirical studies model 
contingencies as selection, or interaction, variables (Doty et al., 1993). While these 
certainly approximate theoretical propositions, they do not fully scrutinize the mode of ‘fit’ 
among variables. The interaction approach ultimately tests the effect of a third (interaction) 
variable on management innovation. It thereby implies linearity of variables (Baker & 
Cullen, 1993). Often there is no theoretical support for the implicit assumption of linearity 
(Donaldson, 2001). For example, overwhelming evidence from research on the effect of 
organizational size on innovation suggests that the two variables, size and innovation, have 
a curvilinear relationship (Camisón-Zornoza et al., 2004; Damanpour, 1992). To further 
complicate matters, contingencies should be modelled as multi-dimensional constructs, 
composed of a variety of variables. However, techniques for testing the fit of 
multidimensional contingency are still being developed (see for instance Parker & 
Witteloostuijn, 2010).  
A second methodological challenge pertains to the interpretation of ideal types. In 
contingency theories, such as Burns’ and Stalker’s (1961) distinction between organic and 
mechanistic structures, ideal types are hypothetical constellations of specific structural 
features. The central argument of contingency theory is that the deviation from such ideal 
types explains whether firms are more or less efficient (Doty et al., 1993; Mahoney & 
Goertz, 2006). To identify ideal types three different approaches are proposed in research 
literature. First, cluster analysis is regularly applied to identify commonalities among 
cases. Second, factor analysis is used to identify common factor loadings in the hope of 
finding meaningful underlying dimensions that together approximate a theoretical ideal 
type (Baldridge et al., 1975; Teece, 1980; Winch, 1947). Finally, some scholar suggest that 
the most accurate approach for determining ideal types would be to ask experts to define - 
based on substantive knowledge - thresholds on measurement instruments that reflect the 
theoretical propositions put forward by contingency models (Delery & Doty, 1996). Once 
ideal types have been identified, most researchers treat them as categories, and assigns 
empirically observed cases to certain groups (Schoonhoven, 1981). 
All methodological approaches, however, come at a certain expense. Cluster analysis, 
for instance, bears the risk of identifying similarities based on theoretically irrelevant 
factors (Fiss, 2007). Factor analysis similarly fails to reflect theoretical propositions. 
Instead, it treats factors as continuous variables with an ‘infinite’ number of categories, 
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among which similarities can always be identified (Hagenaars & Halman, 1989). The pre-
definition of categories, according to substantive theoretical models, is highly dependent 
upon the researcher’s judgment, and thus might lead to instability and uncertainty in 
interpreting results (Fiss, 2007). More questionable, however, is the use of ideal types as 
categories. Assigning observed cases to one of the categories in fact treats all cases within 
one category equally (Schoonhoven, 1981). However, from a contingency perspective the 
deviation from these ideal types is more crucial (Doty et al., 1989), so that other 
techniques, such as deviation analysis, need to be applied. 
Finally, the third challenge pertains to modelling equifinality. Equifinality postulates 
that there is a variety of combinations of conditions (configurations) that lead to 
management innovation (Donaldson, 2001; Fiss, 2007), each being equally effective. 
There is disagreement among contingency theorists whether there is only a limited number 
of configurations, as reflected by Miles and Snow’s (1978) four strategic types4, or an 
unlimited number of configurations, as suggested for instance by Burns and Stalker’s 
(1961) poles of mechanistic vs. organic structures (Donaldson, 2001). Either way, 
equifinality is a core element of contingency models and needs to be acknowledged by 
analytical techniques to substantiate contingency theories.  
In summary, complex, multidimensional modelling aims at more accurately reflecting 
the statements developed by theories. The theoretical adequacy of complex modelling is 
measured against its ability to incorporate and substantiate the notions of ‘fit’, ‘ideal 
types’, and ‘equifinality’ (Doty et al., 1993). In the following section, I describe three 
modelling approaches: selection, interaction and system contingency. These partly reflect 
different understandings of ‘fit’ and contain explicit or implicit conceptualizations of ideal 
types and equifinality.  
Selection Contingency 
The selection contingency approach has been used quite frequently in modelling 
management innovation theories. Analytically, it is based on a comparison of correlations 
or regression coefficients of two categorical groups. As such, scholars have used 
congruence models to test for the contingent effect of types of innovation, contrasting 
structures that improve technical vs. managerial innovation (Kimberly et al., 1981; Zmud, 
1982); the radicalness of innovation (Dewar et al., 1986), the strategic orientation of firms 
(Miller et al., 1982) or stages of management innovation (Gopalakrishnan et al., 1994; 
Pierce & Delbecq, 1977). However, its suitability for substantiating management 
innovation theories is questionable (Doty et al., 1989). Without specifying the mode of 
interaction, the selection approach does not properly reflect the influence of various 
contingent factors. Furthermore, it does not take into account the concept of ideal types, 
and thus prohibits the measurment of deviation of empirically observed strategy-size-
environment combinations (Pennings, 1975). Finally, by comparing observations in two 
categories, equifinality is only implicitly and at best partially incorporated in the selection 
contingency model. 
                                                 
4
  Miles and Snow (1978) propose to distinguish four strategic types of organizations: prospector, defender, 
analyzer, and a residual type, the reactor.  
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Interaction Contingency 
The interaction contingency approach represents an alternative to overcome the 
limitations of modelling conjunctural causations among variables. It features many 
traditional theories defining ‘fit’ as the statistical interaction (Schoonhoven, 1981; 
Venkatraman, 1989). In the late 1980s, scholars began using interaction variables to test 
the combined effect of two variables on management innovation, and until now it 
represents the most prominent contingency approach (Miller, 1988). For instance, Dewar 
and Dutton (1986) hypothesize that the conjunction between managerial attitudes towards 
change and centralization, positively affects the adoption of managerial innovations. Scott 
and Bruce (1994), studying individual innovative behaviour in working teams, argue that 
organizational climate (supportive vs. unsupportive) and task type (routine vs. non-routine) 
moderate team-level factors, such as quality of leader-member exchange or supervisor 
expectation. Although they propose the use of a single hierarchical moderated regression 
analysis, they note that by including six multiplicative interactions, substantial degrees of 
freedom are being lost, leaving only little room to test for such moderating effects. Instead, 
they use a series of six hierarchical regression analyses. To further examine interaction 
effects, they divide their data into various subgroups. This essentially represents a refined 
selection approach. More recently, Mol and Hamel (2009) have hypothesized increased 
effects of ‘fit’ interactions among internal sources, market-based sources, and professional 
sources, and analyzed their effect on management innovation and on firm performance. 
They hypothesize in total nine interaction effects which they test in separate hierarchical 
order logit regressions, finding support for most interactions. Although the discussion 
argues that some of the interactions have been theorized (by other scholars) to be 
moderated by additional factors (see Mol and Hamel 2009: 1227), the available data and 
methods do not allow for testing these associations. In post-hoc, sector-by-sector analysis 
the researchers provide additional insights into the contingency of industry type. 
As the examples show, the interaction contingency approach is frequently used to 
identify conjunctural effects among variables. It certainly represents a more sophisticated 
technique for approximating the assumption of ‘fit’ as hypothesized in contingency 
theories (Donaldson, 2001; Drazin et al., 1985). However, despite its seeming 
attractiveness, the interaction approach offers few advantages to researchers intending to 
substantiate more complex theories. Most importantly, there is “… no reason why 
configurations could not easily consist of multiple interaction effects.” (Fiss, 2007: 1182). 
There is also no reason why such associations should be solely linear. Furthermore, 
systematically analyzing interactions between more than two systems is difficult to 
implement and to interpret. Statistical models lose degrees of freedom due to the 
exponential increase of interaction terms, and hence also lose their explanatory power. 
This essentially requires researchers to abandon deductive, hypotheses-driven approaches 
and pursue less systematic, inductive procedures.  
System Contingencies 
The system contingency approach is the most comprehensive model, in that it aims to 
accommodate all theoretical complexities put forward by scholars (Delery et al., 1996; 
Drazin et al., 1985; Schoonhoven, 1981). It is based on the assumptions that there are 
various, equally effective organizational systems (equifinality), that each of these systems 
Previous Research on Management Innovation  
27 
is a multi-dimensional construct, and that the congruence among these systems explains 
the efficiency of systems. Further, some contingency scholars point out that relationships 
among variables do not necessarily need to be linear (Parker et al., 2010; Schoonhoven, 
1981).  
Unsurprisingly, implementing such theoretical complexity poses methodological 
challenges. Determining ideal types requires comprehensive theoretical understanding and, 
ideally, a multi-rater approach specifying values of items for each variable. Further, 
sophisticated techniques need to be applied to assess multi-dimensional fit contingencies 
(Parker et al., 2010), and non-linear associations among multi-dimensional constructs need 
to be implemented. Finally, once methods have been developed that accommodate 
multiple fits of various ideal types, the deviation from these ideal types needs to be 
analyzed to fully reflect system contingency hypotheses; i.e. the ultimate ‘fit’ is high when 
an empirically observed case shows low deviation from such ideal types (Cattell, 1949; 
Millar, 1978). Deviation analysis is a method specific to the system contingency approach. 
Here, each configuration has its own ideal type (e.g. Doty et al., 1993; Delery & Doty, 
1996), and deviation scores for different variables can be used to measure how much the 
configuration deviates from the ideal type. Cases with low deviation scores, or high ‘fit’ 
with ideal types, represent more efficient configuration. These methods are useful, but 
often they are too dependent on how the ideal type is being defined and operationalized. 
Because ideal types are usually sample-dependent (for example, one standard deviation 
plus or minus the mean), they are sensitive to small estimation errors (Fiss, 2007). 
2.3.4. Final Remarks 
This subsection has dealt with the different methodological approaches to 
substantiating management innovation theories. Modelling conceptual notions inherent in 
complex theories such as equifinality, conjunctural causation, and asymmetric associations 
are of particular concern. Models reflecting process theories are regularly overly complex, 
unsystematic and feature a large number of interrelated factors. Because it is difficult to 
empirically substantiate such models, single or comparative case study methods are the 
dominant analytical modes. By generating insights that are predominantly internally valid, 
these studies implicitly acknowledge equifinality. The lack of systemization also implies 
that both conjunctural causations among asymmetrically associated factors are an element 
of their dominant logic.  
The most dominant modelling in management innovation pertains to outcome 
theories. Most studies in this field apply a universalistic approach using regression analysis 
to estimate net-effects of individual variables. Samples are usually large and allow broader 
generalization of results. However, using statistical, variance-based methods, these models 
in fact treat variables as competing explanations. Consequently, they neither allow for 
equifinality nor for conjunctural causation nor for asymmetric relationships. Some research 
has argued that the inconclusive results generated by such studies are due to the 
insufficient power of these methods (Ferguson & Ketchen, 1999; Fiss, 2007; Wolfe, 1994). 
Subsequently, research has moved towards more sophisticated methodologies that more 
accurately reflect theoretical propositions (Baldridge et al., 1975; Rogers, 1978; van de 
Ven et al., 1988). Contingency models differ in their degree of complexity by reducing 
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simplifying assumptions. More complex approaches found in contingency research, such 
as the selection, interaction, or system approach, offer alternative methods to ease the 
limitations of universalistic models. Both outcome models, as well as contingency models, 
essentially aim at measuring the effect of differently related (or unrelated) variables on a 
dependent variable. The following Figure 2.1 illustrates the logics underlying universalistic 
models and selection, interaction, and system contingency models.  
Universalistic Model Selection Contingency Model
Interaction Contingency Model System Contingency Model
DV: Management 
Innovation
IV: Environment
IV: Structural Variable A
IV: Structural Variable B
IV: Environment
IV: Structural Variable A
IV: Structural Variable B
Contingency Variable X Contingency Variable Y
DV: Management 
Innovation
IV: Environment 
IV: Structural Variable A
IV: Structural Variable B
IV: .....
IV: Environment
IV: Structural Variable A
IV: Structural Variable B
Contingency Variable
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Figure 2.1: Illustration of Simple Outcome and Three Contingency Models 
The system contingency approach seems most promising, as it aims at incorporating 
equifinality and conjunctural causation, and incipiently acknowledges that relationships 
between variables do not necessarily have to be linear. Nevertheless, all three contingency 
approaches have so far largely drawn on econometric methods. Despite the fact that 
theoretical discussions in this field emphasize nonlinearity, synergistic effects, and 
equifinality, such methods by nature imply linearity, additive effects and unifinality (Fiss, 
2007). Furthermore, the more sophisticated the statistical techniques are to be used, the 
higher the requirements on the data quantity and quality.  
The following Table 2.2 provides an overview of the different methodological 
approaches proposed in literature on management innovation. It first and foremost 
examines their ability to incorporate the notions of equifinality, conjunctural causation and 
asymmetry. It also describes the dominant analytical techniques and requirements for the 
empirical material to be used. Finally, advantages and disadvantages are contrasted.  
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2.4. Conclusion 
In this chapter, I have described theoretical and methodological approaches to 
management innovation. As has been shown, management innovation theories 
conceptualize the phenomenon either as an outcome of various determinants, or as 
complex processes of stages, actors, and activities. Contingency theories, while portraying 
management innovation in principle as an outcome, represent an alternative between the 
two camps of outcome and process theories. They acknowledge the complexity of 
antecedents that generate management innovation on the one hand and, on the other hand, 
remain sufficiently systematic to allow the empirical substantiation of theoretical claims. 
Each group of research makes significant contributions to theories of management 
innovation. At the same time, by emphasizing particular theoretical elements, each also 
bears certain limitations. 
Outcome theories provide a wide range of organizational and environmental 
determinants and develop sound theoretical arguments as to how these determinants affect 
management innovation. Empirical results however have been inconclusive. One of the 
reasons – as has been argued by scholars – lies in the universalistic perspective taken by 
outcome theories and in methodologically treating individual variables as competing 
explanations. Another reason is that focus is confined to the analysis to individual firms. 
Hypotheses on the strategic orientation of firms highlight the linkages of an organization to 
other firms and point towards inter-firm relations as the relevant locus of innovation.  
This idea is substantiated by process theories of management innovation that develop 
highly complex models, portraying management innovation as a non-linear sequence of 
events, activities and actors. Case studies show how the interaction between firms leads to 
the development and implementation of new management instruments. Conceptual models 
in this field predominantly focus on inter-firm relations as the appropriate locus of 
innovation. In addition, they contribute to management innovation theory by illustrating 
how the various elements of the process are strongly interrelated. However, the explicit 
focus on the complex interaction between firms underemphasizes the role of organizational 
and environmental conditions under which inter-firm relations operate. After all, these 
contextual conditions provide the framework within which innovative activities take place. 
Last, the unsystematic and highly complex models developed by process theories prohibit 
the empirical substantiation of theoretical propositions. 
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Contingency theories offer an intriguing theoretical approach to amend some of the 
shortcomings of both (simple) outcome and (complex) process models. Particularly 
appealing are the complex theoretical propositions put forward by contingency theory. 
They assume that there is a variety of equifinal ideal types. In addition, these ideal types 
are not unicellular organisms but are comprised of multiple elements that require 
appropriate alignment, suggesting that sets of determinants may group together in 
meaningful substituting or complementary pairs. Finally, this focus has raised awareness 
for the variety in possible associations among variables – not limited to purely linear 
relations. Yet, despite the fact that contingency theories are commonly more systematic 
compared to process theories and in this respect facilitate their empirical implementation, 
the requirements for analytical techniques (for instance to measure the deviation from a 
multi-dimensional construct of ‘fit’) and quality and quantity of data (for instance when 
computing multiple interaction terms) are prohibitively high.  
Finally, the literature review indicates a mismatch between theories and methods 
employed to examine and substantiate management innovation theories. Methodological 
challenges in the study of management innovation range from data collection to data 
analysis methods. Moreover, the very specific nature of management innovation poses 
methodological difficulties. It is highly context and time specific, and its value - if at all 
objectively measurable - is not known before it is implemented (Henrekson & Sanandaji, 
2010). Second, data collection takes place as archival research, interviews with open or 
closed questions, or surveys. Surveys in particular allow the inclusion of a large number of 
observations in the analysis, yet bear the risk of tainting both the validity as well as 
reliability of responses. Third, analytical methods applied in management innovation 
research range from conceptual models, case studies and comparative case studies to 
simple and more complex quantitative methods. The choice of method for substantiating 
management innovation theories poses a multi-dimensional decision problem. The 
accuracy of models has to be balanced with the availability of analytical techniques and the 
potential extrapolation of results. Single case studies allow very precise analysis of 
management innovation yet are primarily internally valid. In contrast, larger, representative 
data allows for broader generalization of results. At the same time, incorporating 
theoretically complex propositions such as equifinality, conjunctural causation and 
asymmetric relations poses demanding requirements on data quality and quantity and is 
difficult, if not impossible, to implement technically. 
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3. Configurations of Inter-firm Relations in Management Innovation 
I contribute to research on management innovation by matching a holistic, theoretical 
approach with a likewise holistic method of analysis. Acknowledging insights gained by 
process theories and post-hoc theorization in outcome theories, I shift the focus of the 
analysis to the inter-firm relation (Birkinshaw et al., 2008). Rather than the individual firm, 
I consider the inter-firm relation the social action system in which management innovation 
takes places (van de Ven, 1976). Subsequently, I make use of the contributions of outcome 
theories and select conditions of such social action systems hypothesized to facilitate 
management innovation. I thereby specify under which relational, structural, and 
environmental conditions inter-firm relations operate while developing and implementing 
new managerial instruments. Finally, I consider contingency arguments by formulating 
additional hypotheses directed at the theoretically complex antecedents of management 
innovation. To substantiate the theoretical claims I apply a novel analytical technique. 
Qualitative Comparative Analysis (QCA) holistically examines and systematically 
compares entire configurations of conditions (Ragin, 1987). Instead of analyzing net 
effects of independent variables, it thereby maintains the integrity of each case (Fiss, 
2007). Minimization procedures based on Boolean logic are then applied to reduce the 
complexity of the data to the minimal number of configurations of facilitating conditions.  
In this chapter, I first outline the theoretical framework and develop hypotheses on 
the basis of extant literature. I then introduce QCA as a methodological approach to 
illustrate how the method allows me to test the configurational model and to contribute to 
management innovation theory. The following two subsections provide the conceptual and 
methodological components for the empirical study on management innovation in China’s 
biopharmaceutical industry.  
3.1. Theoretical Framework 
3.1.1. Shifting the Focus of the Analysis to the Inter-Firm Relation 
Outcome theories, as well as process theories, provide a range of arguments 
suggesting that the generative mechanisms leading to management innovation are located 
within the interaction between firms. Outcome theories, hypothesizing on the role of firms’ 
strategic orientation as observed in environmental scanning and external communication, 
hint at significant events taking place outside the boundaries of the firm. In addition, 
empirical evidence points towards the focal role of inter-firm relations. For instance, 
Sapolsky (1967: 505), in his study on department stores in the U.S., observes that “… the 
relationships [with controllers] in other firms are often a stimulus for change”. Further, 
post-hoc theorization regularly focuses on inter-firm relations. For example, Corwin 
(1972), interviewing participants of the Teachers Corps program, concludes that the 
amount of cooperation and the nature of the inter-organizational relationship between 
schools are important factors for innovation. Even more compelling are conceptual models 
and theoretical arguments put forward by process theories. Case studies illustrate how 
interacting firms participate in the generative mechanism by which new management ideas 
are created and put into practice (Hamel, 2006). They also show that while these 
management ideas are created in the context of inter-firm relations, they are practiced 
 34 
within individual firms. In addition, conceptual process models provide theoretical 
explanations on how the various actors and their activities work towards developing and 
implementing new management instruments (Birkinshaw et al., 2008).  
Where outcome and process theories give insights into the inter-firm relation as the 
locus of management innovation, general theories of inter-firm relations provide a more 
thorough theoretical groundwork as to why these social action systems are crucial in the 
development and implementation of innovative ideas. In addition, they show how inter-
firm relations ought to be configured to support innovative processes. General inter-firm 
theories are predominantly embedded in two theoretical perspectives: the knowledge and 
learning perspective and the resource based view of the firm.  
Lundvall (1992) concisely summarizes the knowledge and learning perspective as 
follows: knowledge is the most important resource for innovation, and learning its key 
process. Most scholars concur and advocate knowledge re-combination and development 
understanding (Kogut, 2000; Vlaar et al., 2006). The knowledge perspective 
conceptualizes organizations as entities of distinct knowledge and production domains. 
Their survival depends on the successful re-production of existing domains or the 
development of new domains (Grant, 1996, 2002; Grant & Baden-Fuller, 1995). These 
knowledge domains, however, extend beyond the legal and operational boundaries of firms 
(Brusoni, Prencipe, & Pavitt, 2001; Patel & Pavitt, 1994). Empirical research has, for 
instance, shown that services and products developed and commercialized by firms contain 
knowledge that cannot not be accounted for solely by the resources that exist within the 
firm. In support of this, Clayton et al. (2002) find that the modularization of product 
components only explains low performing firms and not high performance market players. 
They reach the conclusion that modularization is not a stable competitive strategy. The 
survival of firms ultimately depends on their engagement in ‘iterative co-design’ 
partnerships, which permit the incorporation of partners in the design specification of 
products (Gilson, Sabel, & Scott, 2009). 
In contrast, the resource perspective is primarily based on transaction cost arguments 
explaining factors that reduce transaction costs and transaction-related risks (Nooteboom, 
1999). Interactions between firms pose various relational risks. Thus, when faced with the 
question of why firms interact in the first place, scholars have pointed to an intensification 
of the firms’ need for resources (Gilson et al., 2009). Ettlie (1983), studying equipment and 
packaging suppliers in the food industry, finds that the involvement of both suppliers and 
customers is an important factor for organizational innovation. He argues that their 
involvement demonstrates high priority and commitment, ultimately reducing perceived 
risks. Literature on inter-firm relations based on the transaction cost perspective, 
interestingly, suggests that a conceptualization of transaction costs that considers learning 
processes allows the analysis of relational risks and factors that reduce such risks 
(Nooteboom, 1999; Teece, 1986; Williamson, 1993). In the context of a dynamic 
transaction costs, the notion of trust, as a cost-reducing governance form, is crucial 
(Berger, Noorderhaven, & Nooteboom, 1995; Nooteboom, 1996; Nooteboom, Berger, & 
Noorderhaven, 1997).  
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The theoretical arguments put forward by the knowledge and transaction cost 
perspective have somewhat different origins. Yet, central to their theories of inter-firm 
relations are the notions of knowledge exchange and resource dependency. These 
mechanisms facilitate the sharing of knowledge and the development of a common 
language between interacting organizations (Aiken et al., 1968; Kogut et al., 1992; 
Nickerson et al., 2004; Nooteboom, 2004; Pierce et al., 1977; Sheppard & Sherman, 1998; 
van de Ven, 1976). In innovation studies, the role of inter-firm relations has predominantly 
been applied to research on technical innovation (Chompalov, Genuth, & Shrum, 2002; 
Pisano, 1990). Based on similar arguments, they suggest that inter-firm relations allow 
organizations to reduce fixed costs, increase flexibility, and enable joint-learning 
mechanisms. Others have provided evidence that a portfolio strategy, i.e. one that focuses 
on managing various inter-firm relations, is an exceptionally effective strategy to enhance 
innovation (Faems, Looy, & Debackere, 2005).  
Inter-firm relations therefore constitute a unique system for the development and 
implementation of new managerial instruments. The explicit focus on inter-firm relations 
advocates a modified understanding of management innovation. Management innovation is 
conceptualized as a heuristic search process, in which interacting firms find solutions to 
complex problems by freely and extensively exchanging information (Nickerson 2004). It 
is thus the outcome of a process of interrelated conditions that facilitate the sharing of 
knowledge and the development of a shared language between firms (Grandori et al., 
2008; Thompson, 1965). While the development and implementation of new management 
practices, processes, or structures takes place in the realm of inter-firm relations, the newly 
developed managerial instruments may be implemented in and applied by individual firms.  
3.1.2. Facilitating Conditions of Management Innovation 
Although inter-firm relations represent an intriguing organizational system for the 
exchange of knowledge, it is assumed that management innovation requires, on the one 
hand, the presence of diverse sets of knowledge and, on the other hand, the conditions for 
that knowledge to be exchanged (Vaccaro, 2010). In the following section, I develop 
hypotheses on the conditions of inter-firm relations that facilitate management innovation.  
Inter-firm relations bear relational risks that need to be mitigated to reciprocally 
access unique resources. Loosely dependent partnerships contain risks such as indiscretion, 
unreliability, defection and poor coordination (Sheppard et al., 1998). Mutually dependent 
relationships, in contrast, established when firms dispose of unique resources of crucial 
interest to one another, reduce relational risks. Here, firms cannot act without taking into 
account the knowledge, experiences, ideas and preferences of their partner (Chaves & 
Moro, 2007) to the effect that “… agents are to be seen as each other’s principles and 
agents at the same time.” (Nooteboom, 2004: 18). Mutually dependent partnerships 
thereby avert unilateral enforcements, mitigate relational risks and establish the necessary 
preconditions for the circulation of information (Aiken et al., 1980). This leads to 
hypothesis 1:  
Hypothesis 1  Mutual dependence between interacting firms facilitates 
management innovation.  
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In addition to substantiating the role of mutual dependence in inter-firm relations, the 
general literature on organizational relationships has considered the effects of structural 
factors on the way firms interact. Most fundamentally, these theories rest on an 
understanding of inter-firm relations as alternative social action systems (van de Ven, 
1976) that can be analyzed using similar factors considered in analyses of individual firms. 
Based on this argument, scholars have examined the role of decentralization (Aiken et al., 
1968) or formalization (Vlaar et al., 2006) in inter-firm relations. I follow this tradition and 
make use of the range of determinants and their theoretical mechanisms developed by 
outcome theories on management innovation.  
Specialization has been assumed to facilitate the development and implementation of 
new management ideas. Specialization provides repositories of professional expertise that 
can be used for the re-combination of knowledge. In inter-firm relations, it facilitates 
activities such as idea contextualization, linking, refinement and testing (Birkinshaw et al., 
2008). Specialization is often interpreted as the depth of knowledge and manifests itself in 
the variety of professional specialties found among interacting firms. It is commonly 
measured by the number of different titles and occupational employments within an 
organization (Damanpour, 1991). For its provision of knowledge, I hypothesize that: 
Hypothesis 2 Specialization within inter-firm relations facilitates 
management innovation.  
Similarly, heterogeneity has been assumed to positively influence management 
innovation (Birkinshaw et al., 2008; Kogut et al., 1992). Whereas specialization describes 
the depth of knowledge, heterogeneity is often referred to as the breadth of knowledge. 
Arguments on the role of heterogeneity follow those on specialization by suggesting that it 
provides a pool of knowledge and experience that can be used in the development of ideas 
(Kimberly et al., 1981; Lounsbury et al., 2007). Heterogeneity has been considered on the 
individual (Hage & Dewar, 1973) as well as on the organizational level (Mol et al., 2009) 
for instance by taking into account the range of geographical, cultural, or organizational 
knowledge and experience present within inter-firm relations (Chen, 2008; Mol et al., 
2009). This leads to hypothesis 3:  
Hypothesis 3  Heterogeneity within inter-firm relations facilitates 
management innovation.  
Centralization refers to the concentration of decision-making power within 
organizations. In centralized organizations, higher ranked employees have decision-
making power over subordinates. Therefore it has been suggested that centralization 
discourages specialists from participating in processes which provide solutions (Nickerson 
et al., 2004). In contrast, de-centralized organizations delegate authority, and thereby 
encourage the participation of specialists in the pursuit of organizational goals by raising 
their levels of awareness, commitment, and involvement (Damanpour, 1991; Thompson, 
1965). Decentralization thus facilitates the inclusion of employees offers incentives to 
participate in negotiations. Therefore, I hypothesize that: 
Hypothesis 4  Decentralization of inter-firm relations facilitates management 
innovation.  
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Formalization refers to the provision of a specific kind of codified coordination 
mechanisms that define situations and prescribe expected behaviour (Thompson, 1965). To 
enforce rules, organizations provide incentives for compliance, while non-compliance is 
penalized. Therefore, formalization has been hypothesized to discourage innovation by 
inhibiting experimentation and divergence from available practices or techniques (Hage et 
al., 1971). However, empirical studies have not been able to provide conclusive evidence 
(Damanpour, 1991) and subsequent theorization has contested their negative association 
(Adler et al., 1996). In particular, in the context of inter-firm relations it has been argued 
that formalization triggers important sense-making mechanisms, such as focused attention, 
articulation, and reflection that facilitate interaction between firms (Vlaar et al., 2006). I 
include formalization, yet due to the inconclusive evidence and the conflicting theoretical 
arguments, I refrain from predicting the principle direction of formalization on 
management innovation. Instead, I formulate two competing hypotheses.  
Hypothesis 5a  Formalization of inter-firm relations facilitates management 
innovation.  
Hypothesis 5b Formalization of inter-firm relations obstructs management 
innovation.  
A high level of vertical differentiation, the number of hierarchical levels within an 
organizational structure, has originally been hypothesized to have a negative effect on 
innovation (Hull, Hage, & Azumi, 1985). It was argued that more hierarchical levels 
hinder the flow of information and prevent knowledge from reaching the locations where it 
is required. Evan (1966), however, theorized that management innovation, unlike 
technological innovation, originate from the administrative core of an organization (Daft, 
1978), suggesting that vertical differentiation facilitates management innovation. This 
emphasis on the role of management in promoting management innovation has also 
received attention in knowledge-based models. Nickerson and Zenger (2004) for instance 
understand leadership positions as organizational elements that align interests, avoid 
disagreement and create consensus among interacting firms. In support of these arguments 
both case studies, as well as quantitative studies, revealed significantly positive effects of 
vertical differentiation on management innovation (Chompalov et al., 2002; Damanpour, 
1991). This suggests that: 
Hypothesis 6  Vertical differentiation of inter-firm relations facilitates 
management innovation.  
Finally, environmental uncertainty, in the form of potential threats and unrealized 
opportunities, has been associated with management innovation (Child, 1972). Market, 
regulatory, or technical complexities, as well as rates of change, trigger problem-solving or 
opportunity-seeking processes within organizations. Research on administrative innovation 
considers the extent to which organizations communicate with their environment 
(Damanpour, 1991; Dewar et al., 1986). Process models of management innovation rely on 
the influence of external actors to contextualize and refine existing ideas for new 
managerial practices (Birkinshaw et al., 2008). Consequently, I argue that: 
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Hypothesis 7  Environmental uncertainties experienced by inter-firm 
relations trigger management innovation.  
In sum, I consider the following conditions of inter-firm relations as facilitating the 
development and introduction of new managerial instruments: heterogeneity, 
specialization, vertical differentiation, centralization, and environmental uncertainty. 
Further, the role of formalization is ambiguous in that it may facilitate or hinder 
management innovation processes. These facilitating conditions provide the contextual 
foundation for management innovation. On the one side, they provide a repository of 
experience and expertise, and on the other side the structural and environmental conditions 
that properly allocate these knowledge resources to the activities between firms crucial for 
the management innovation process.  
3.1.3. The Complexity of Antecedents of Management Innovation 
Based on contingency arguments and conceptual models, I explicitly acknowledge 
the conceptual complexity underlying the antecedents of management innovation.  
Contingency theories have long argued that there are different structural 
configurations that may be equally appropriate in the pursuit of the same objective. In 
management innovation research empirical observations reported in case studies, as well as 
post-hoc theorization, suggest that there is a variety of inter-firm relations that allow the 
development and implementation of new managerial instruments. The objective of 
analytically reducing the diversity inherent in empirical observations is to minimize 
variations and report findings “… as simply as possible, but no simpler.” (Citation by 
Einstein, referenced in Rihoux and Ragin, 2009: 10). Regression analysis has consequently 
been criticized for its restrictive assumptions of unicausality and linearity, and its 
generation of overly simplified results. Instead, it is suggested that there are equifinal 
configurations: inter-firm relations with facilitating conditions that allow the development 
and implementation of new managerial instruments. More importantly these configurations 
are conceptually different, in that they exhibit different core conditions (Martin-Pena et al., 
2008). I consequently hypothesize that  
Hypothesis 8  Inter-firm relations that develop and introduce new 
management instruments group together in equifinal 
configurations that conceptually differ in that they feature 
alternative core conditions.  
Furthermore, previous theories on management innovation have suggested that there 
are substantial interdependencies among determinants, and that these structural 
complexities better explain management innovation (Mol et al., 2009). For instance, the 
impact of heterogeneous bodies of knowledge and experiences in inter-firm relations 
should be amplified under a decentralized structure that facilitates the access to such 
resources by allowing the participation of employees in the management innovation 
processes. This suggests that the two determinants might be complementary. In contrast, 
the function of mutual dependence is in reducing relational risks and providing a safe 
environment for participants to openly share information. This function may well be 
substituted by formalizing the relationship and using contracts and policies to provide for 
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such safety. Then again, overly coercive formalization may discourage employees from 
participating in the creative process – an effect intensified, for instance, by strongly 
centralized structures which allocate all decision-making authority to a few senior 
members of the organization. As argued by contingency theory, the various possible 
associations among determinants should reflect meaningful constellations (Damanpour, 
1996; Donaldson, 2001). Through acknowledging these interdependencies it becomes 
possible to formulate a series of contingency hypotheses. This task, however, becomes 
rather difficult once multiple interdependencies are taken into account or even all possible 
configurations are to be considered. I therefore summarize all possible combinations of 
determinants of management innovation and hypothesize that: 
Hypothesis 9  Inter-firm configurations are multi-dimensional collections of 
relational, structural, and environmental determinants of 
management innovation that cluster together in meaningful 
ways.  
This hypothesis remains pointless without determining criteria that allow for its 
substantiation. As will be shown in this study, the analytical technique applied in this 
thesis provides for opportunities to specify consistency thresholds, i.e. levels measuring the 
extent to which the overall solution is consistent with the available data. The hypothesis 
can thereby be falsified if configurations encompassed by consistent solutions feature only 
one or two facilitating conditions.  
Finally, critics of the empirical implementation of contingency models have pointed 
to the largely inappropriate modelling of the nature and direction of associations among 
variables. Originally, this had not been of concern. However, as researchers began 
implementing contingencies as statistical interaction terms, implying linearity while results 
from empirical research revealed a series of non-linear relationships, theorists grew aware 
of the multitude of alternative associations. The structural conditions identified above may 
well have asymmetric effects on innovation depending on the level of uncertainty. While 
statistically these have to be modelled as symmetric relationships (linear, curvilinear, 
monotone, etc.), some scholars have suggested that there are substantial asymmetries 
(Lieberson, 1987) among conditions, that need to be acknowledged in order to explain 
certain outcomes. Consequently, I expect that: 
Hypothesis 10  There are substantial asymmetries in nature and direction 
among associations of relational, structural, and 
environmental conditions that facilitate management 
innovation. 
Similar to the previous one, this last hypothesis requires further methodological 
specification to be substantiated. The method employed in what follows pursues a 
‘controlled inductive’, i.e. systematic approach to specifying the nature of associations 
among conditions and is thereby suitable for substantiating this hypothesis.  
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3.1.4. Final Remarks 
I this section, I make use of previous theories on management innovation to develop 
the theoretical framework for the empirical study. In particular, I identify inter-firm 
relations as the unit of analysis – acknowledging post-hoc theorization of outcome 
approaches and substantial conceptual contributions in process approaches to management 
innovation. Following the literature on inter-firm relations, that considers inter-
organizational relationships as social action systems similar to individual firms, I formulate 
seven hypotheses to describe the conditions facilitating management innovation. Finally, I 
explicitly acknowledge the complexity in antecedents of management innovation with 
three additional hypotheses related to equifinality, conjunctural causations and asymmetric 
relations.  
3.2. New Methodological Approach: fuzzy set Qualitative Comparative Analysis 
In order to substantiate and test the formulated hypotheses, I apply a novel analytical 
technique known as Qualitative Comparative Analysis (QCA). QCA is relatively new to 
organization theory, and differs substantially from more conventional analytical methods. I 
use this section to introduce QCA in more detail.5 I describe its underlying logic and 
mechanisms using an example closely aligned with the empirical analysis on management 
innovation reported later in the thesis. I then discuss three epistemological aspects that are 
central to QCA. Finally, I compare QCA to case study and statistical methods to illustrate 
how the application of QCA provides an intriguing approach to improve the alignment of 
theory and methods. It thereby contributes to theories of management innovation by 
substantiating the role of inter-firm relations and developing a taxonomy of configurations 
facilitating management innovation.  
QCA was developed during the 1980s by political scientists conducting empirical 
research on country level data (Ragin, 1987). Facing difficulties in applying statistical 
methods, due to the naturally limited size of their observations, scholars aimed at 
developing more appropriate analytical methods that, on the one hand would permit the 
exploration of interdependencies among conditions, and on the other hand avoid some of 
the pit-falls of non-experimental research (Eisenhardt, 1989; Pettigrew, 1990). The first 
comprehensive monograph published on QCA, by Charles Ragin, appeared in 1987 under 
the title The Comparative Method. Since then, methodological developments have 
continued and led to other seminal publications (Fiss, 2007; Ragin, 2000, 2008b; Rihoux & 
Ragin, 2009). In organization theory, QCA is a rather recent phenomenon (Fiss, 2010; 
Greckhamer et al., 2008; Kogut, MacDuffie, & Ragin, 2004; Öz, 2004; Pajunen, 2008) yet 
is increasingly applied as it accurately translates theoretical ideas into empirical models 
(Fiss, 2007).  
                                                 
5
  QCA comes along with a specific terminology. ’Condition’ refers to factors that causally explain the 
phenomena of interest. These can be compared with independent variables in statistical methods. Similarly, 
the term ‘outcome’ refers to the phenomena to be explained and is best compared to the ‘dependent variable’ 
in statistical methods. Please consult the Glossary in the back of the thesis for definitions of technical terms.  
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3.2.1. QCA: Set Theory and Boolean Logic 
QCA is based on set-theory and uses Boolean comparative logic to reduce and 
identify combinations of conditions and configurations that, in conjunction, explain a 
given outcome (Ragin, 1987).6 To illustrate the logics underlying QCA, consider the 
following four inter-firm relations, i.e. four pairs of cooperating organizations shown in 
Table 3.1. To explain under what conditions inter-firm relations managerially innovate, 
three conditions are considered: whether the interacting firms have a diverse background 
(C1) and whether the inter-firm relation contains hierarchical levels (vertical 
differentiation – C2) and decision-making authority is concentrated at the top 
(centralization –C3). 
Table 3.1: Exemplary Dataset 
Case/ 
Condition 
C1 
Diversity 
C2 
Vert. Differentiation 
C3 
Centralization 
Outcome 
Management Innovation 
IFR A 1 1 0 1 
IFR B 0 1 0 0 
IFR C 1 1 1 1 
IFR D 0 0 1 1 
The last column indicates whether the inter-firm relation had been observed to 
develop and introduce new management instruments. The first inter-firm relation (IFR A), 
for instance, developed a new business model and IFR C, as well as IFR D, developed and 
introduced new guidelines to improve customer satisfaction. In contrast, IFR B did not 
implement any new managerial instrument.  
The basis of QCA in set theory consists in considering values of variables as 
membership scores within clearly defined sets. Using the example above (presented in 
table 1), one might specify the ‘set of centralized inter-firm relations’. Each observed case 
can then be assessed as to whether it falls into this set (1), i.e. when it is centrally 
organized, or falls outside of the set (0), i.e. it is not centrally organized. Cases A and B are 
not members of this set, whereas case C and case D show membership in the set of 
centralized inter-firm relations.  
There are two dominant types of QCA. They differ in their approach to measuring 
membership scores for condition and outcome sets. In the example above, membership 
                                                 
6
  Set theory examines collections of cases and studies the relations of overlapping sets. In particular, subset and 
superset relations are analyzed with the help of set-theoretic operations such as union and intersection. 
Boolean logic is most commonly known from internet search engines (such as Baidu or Google). It refers to 
the logical relationships among items and uses the three logical operators OR, AND, and NOT.  
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scores are dichotomized, i.e. they are crisp in merely distinguishing inside or outside a 
given set. This type is consequently called crisp set Qualitative Comparative Analysis 
(csQCA). A more refined alternative is the use of fuzzy sets. Fuzzy set Qualitative 
Comparative Analysis (fsQCA) considers different degrees of membership. These range 
from no membership to full membership and are measured on a membership scale between 
0 and 1. fsQCA hence allows a more accurate and detailed measurement of theoretical 
concepts and analytical constructs (Kvist, 2007). While fsQCA is more complicated, it 
shares underlying principles with csQCA. Therefore, for the purpose of illustration, I will 
continue with the crisp set example. 
Set Theory as the Foundation of QCA 
The set-theoretical background of QCA is well illustrated using Venn diagrams. The 
following Figure 3.1 shows such a diagram using the example of the four inter-firm 
relations.  
IFR A
IFR B
IFR C
IFR D
Diversity
1
Fuzzy set
membership scale
Centralization Vertical 
differentiation
0
 
Figure 3.1: Exemplary Venn Diagram and Fuzzy Set Membership Scale 
Each circle represents one of the specified sets. The upper circle outlines the set of 
diverse inter-firm relations, the set to the right shows those inter-firm relations that are 
vertically differentiated, and the final set to the left covers centralized inter-firm relations. 
The first case (IFR A) shows membership in the set of diverse inter-firm relations and in 
the set of vertically differentiated inter-firm relations; the second case (IFR B) shows 
membership in the set of vertically differentiated inter-firm relations, yet no membership 
in the set of diverse or centralized inter-firm relations. The third case (IFR C) is member of 
all three sets. Finally, the last case (IFR D) only has membership in the set of centrally 
organized inter-firm relations. Again, csQCA, as used for this example, only distinguished 
membership from no membership. In contrast, fsQCA allows measuring degrees of 
membership. The double arrow in the set of centralized inter-firm relationships indicates 
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such a fuzzy set membership scale. Cases with full membership would then be allocated in 
the centre of the set and given the membership score of one (1). This score gradually 
declines with lower membership scores towards the boarder of the set where it ultimately 
indicates full non-membership (0) once cases are located outside the set.  
Minimizations in QCA 
In order to minimize data, QCA uses Boolean logic. It hereby closely follows Mill’s 
method of difference, which stipulates that if two configurations differ only in a single 
condition but show the same outcome, this distinguishing condition is irrelevant and can be 
eliminated (Ragin, 1987). Case A and case C are both diverse in background and vertically 
differentiated. Both, in addition, have developed new managerial instruments. However, 
case A did so without centrally organizing their activities while the inter-firm relation in 
case C was centrally structured. In this example, neither the presence nor the absence of 
centralization explains when inter-firm relations engage in management innovation. It can 
therefore be eliminated from the solution. In contrast to case A and case C, the inter-firm 
relation of case D developed new management instruments in the absence of diversity and 
vertical differentiation but with centralized structures. On the basis of this data, a solution 
statement explaining when inter-firm relations engage in management innovation would 
then state the following: Inter-firm relations develop new management instruments either 
when partners have a diverse background and use a vertically differentiated structure 
(derived from case A and case C), or when their partnership is centrally organized (derived 
from case D).  
To systematically compare observations, QCA makes use of a truth table. A truth 
table is a conventional instrument in logic that exhibits all possible combinations of 
present and absent conditions. It thereby “…allows structured, focused comparison (Ragin 
2008: 23). The number of rows in a truth table is calculated as 2k (with k denoting the 
number of conditions taken into account). The truth table for the example above 
consequently lists eight (23) rows, one for each logically possible configuration. By listing 
not only the empirically observed configurations but also those that only logically remain, 
truth tables directly address the issue of limited diversity (Lewis, 1973; Ragin & Sonnett, 
2004). Limited diversity refers to the claim that social phenomena are naturally limited in 
their diversity (Ragin et al., 2004); one cannot expect to find empirical evidence for all 
logically possible configurations. Logical remainders, i.e. those configurations that have 
not been observed empirically, can be used to further minimize data. This is accomplished 
by conducting thought experiments which - beginning with Max Weber (1905) - have an 
established history in sociological analyses (Hicks, Misra, & Tang, 1995; Tetlock & 
Belkin, 1996; Weber, 1905/ 1949). For instance, consider a hypothetical case Y, the 
cooperation between two firms that is not diverse but shows both vertical differentiation 
and a centralized structure. In a though experiment, one might assume that the 
configuration of these conditions would also allow inter-firm relations to develop new 
management structures. Based in this assumption, this hypothetical case when compared to 
Case A differs only in the absence of diversity, so that diversity, as an explanatory 
condition, could be eliminated from the solution.  
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Identifying Core and Contributing Conditions 
Depending on the plausibility of such ‘simplifying assumptions’ QCA identifies 
‘core’ and ‘contributing’ conditions (Fiss, 2010). Core conditions are those that necessarily 
have to be part of any representation of the data. These are identified by permitting the 
inclusion of any simplifying assumption to minimize data. In the example above for 
instance, one would always make the assumption that under these conditions, the inter-firm 
relation of case Y would be able to develop new managerial tools. In contrast, to identify 
contributing conditions, minimization procedures on the basis of thought experiments are 
only conducted when the simplifying assumptions are in accordance with substantive and 
theoretical knowledge. For the hypothetical case Y, the researcher ideally has sound 
theoretical or substantive knowledge that make this assumption plausible.  
Estimating the Quality of Results 
In order to assess the relevance and quality of results, QCA uses two model 
coefficients: coverage and consistency. Coverage considers the proportion of consistent 
cases that display a given outcome and thus “... gauges empirical relevance or importance” 
(Ragin, 2006: 2) of conditions to outcome. The coverage score somewhat resembles the R2 
in regression analyses by determining the relevance of the solution term. There are only 
few guidelines to assess the appropriate coverage level. Smaller datasets that allow for 
more intimacy and consequently more context-specific calibration commonly exhibit 
higher coverage scores (Wagemann & Schneider, 2007); QCA models using larger 
datasets usually suffice with lower coverage scores (Fiss, 2010). Arguably more 
importance adheres to the consistency coefficient. Consistency describes degree to which 
cases exhibit the set-theoretical associations in a given solution term. It is calculated by 
taking the proportion of cases consistent with the outcome. Consistency scores of 0 and 1 
indicate high levels of consistency. A consistency score of 0.5 indicates that results are 
most inconsistent (Ragin, 2008a). Among QCA scholars, there is somewhat disagreement 
concerning the appropriate consistency level. In general, values below 0.75 are considered 
to indicate inconsistency (Ragin, 2008a). Most scholars consider scores of 0.8 as sufficient 
(Fiss, 2010; Jackson, 2005; Ragin, 2006). As has been pointed out in hypotheses nine and 
ten, the consistency score is crucial for testing the two expectations. In case, management 
innovation is explained with unicausal (in contrast to multi-causal) and symmetric (in 
contrast to asymmetric) relationships among facilitating conditions, the results falsify both 
hypotheses.  
3.2.2. Three epistemological Issues in QCA 
Based on this structure, QCA addresses three epistemological issues that have been 
raised in the review of contingency theories of management innovation, and that are 
addressed in the theoretical framework for the empirical study reported in the following 
chapter. First, QCA allows for multiple, alternative solutions. As in the example above, 
one configuration of inter-firm conditions that lead to the development of new 
management instruments contained diversity in background in combination with vertical 
differentiated structures (IFR A). A second configuration features only centralization yet 
absent diversity and vertical differentiation (IFR D). Both are equally effective in 
facilitating management innovation. QCA thereby allows for equifinality. Second, 
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solutions focus on configurations not individual variables. By holistically comparing cases, 
QCA examines combinations of conditions that explain a given outcome. It thereby 
explicitly focuses the analysis on conjunctural causation, i.e. the association of two or 
more variables with a given outcome. Third, by considering conditions that are both 
present as well as absent, and by refraining from specifying the nature and direction of the 
relationships a priori, QCA enables the identification of asymmetries among conditions. 
As in the example, in one configuration (IFR D), the presence of centralization explains 
management innovation. In the other configurations however (IFR A, IFR C) neither the 
presence nor the absence of centralization are elements of the solution. Hypothetically (and 
methodologically) the absence of centralization may explain when inter-firm relations 
develop new managerial instruments, too. 
3.2.3. Practical Issues: Case Selection and Scale Development  
Before positioning QCA, in the context of case study analysis on the one hand and 
statistical on the other hand, two practical issues deserve further attention. First, a central 
concern in qualitative, case-oriented research lies in the selection of cases. A clear 
understanding of cases and their selection is consequently of considerable importance for 
studies using QCA. Ideally, the selection of cases should be informed by theoretical, 
instead of statistical reasons (Eisenhardt, 1989) and literature in comparative methods 
provides a list of criteria for selecting cases (Collier, Mahoney, & Seawright, 2004; King, 
Keonhane, & Verba, 1994). For instance it has been suggested that organizational theory 
research should focus on organizations that work in extreme situations, experience critical 
incidents or social dramas (Pettigrew, 1990). Furthermore, researchers might consider 
polarities that allow comparison with similar cases and contrast between disparate cases 
(Dion, 1998; Öz, 2004; Yin, 2003). Otherwise, one might examine sites with relatively 
high experience with the phenomena under study (Fiss, 2007; Pettigrew, 1990). These 
general rules for case selection also hold for QCA. While the selection of cases is an 
important criteria in small to medium size samples, that allow ‘intimacy’ between 
researchers and cases, more recent QCA studies on larger datasets move away somewhat 
from such a strong case oriented approach and aim, in addition, for external validity that 
allows a broader generalization of results (e.g. see Fiss 2010).  
The second practical issue concerns the development of scales in fuzzy set 
Qualitative Comparative Analysis. Instead of constructing variables based on inductive, 
sample-specific standards, such as means or standard deviations (Ragin, 2008b), fuzzy 
scales in QCA ought to “…accurately reflect theoretical concepts and analytical constructs 
with precise meaning.” (Kvist 2007: 477). In order to accomplish this, QCA proposes 
calibration as an approach to coding data. Calibration is a technique adopted from the 
natural sciences that assigns, not relative but meaningful, floor and ceiling values to scales 
using external criteria such as definitional elements, theoretical reasoning or empirical 
knowledge.7 Calibrated scales best correspond to ordinal scales used in statistical methods. 
Ordinal scales arrange ranked categories that are relative to one another, just as calibrated 
                                                 
7
  A common example of a calibrated scale that illustrates this point well, is that of the Celsius scale, in which 
temperature is calibrated according to the changes in physical properties of water. At 0°C (frozen to liquid) 
and 100°C (liquid to gas) the Celsius scale entails anchors representing meaningful points.  
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scales ideally specify membership scores that are reflected in empirical reality by 
arranging thresholds on the basis of substantive and theoretical knowledge.  
There are two dominant approaches to calibration: the direct and the indirect method 
(Ragin, 2008c). The direct method specifies the value of an internal scale, corresponding to 
three qualitative breakpoints that are significant in set-theory: Full membership, full non-
membership, and the crossover point. First, one is to specify points that determine either 
full membership or full non-membership in a given set. Assume one would want to assess 
whether a given organization belongs to the set of vertically differentiated organizations by 
counting the number of levels in an organization’s hierarchy. A firm with only one or two 
levels would then be considered to have full non membership in the set of vertically 
differentiated firms. In contrast, a strongly hierarchically organized firm would receive full 
membership in the set of vertically differentiated organizations. Finally, the crossover 
point defines when observations ‘migrate’ from being full membership to full non 
membership in the set. This point is crucial as it represents the point of highest ambiguity 
(Ragin, 2008c). Essentially, the membership score of 0.5 indicates that the affiliation, or 
lack of affiliation, of a given case to the set cannot be determined. Having defined these 
three thresholds, researchers may then assign membership scores to individual cases. The 
main advantage of this method is that irrelevant variation is excluded from the dataset.  
In contrast, the indirect method uses the qualitative assessment of the researcher 
(Berg-Schlosser, Meur, Rihoux, & Ragin, 2009). Using the indirect method, researchers 
assign cases into categories, and use simple estimation techniques to rescale the original 
measure. For instance, having asked respondents in questionnaires to select one of six 
categories ranging the number of hierarchical levels from (0-1), (2-3), (4-5), (6-7), (8-9), 
(10 or higher), the researcher would assign the following membership scores to each of the 
six qualitative anchors respectively: [0.0], [0.2], [0.4], [0.6], [0.8], [1.0]. The choice 
between the direct and the indirect method largely depends on the type, quality, and 
availability of data, and the substantive theoretical and empirical knowledge of the 
researchers. Most importantly, however, good practice in QCA stipulates that the decisions 
for calibration are to be made transparent and explicit (Wagemann et al., 2007).  
3.2.4. Positioning QCA within the Context of Traditional Methods 
Having discussed the technical, epistemological, and practical tenets of QCA, the 
method can be positioned within the context of the two most widely used methods in 
organization theory: quantitative statistical methods and qualitative case study methods. As 
has been mentioned above, one of the initial motivations for developing QCA was the 
naturally limited size of the datasets. QCA – as was suggested early on – was suitable for 
medium size samples. In contrast, statistical methods are suitable for large samples where 
case studies commonly focus on single or few observations. Another peculiarity of QCA 
lies in its consideration of all logically possible configurations. This sets practical limits on 
the number of variables included in the analysis as every additional condition 
exponentially increases the number of possible configurations (Marx, 2006). As in the 
example above, three conditions resulted in eight possible configurations. If one were to 
include eight conditions, the number of configurations would increases to 256. Statistical 
methods instead are capable of examining large numbers of independent variables 
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(although once interaction terms are included, the number of variables requires 
adjustment). Similarly, the rather exploratory nature of case study methods allows the 
examination of a large number of potentially influencing factors. Aspects concerning the 
size of samples and the number of included variables (or conditions) are certainly 
important. Nevertheless, in all three methods there are possibilities to balance the relation 
between sample size and the number of independent variables.  
Most significantly, there are substantial epistemological differences between the three 
approaches. First, statistical methods aim at analyzing net effects of a range of independent 
variables on the dependent variables. They focus on identifying singular, ‘one-size-fits-all’ 
solutions, and they thereby imply unifinality. As has been shown above, QCA instead 
allows for multiple solutions and thus explicitly entails equifinality. Case studies are not 
explicit yet by their very nature acknowledge variation in empirical observations and are 
thus implicitly equifinal. Second, there are substantial differences between the ways in 
which the various methods understand of relationships between variables. Statistical 
analysis, by treating influencing factors as independent variables, considers net effects on 
the dependent variables. It is then possible to add together their joint effect. Statistical 
methods thereby assume additivity of variables. In contrast, by holistically examining and 
comparing entire cases, QCA directly focuses on the conjunctural impact of conditions. It 
maintains the integrity of each individual case and assumes that their joint impact, rather 
than the individual contribution, explains certain outcomes. Again, case study methods 
implicitly argue for conjunctural causation, although the in-depth focus commonly leads to 
context specific explanations. At last, the three methods make different assumptions about 
the nature of the relationship between variables. Statistical methods usually assume 
symmetric relationships, which are usually linear or curvilinear.8 In contrast, QCA remains 
indifferent ex ante and takes an exploratory approach to determining the nature of the 
relationship between variables. QCA effectively makes no a priori assumption and thus 
allows for asymmetric relationships.  
Differences between quantitative statistical methods and the rather qualitative QCA 
approach also exist in their respective approaches to scale development. The use of 
calibration techniques to meaningfully represent data within the selection of cases, clearly 
distinguishes QCA from quantitative, internally consistent measures used in statistical 
methods. The differences can mainly be traced back to the set-theoretic foundations of 
QCA. It requires coding (or better calibrating) conditions as membership scores in various 
sets. Ordinal scales in quantitative analysis, which rank categories and arrange values 
relative to each other, are transformed in QCA and arranged according to substantive and 
theoretical knowledge. Case studies predominantly rely on implicit calibration or ordinal 
scales.  
Finally, the differences in sampling, inclusion of variables, epistemological 
assumptions and scale developed manifest themselves in the general research approach, the 
theoretical fit and the potential for generalization. Although exploratory elements exist, 
statistical methods are certainly more deductive, pursuing hypothesis driven research 
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  I say usually because in fact there are statistical techniques to account for asymmetric relationships. These, 
however, are to my knowledge not or only rarely applied in management research.  
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agenda. QCA in contrast demands specifying a range of conditions that – similar to 
hypotheses – provide the general framework for the analysis. Once determined, QCA parts 
from this deductive approach and remains relatively open (or inductive) towards the 
solution. In contrast to QCA and statistical methods, case studies are inductive. The 
implicit assumptions, of statistical methods of singular causality and linearity, do not – as 
the literature review has shown – allow for an appropriate fit between theory and methods. 
QCA, in this respect, certainly provides a more suitable approach. Case studies are often 
rather exploratory and inductive, they are used to develop theory and consequently, it is 
not required that they conform to theory. Finally, there are differences regarding the extent 
to which one can generalize in regards to the results. Statistical analyses based on 
randomly sampled observations allow for the broad generalization in regards to the overall 
population. In QCA, researchers instead select cases on a certain theoretical rational, and 
allow merely for modest generalization  (Ragin et al., 2004). The following Table 3.2 
summarizes the comparison of QCA to quantitative statistical methods and qualitative case 
study methods. 
Table 3.2: Positioning QCA in the Context of Statistical and Case Study Methods 
 Statistical Analysis QCA Case Study Analysis 
No. of observations Large Large, medium, small Singular (descriptive or paired comparison) 
No. of variables Large Medium Large 
Paradigmatic 
assumptions 
Unifinality Equifinality (explicit) Equifinality (implicit) 
Additivity of variables Conjectural impact Contextual dependence 
Symmetric causality Asymmetric causality  
Scales    
 Development No calibration Calibration Implicit calibration 
 Characteristics 
Ordinal scales 
. Ranking categories 
. No reference to set 
membership 
. Arranged relative to 
each other 
Fuzzy set scale 
. Calibrated membership 
. Specific reference to set 
membership 
. Arranged based on 
substantive and theoretical 
knowledge 
Ordinal scales 
Research approach Deductive Deductive/ inductive Inductive 
Theoretical fit Somewhat tailored to fit theory Tailored to fit theory Not taken into account 
Generalization Broad generalization Modest generalization Limited generalization 
3.2.5. Final Remarks 
QCA holistically examines cases as configurations of conditions, instead of 
measuring the net effect of individual variables on the dependent outcome (Ragin et al., 
2004). It thereby maintains the integrity of each case and considers all variables in 
conjunction with one another (Fiss, 2007). It does so by using set theory to organize the 
data, and Boolean logic to analyze interdependencies among conditions (independent 
variables) and the specified outcome (dependent variable). 
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QCA thereby opens opportunities to model complex theoretical propositions that are 
difficult to implement using statistical methods. Firstly, it allows a given outcome to be 
explained by various alternative results, thus entailing equifinality. Secondly, it 
specifically focuses on conjunctural causations among conditions, and there is no 
(methodological) limit to the number of interacting conditions included in solution terms. 
Finally, QCA does not make implicit assumptions about the nature of the relationship 
among variables but allows for the identification of asymmetries among conditions. These 
epistemological tenets of QCA help to overcome the “…fundamental mismatch between 
the analysis of linear relations – the central concern of the most popular and most used 
quantitative methods – and theoretical discourse.” (Ragin 2000: xiv). This certainly seems 
true considering the complex theoretical propositions put forward by contingency theories 
of management innovation.  
At the same time, there are disadvantages to using QCA. Calibration techniques and 
minimization procedures depend on the subjective assessment of the researcher. These 
judgments should certainly have substantial and theoretical foundations; nevertheless it is 
important to transparently report the various decisions made by the researcher (Wagemann 
et al., 2007). QCA only allows distinguishing core conditions from contributing 
conditions, it does not permit a more detailed assessment of the relative significance of 
individual conditions. Furthermore, there is little consensus among researchers concerning 
the appropriate level of quality indicators for models or results. So far coverage and 
consistency are the most widely used measures to assess the quality of QCA results; yet, 
depending on the size of the sample and the number of conditions included, there is 
variation among the two coefficients as reported in studies. Finally, QCA is relatively new 
it underlies continuous methodological developments (Wagemann et al., 2007). For 
instance, scholars are increasingly applying QCA to larger datasets to derive broader 
generalizations (Fiss, 2010; Grandori et al., 2008). This requires improvements in 
computational methods, and shifts the focus away from its initially qualitative focus. To 
develop new measures for the reliability of models, scholars are also working on type 2 
fuzzy sets that allow estimating the level of uncertainty regarding whether or not a 
particular case does or does not belong to a particular set. In addition, while there is so far 
no QCA approach that permits longitudinal analyses, researchers are developing 
techniques to incorporate such alternatives. These developments should help to ameliorate 
some of the disadvantages that are currently related to QCA. 
3.3. Conclusion 
In this chapter I have laid the foundation for the empirical analysis that will be 
reported later. In particular, I propose to focus the analysis upon the inter-firm relation, 
instead of the individual firm. This shift is supported by narrative evidence and post-hoc 
theorization in outcome studies, and is substantiated by conceptual models and in-depth 
case studies by process research of management innovation (Birkinshaw et al., 2008). 
General theories of inter-firm relations, taking a governance perspective on the one hand 
and a structural knowledge perspective on the other, provide solid theoretical arguments 
for the dynamics of resource exchange and knowledge development between firms; these 
being the prerequisites of management innovation (Nooteboom, 2004). These theories 
point towards the crucial role of mutual dependence in providing the necessary level of 
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trust between partnering firms to reduce relational risks. Only when such risks are 
mitigated will firms reciprocally exchange knowledge and information (Sheppard et al., 
1998). In addition, this dynamic inter-firm environment requires both the presence of 
diverse sets of knowledge, as well as the conditions that allow the unobstructed flow and 
combination of knowledge. To specify these facilitating conditions of management 
innovation I follow established research that considers inter-firm relations as social action 
systems. These can be analyzed using similar factors as those that are being used for 
individual firms (van de Ven, 1976). I subsequently make use of determinants identified by 
outcome studies of management innovation, and develop hypotheses for conditions on the 
inter-firm level that facilitate the development and implementation of new management 
instruments. Hence, instead of speculating about what interacting organizations do to 
introduce new management practices, I analyze different combinations of conditions 
governing inter-firm relations that enable management innovation. Finally, acknowledging 
the theoretically complex antecedents of management innovation, as suggested by process 
studies and especially contingency theories, I formulate three additional hypotheses.  
To test these and thereby contribute to the growing body of literature on management 
innovation, I propose the application of a relatively novel analytical technique. fsQCA 
holistically considers entire configurations of conditions instead of analyzing the net-effect 
of individual variables on the outcome (Fiss, 2007; Ragin, 2008b). It thereby maintains the 
integrity of each case and probes into the complex constellations of facilitating conditions. 
Underlying QCA is the organization of data into set-theoretical relationships, which are 
minimized using Boolean logic.  
QCA is well suited to advance our understanding of management innovation. It 
improves the alignment between theory and empirical models threefold. QCA allows for 
solutions to express equifinality, i.e. in case there are conceptually different combinations 
of conditions that equally explain when inter-firm relations develop and implement new 
management instruments, these will be reported as separate, equifinal paths. In addition, by 
considering entire cases, and not disaggregating these into individual variables, QCA 
explicitly identifies conjunctural causations among facilitating conditions. These extend 
beyond the possibilities offered by statistical methods and allow the identification of 
“…complementarity, additive, substitution or suppression effects.” (Fiss, 2010: in press). 
Finally, QCA does not limit associations to linearity but allows for complex asymmetries 
to exist among conditions. In sum, QCA’s ability to accurately reflect complex theoretical 
arguments within empirical models makes it a promising methodological approach. 
Furthermore, QCA offers a few advantages with regards to the practical aspects of 
empirical research. On the one hand, it is suitable for the analysis of small to medium size 
samples. As has been shown earlier, management innovation is a rather transient and 
context dependent phenomenon that requires careful attention to data collection. On the 
other hand, the technique for coding collected data, namely calibration, permits taking into 
account the context specificities of observed management innovations.  
Ultimately, this approach allows the development of a taxonomy of configurations of 
conditions which facilitate the development and implementation of new managerial tools. 
It identifies multiple sets of complex associations and identifies underlying 
complementarities and substitution effects. As decision-making tools taxonomies are 
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appealing, as they allow for the reduction of complex phenomena through the emphasis 
and comparison of common features between observations.  
The next chapter introduces the empirical background of the configurational study of 
inter-firm relationships within China’s biopharmaceutical industry. This industry imposes 
severe technical, market and regulatory challenges upon the firms which operate within it. 
In addition, due to the various complex knowledge domains which are so characteristic 
amongst activities pertaining to biopharmaceuticals, firms strongly rely on relationships 
with other firms. This industry in China is particularly young, and contains a highly 
diverse population of firms. Its market growth is outpacing other markets around the world 
and its regulatory framework is highly unstable. Inter-firm relations consequently operate 
under extremely volatile conditions that require the constant development of new 
managerial instruments to address these dynamics. The biopharmaceutical industry in 
China is, therefore, an appropriate research field to empirically validate the link between 
inter-firm configurations and management innovation. The next chapter will highlight the 
empirical relevance of this study in the investigation into the conditions under which new 
managerial tools are being developed and introduced.  
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4. The Biopharmaceutical Industry in China 
The biopharmaceutical industry in general is widely acknowledged to lack the 
appropriate managerial practices which would allow firms to benefit from the variety of 
scientific approaches9 and to economically coordinate research and development (R&D) 
and commercialization activities (Pisano, 2006). In China, a modern biopharmaceutical 
industry has emerged during the 1990s, but only recently, during the past five years, has it 
begun to flourish (Frew et al., 2008). The industry is populated with a large variety of 
organizations and institutional arrangements are either absent or changing rapidly. Hence, 
the business environment of China’s biopharmaceutical industry adds to the challenges 
faced by biopharmaceutical firms in general. Under such conditions, management 
innovation as one form of organizational change is expected to take place frequently.  
Information on the biopharmaceutical industry in China is difficult to obtain. SIC 
(Standard Industrial Classification) codes, categorizing firms according to their output, 
cannot be used to identify biopharmaceutical firms, as these instead share the technologies 
underlying their products. Also, the industry lies at the intersection of the pharmaceutical 
and the biotechnology industry. While information on these two is readily available, there 
are only a few supranational or national organizations that systematically collect data 
specifically on biopharmaceuticals. Finally, the rapid developments within China’s 
biopharmaceutical industry complicate the collection of data. This chapter therefore 
employs a variety of sources to comprehensively describe the industry in China. These 
include secondary sources, such as newspaper and scientific articles as well as industry and 
trade reports. Also, I make use of observational and anecdotal evidence collected during 
field research undertaken in China between 2007 and 2008. In addition, I use in a few 
instances information gathered during 56 interviews with managers of firms in China’s 
biopharmaceutical industry. The data was predominantly collected for the empirical study 
reported later in next chapters. Selected items however provide interesting insights into 
China’s institutional environment.10  
I proceed by introducing the biopharmaceutical industry in general, focusing on the 
complexity of drug design, the technologies developed during the last decades and 
highlighting organizational challenges in the management of biopharmaceutical firms. I 
then focus on the biopharmaceutical industry in China in particular providing a short 
historical introduction and describing the large diversity in organizations operating within 
China’s biopharmaceutical industry. Further, I provide information on the recent 
developments in China’s institutional architecture to illustrate the specific business 
environment in China. The concluding section summarizes the uncertainties under which 
organizations in China’s biopharmaceutical industry operate.  
 
                                                 
9
  Modern technologies for identification and validation of targets are for instance Genomics, Proteomics, 
Systems biology, or RNAi. Modern technologies used for lead identification and optimization are rDNA, 
MAb, rational drug design, combinatorial chemistry, or high thoughput screening (Pisano, 2006) 
10
  More information on the interview partners and the interviews themselves is provided in Chapter 5, the 
empirical study in China’s biopharmaceutical industry. I refer to this source throughout this chapter as the 
survey. 
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4.1. Biopharmaceutical Business 
Biopharmaceutical business is concerned with the development and 
commercialization of medicinal products based on biotechnology (Pisano, 2006). 
Biopharmaceuticals differ from ‘traditional’ pharmaceutical products in two general ways. 
First, whereas pharmaceutical companies focus on small molecules to chemically engineer 
drugs, biopharmaceutical firms focus on complex macromolecules. Second, they use 
modern drug discovery tools to identify new therapeutic agents (Pharmahorizons, 2001).  
The origins of the biopharmaceutical industry are found in the discovery of 
recombinant DNA (rDNA) in the early 1970s. Based on this discovery, Genentech, the 
first biopharmaceutical company was established in 1976. Since then, the industry has 
grown rapidly especially in North America, Japan, and Western Europe. More recently, 
biopharmaceutical industries have emerged in developing countries such as India, Brazil or 
China (Lakhan, 2006). Biopharmaceuticals is a core sector of any knowledge based 
economy and heavily relies on highly skilled and educated employees. Because of its 
crucial role, national industries are strongly influenced by the initiatives of governmental 
programs, in frameworks of National Systems of Innovation (Devine, 2005; Europe Innova 
- Innovation and Clusters, 2007; Lakhan, 2006; Whitley, 2000). In most countries, the 
financial investment from public sources exceeds those from the business community 
(Zhao, 2006). Because of the potentially severe consequences of biopharmaceutical 
products upon humanity, the industry is subject to strict regulatory regimes. Even after 
approval by regulatory authorities the economic success of biopharmaceutical products 
remains uncertain, due to the difficulties in estimating the acceptance of drugs by both 
patients and doctors. These peculiarities are the reason for the poor economic performance 
of the industry. Even in the U.S., with the most developed biopharmaceutical industry it is 
estimated that as a whole a net loss of more than US$ 100 billion has been accumulated 
(Pisano, 2006). This staggering underperformance cannot be accounted for by a lack of 
revenues which have consistently increased and were estimated to lie around US$ 37 
billion annually in 2004. Profits however have remained well below zero. In 2006, only 54 
out of 342 listed U.S. biotechnology firms were profitable (Ernst & Young, 2006). 
Biopharmaceutical business is characterized by distinctive features that pose specific 
challenges to making science a business. Consequently firms face organizational 
challenges arising from substantial and persistent uncertainties, the complex and integral 
nature of the underlying science, and the need to develop mechanisms for organizational 
learning, which I discuss below (Pisano, 2006). 
4.1.1. Long, Costly, and Uncertain Development Cycles 
Even though medicinal drugs reach consumers in a relatively simple form, whether 
they are pills, ointments, powders, or liquids, the manufacturing processes of drugs can be 
far more sophisticated and complex than most other technologically-intensive goods. Due 
to the complexity of human biology there is high uncertainty regarding the effect of these 
products upon patients. Biopharmaceutical products may therefore have severe negative 
effects on patients. Therefore, biopharmaceutical R&D is subject to extensive regulations. 
The process of developing and marketing a biopharmaceutical product is therefore 
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particularly expensive, time-consuming, and risky. It can broadly be separated into five 
phases.  
1. The discovery phase aims at identifying and validating targets, such as genes or 
proteins, that cause disease by interfering with biological mechanisms (Ficenec et 
al., 2003). Identification of the disease-causing target requires a thorough 
understanding of the chemical, biological, and physical mechanisms involved. After 
having identified such a target, researchers search for a molecule that will inhibit 
enzymes which speed up the process of the target interfering with the subject’s 
biological mechanisms. The resulting enzyme-inhibiting compound is synthesized 
and optimized against the target, in the hope that it will slow or prevent the disease 
caused by the target.  
2. The molecules then proceed to pre-clinical trials, where they undergo safety and 
efficacy tests. Research is conducted in the form of in-vitro trials (controlled 
experiments in test tubes) and in-vivo trials (experiments involving living 
organisms). The active, enzyme-inhibiting, compound and the inactive ingredient, 
used either for delivering the active compound or for changing the taste and colour 
of the medicine, are highly interdependent in their formulation so that successful 
research often depends on the scientist’s tacit knowledge and experience with the 
compound.  
3. Filing an Investigational New Drug (IND) application with the regulatory 
authorities permits proceeding to clinical trials. Depending on the research results 
and the field of application, clinical trials may include tens of thousands of patients, 
and are thus time and cost intensive. They serve to test and guarantee the safety and 
efficiency of the designed drug in the human biological system and help to make 
initial estimations about its market potential.  
4. With satisfying results during the clinical trial phase, a firm can file a New Drug 
Application (NDA). In case of approval, a manufacturing base has to be set up 
according to Good Laboratory (GLP) and Good Manufacturing Practices (GMP).  
5. During commercialization, the company will try to maximize the acceptance of the 
drug, prepare for the time when the patent protection runs out and fight against 
generic copies. During this phase the focus is upon the marketing of the drug 
towards health care providers (doctors) and patients, and protecting revenue from 
Intellectual Property (IP) Rights infringements. 
The process may take up to twenty years and involves substantial costs and 
regulations. Succeeding from one phase to the next is highly uncertain. From the ten to 
twelve thousand compounds initially screened, only one will eventually be brought onto 
the market. This technological uncertainty is a consequence of the variety of different 
scientific approaches available to researchers and the complexity of human biology.  
4.1.2. The Complex, Heterogeneous and Integral Nature of 
Biopharmaceutical Science 
In contrast to ‘classical’ drug design primarily based on medicinal chemistry and 
small molecules, modern biotechnology developed and applied several new and 
independent approaches to the drug development process. These can be distinguished 
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according to three functional groups: first, approaches to the synthesis of large molecules, 
such as rDNA, monoclonal antibodies or combinatorial chemistry; second, new approaches 
to understanding biological processes such as structural genomics, proteomics, RNAi, or 
system biology; and third, new approaches to the design and screening of the match 
between compounds and targets such as ‘rational’ drug design, high-throughput screening, 
or random drug design (Pisano, 2006). These new technological approaches are 
supplemented with developments in bio-informatics or imaging techniques (Ficenec et al., 
2003). 
In the early years of the biopharmaceutical industry it was argued that with newly 
available means provided by improvements in technology, the complex and uncertain 
traditional processes of drug design would be revolutionized. By creating fundamentally 
novel diagnostics and therapeutics, and increasing the quantity of marketable compounds 
(Hamilton, 1993) both time, as well as the uncertainty involved in the development 
process, could be reduced and a large number of new drugs brought onto the market. 
Despite the fact that the new biological mechanisms that were the subject of 
biopharmaceutical research proved to be more complex than anticipated, research into 
these mechanisms also led to a series of ‘technological revolutions’, which significantly 
extended the range of instruments that were available to researchers for the development of 
new drugs. However, as has been shown (Marsili, 1999), these technological regimes 
differ in the logics and languages used in the identification, formulation, and solution of 
problems, and are responsible for difficulties in communication between scientists. As a 
consequence, biopharmaceutical firms not only need to deal with technological 
uncertainties, but are also challenged in finding viable organizational solutions.  
4.1.3. Organizational Challenges 
Each of the scientific disciplines of biotechnology (rDNA, MAbs, genetics, etc.) 
helps to shed light on a given problem, but none of these disciplines by themselves can 
give a comprehensive answer. Instead, problem-solving requires integrating several 
technological approaches and depends on a continuous exchange of knowledge and 
experience, as well as the effective coordination of research to allow cumulative learning. 
Choices taken in one scientific discipline significantly affect the researchers’ 
understanding of the other biological features of a molecule. Therefore, drugs cannot be 
designed by separately solving isolated problems. The necessity of integrating a large 
number of technological regimes adds to the challenges of drug R&D. Because of the 
technological complexities and the variety in scientific approaches that are necessary, 
firms are required to cooperate with numerous organizations (Powell et al., 1996; 
Zhenzhen et al., 2004). The biopharmaceutical industry is known for its diversity of inter-
firm relations in which organizational partners range from public domestic research 
institutes to large multinational pharmaceuticals (Pisano, 2006; Zhao, 2006).  
To make things worse, the difficulties in finding solutions to organizational 
challenges are exacerbated by frequent changes in the values, norms and practices that 
govern the research throughout the different phases. During the early phases of research, 
knowledge needs to be shared; this requires openness amongst those researchers that are 
both inside and outside of the organizations. In contrast, secrecy is required in the later 
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stages to prevent misappropriation of generated IP. Furthermore, parameters for assessing 
the quality of work change. Substantial scientific achievements require validity, whereas 
marketable goods need to exhibit utility to find acceptance among doctors and patients. 
Different performance measurements are closely linked to these shifts in parameters. For a 
young biopharmaceutical company, success is measured and potential is assessed by 
considering the reputation and publication history of the senior scientists that are involved 
with the company. However, later on these indicators shift and economic indicators, 
measuring the financial performance of the firm, gain more importance.  
In general, biopharmaceutical business is challenged by the profound and persistent 
uncertainty that is involved in the research, development and commercialization of its 
products. The industry’s complex scientific nature and its requirement of cumulative 
learning challenge firms to find appropriate organizational structures and management 
techniques. In addition, the industry significantly depends upon broader institutions such 
as education systems, financial instruments, and regulatory regimes. As the following 
subsection will show, in China these challenges are exacerbated by either an absent, or a 
rapidly changing, institutional infrastructure relating to regulation, finances, marketing, 
HR, and intellectual property rights.  
4.2. The Chinese Biopharmaceutical Industry  
In 1973 Professors Cohen and Boyer discovered rDNA, thereby clearing the way for 
the biotechnological scientific advancements that were to follow. Meanwhile China was in 
the midst of the Cultural Revolution (1966 – 1976). This decade of long agony not only 
had devastating effects on the Chinese population, but also severely damaged the nation’s 
educational system and scientific endeavour. Intellectuals, academics and researchers were 
stigmatized as imperialists and suffered persecution. Universities and other research 
institutions were closed (Lakhan, 2006). The consequences of the Cultural Revolution on 
the development of China’s scientific community were immense. Not only did the country 
loose a decade of adolescent scientists: due to the widespread scepticism among the 
Chinese people, science was not an attractive career path among younger generations. 
Those that did choose this path, or those that had done so before the Cultural Revolution 
were ill-equipped for modern research, both because they were unfamiliar with the current 
literature and because they had been barred from performing their work in laboratories and 
libraries.  
Shortly after the Cultural Revolution, the Chinese government, under Deng Xiaoping, 
took steps towards the development of an advanced biotechnology-based knowledge sector 
in China. In 1982, the Chinese Academy of Science (CAS) re-opened its institutes and 
began teaching regular courses. By 1983 the government had initiated the China National 
Center for Biotechnology Development (CNCBD), responsible for the management and 
distribution of funds for biotechnological research. Increasingly, public investments were 
directed towards the biopharmaceutical industry. In 1986, the ‘Frontiers in High 
Technology Program Fund’ was created dedicated to projects in the applied sciences. From 
the 1990s on, a central objective of the government’s Five Year Plans lay the development 
of a modern biopharmaceutical industry. During the 7th Five Year Plan (1986 – 1990) 
public spending significantly increased and concrete policy objectives for the 
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biopharmaceutical sector were formulated (Hamer & Kung, 1989). From the 1990s 
onwards, the industry has represented the core knowledge-intensive industry in China, and 
the government is heavily investing in its activities.  
This emphasis on the biopharmaceutical industry however was not only economically 
motivated. An efficient and successful domestic biopharmaceutical industry is considered 
crucial to guarantee the health and safety of the Chinese population (Liu, 2006). The 
political challenges arising from a rather peculiar public health profile are enormous 
(Jackson & Howe, 2004). Consequently, the latest Five Year Plan (2006 – 2010) set 
ambitious objectives, such as fostering the development of five to fifteen innovative, 
domestic drugs and vaccines, exporting at least five pharmaceutical drugs developed in 
China to the U.S. and Europe, and consolidating the industry by supporting the 
development of five large scale pharmaceutical groups (Zhou, 2007).  
Until the end of the 1990’s, the industry was dominated by large, state-owned 
pharmaceutical companies; most of them economically inefficient and technologically un-
innovative. By 1997, it was estimated that some 5000 firms were operating in China’s 
biopharmaceutical industry (Cataldo, 1998).11 Only seven years later, the number 
significantly declined to an estimated 900 firms (Chen, Wang, Wen, & Wang, 2007; Ding, 
2007). This collapse was mainly ascribed to the reforms of the regulatory system in 2005 
which lead to stronger local competition and significantly improved the scientific and 
business environment for biopharmaceutical firms. Although reliable numbers are difficult 
to obtain, it was estimated that by 2008, between 300 and 500 biopharmaceutical firms 
remained operating within China (Chervenak, 2009; Langer, 2006). Nowadays, the 
industry not only comprises old state-owned, or formally state owned enterprises, but also 
foreign firms, and a growing number of young and innovative private Chinese firms.  
What attracts firms is the rapidly emerging market for biopharmaceutical products in 
China. Between 2005 and 2009 alone, the market expanded by 211% to an estimated 
output value of 13.5 billion USD (CCM Int. Ltd, 2009). Although it only represents about 
2% of the global market, putting China on 10th position worldwide, it is expected to 
continue growing between 20 – 30% annually (compared to 7% growth for the global 
market) throughout the next decade (Zhou, 2007). China’s market for biopharmaceutical 
products is expected to become the fifth largest in the world within the next three to five 
years (Langer, 2006) and the world’s largest by 2050 (Anon, 2009). These perspectives are 
the consequence of a growing and aging population, increasingly suffering from ‘modern’ 
health problems such as diabetes, obesity and cancer (Jackson et al., 2004). Both the 
                                                 
11
  The abovementioned difficulties in finding reliable information for the biopharmaceutical industry in China 
also holds for estimations concerning the number of operating firms. The quantities above are based on 
information from various sources. In 1997, Cataldo (1998) reports on 5000 firms. In 2005, Chen (2007) 
estimates that 500 companies operate in China’s biopharmaceutical industry. This number is supported by 
Ding (2007) with a reference to the Bio-industry in China annual report 2005. In contrast, Wikipedia’s (2009) 
entry for the industry speaks of 900 firms. Another source, the National Center for Drug Screening of the 
Shanghai Institute of Materia Medica estimates that 1.000 small to medium size biopharmaceutical companies 
operate in China (Wang et al. 2005). In 2007, according to Teh (2007) there are 400 firms. Finally, in 2008, 
BioPlan Associates (2008), a U.S. based consulting company, claims that 500 biopharmaceutical firms are 
active in China while Chervenak (2009) in the most recent article I found states estimates some 300 firms.  
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government and individuals are spending more on health care and the coverage of medical 
insurance has been extended. Alongside market opportunities, the initiation of preferential 
policies and the de-politicization of the Chinese economy have stimulated entrepreneurship 
(Greeven, 2009; Krug, 2004). The significant increase in public spending, targeting 
innovative, technology-intensive companies, encourages overseas Chinese, so called Hui 
Gui’s12, and local scientists alike to establish domestic biopharmaceutical companies.  
During the last few years, the industrial structure of biopharmaceuticals in China has 
been radically transformed, and firms operating in this business environment have 
experienced, and participated in, rapid and fundamental developments towards a modern 
biopharmaceutical industry. How this transformation has taken place and how it affects 
organizations in China’s biopharmaceutical industry is subject of the following sections.  
4.2.1. Industry Structure 
Literature on the biopharmaceutical industry commonly differentiates three types of 
organizations (Pisano, 2006). First, so called Dedicated Biotechnology Firms (DBF), spin-
offs from universities usually founded by scientists (OECD, 2005). Second, 
pharmaceutical firms that specialize in the development of ‘traditional’ drugs and their 
global commercialization. And third, service-providing firms supporting the industry with 
platform technologies, training and financial or legal consulting services (Pharmahorizons, 
2001). The diversity of firms operating in China however requires further distinguishing 
the following three types of DBFs: those founded by domestic researchers, those founded 
by Chinese Returnees, and those financed by diversified Chinese business groups. Each 
carries features similar to North American or European firms, such as indigenous 
innovation, international competitive product pipelines, or global patenting behaviour. In 
addition, however, they exhibit unique features that require and allow them to operate in 
the Chinese business environment (Zhenzhen et al., 2004). Furthermore, I discuss foreign 
firms and traditional Chinese firms separately. To give an indication as to how many firms 
belong to each of these groups, I provide rough estimations based on discussions with 
interview partners, industry experts and colleagues. However, since there is not a single 
organization comprehensively collecting data specifically on the biopharmaceutical 
industry in China, these estimations should be used with caution.  
Foreign Pharmaceutical Companies 
Foreign firms in China are mainly large, multinational pharmaceuticals. The number 
of small to medium size foreign firms operating within China is insignificant. Most foreign 
pharmaceuticals had established subsidiaries in Hong Kong and Taiwan as early as the 
1980s and began re-locating to Mainland China in the 1990s. Initially, foreign 
pharmaceuticals were motivated by the low wages and costs of raw materials, as well as 
access to the Chinese market.  
                                                 
12
 Hui Gui literally translates into ‘sea turtles’. Born at the shore, they grow up at sea, and eventually return to 
the same place to lay eggs. Similarly, Chinese Returnees grow up in China, move abroad for studying and 
working, and eventually return to China. The term was coined in Taiwan in the 1960s, referring to returning 
Taiwanese that significantly contributed to the country’s economic success during that period. I use the term 
Hai Gui’s to refer to Chinese who have studied and worked outside China for more than five years.  
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By 2009, nearly all foreign multinational pharmaceuticals operated R&D centres in 
China, predominantly in Shanghai and Beijing. While they continue to benefit from lower 
costs, estimated to lie at 20% of operations in Western countries, seizing R&D 
opportunities in China is emerging as their primary motivation (Chervenak, 2009).  
Despite this general trend, strategies pursued by foreign multinationals to exploit 
R&D opportunities in China vary significantly, as the following three examples illustrate. 
GlaxoSmithKline (GSK) opened an R&D centre in Shanghai in 2007 with more than 100 
scientists, conducting neurological research. The reasons for this R&D are found in the 
strengths of China’s education system in neurology and oncology. In contrast, Eli Lilly’s 
R&D operations in China began with the opening of a small office in Shanghai in 2003. 
The company selected two local firms as exclusive partners and strategically built up these 
firms capability in regards to the drug delivery process. Eli Lilly did not hire personnel 
specifically for its activities in China. Instead, they flexibly assigned professionals from 
their American R&D centre to China. Their research focuses on disease groups relevant to 
China’s public health profile. Third, Hoffmann-La-Roche began its operations in China at 
the end of the 1990s and nowadays employs 1,700 workers across China. In 2004, it 
opened its fifth global research centre in Shanghai with approximately 80 researchers 
(Tremblay, 2006) and is planning to host some 250 scientists in the near future. Also, 
Roche has started a program supporting spin-offs by its domestic scientists.  
As these examples have shown the strategies pursued by foreign pharmaceuticals 
differ substantially, both with regards to setting up R&D activities, as well as regards to 
developing the Chinese market. The flexible trial and error approach chosen by Eli Lilly 
indicates that there is not a single best strategy. Yet, the economic, scientific and 
institutional impact of foreign MNCs has been considerable. They not only invest in 
manufacturing facilities and R&D, offer attractive workplaces for scientists and transfer 
technologies to China, but also collaborate closely with local and central governments. 
From discussions with industry experts, foreign multinationals represent approximately 2% 
of the organizations in China’s biopharmaceutical industry. 
Traditional, Domestic Pharmaceuticals 
Most of the traditional Chinese firms are spin-offs of former state owned 
pharmaceutical manufacturers or public research institutes. Despite their privatization, 
many remain responsible for the supply of basic medicinal products (such as vaccines), the 
manufacturing of raw materials, generics, Traditional Chinese Medicine (TCM) products, 
and other over-the-counter (OTC) drugs. Many function as wholesalers for the distribution 
of pharmaceutical products. Due to their history and size, traditional Chinese 
pharmaceuticals usually maintain strong relations to central, provincial and local 
governments guaranteeing the sale of their products and offering favourable operating 
conditions. 
Before 2004, traditional Chinese pharmaceutical firms were relatively well equipped 
and well disposed towards advanced technologies. However, they were severely inhibited 
by out-dated manufacturing processes, weak international trading competitiveness, 
duplicate production processes and inflexible management structures (Fu, 2010; Zhenzhen 
et al., 2004). According to my interviews, by 2008 most traditional Chinese 
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pharmaceutical firms had experienced a radical deterioration of their management structure 
and drug pipeline. With disappearing technological capacities, most of the traditional 
Chinese firms abandoned R&D activities and focused solely on commercializing their 
remaining, often uncompetitive drugs.  
Traditional, domestic pharmaceuticals were mostly affected by the regulatory reforms 
after 2004 (Wang, Chen, & Chen, 2005). With out-dated manufacturing processes and 
research facilities, and without the opportunities to raise the capital for investing in GMP 
and GLP facilities, a large number of traditional Chinese pharmaceutical companies were 
shut down. Others were acquired by more innovative, younger Chinese biopharmaceutical 
companies in order to build up manufacturing and sales networks. These developments 
explain the significant decrease of the organizational population of China’s 
biopharmaceutical company after 2004. While management changes, foreclosures and 
acquisitions should continue to further reduce the number of traditional, domestic 
companies, they currently remain the largest type of firm operating within China’s 
biopharmaceutical industry, accounting for approximately 70% of the population 
(Zhenzhen et al., 2004).  
Domestic Dedicated Biotechnology Firms (DBFs) 
During the last decade, the Chinese biopharmaceutical industry has witnessed the 
emergence of domestic Dedicated Biotechnology Firms (DBF) described by the OECD 
(2005) as any biotechnology firm whose predominant activity involves the application of 
biotechnology techniques to produce goods or services. These are either established by 
returning scientists, domestic scientists, or financed by diversified business groups. 
Altogether, they account for approximately 28% of firms operating in China and are 
rapidly growing in number. 
DBFs established by Hui Gui’s  
Chinese DBFs established by returning scientists are now between five and six years 
old. Their founders spent four to fifteen years overseas and obtained graduate university 
degrees. They gained experience in academia or in corporate research centres working for 
multinational pharmaceuticals and larger biotechnology firms, or through running their 
own companies. One distinctive feature of Chinese exchange students during the last 
decades is that they almost exclusively went to highly reputable universities, such as 
Harvard Medical School, Stanford University Medical School, or the Karolinska Institute 
in Stockholm.  
The motivations of Hui Gui’s to return to China are manifold. On the one hand, from 
interviews and discussions I have learned that many had faced discrimination when they 
were abroad. In particular, they felt that this discrimination prevented them from achieving 
career goals which would lead to the highest levels at corporate headquarters or to tenured 
university posts. Others returned for personnel reasons, for instance finding it difficult to 
adequately integrate into their host-society. On the other hand, pull factors have 
increasingly motivated Chinese scientists to return to China (Gross & Connor, 2007). For 
instance, on the personal side, the wish of spouses, or the urge to care for parents in China 
often motivated Chinese scientists to return. In addition, the Chinese government actively 
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encourages their return by designing preferential public policies and funding programs. 
These include direct financial support for professional activities, such as low interest start-
up capital, but also other financial support, such as coverage of tuition fees for children, 
guaranteed access to top universities and the provision of flats or company cars (Edunet, 
2007; Zweig, 2006). Furthermore, Returnees enjoy a very high reputation in Chinese 
society, granting them access to government officials or public administrators (Cheng, 
2005). However, Hui Gui’s also face difficulties upon their return (Fan, 2008). Some may 
have forgotten the customs necessary to manoeuvre within Chinese society, especially 
those that have lived abroad for many decades. While some were able to re-activate their 
domestic network of family and friends, others have complained that for them these 
relationships were much weaker than those of researchers that had not left to study abroad. 
Hui Gui’s thus seem to suffer from weak embeddedness. 
Despite the disadvantages, Chinese DBFs established by Hui Gui’s predominantly 
benefit from the quality of the education and the knowledge and experience of their 
founders. Also, they clearly benefit from a language advantage that facilitates forming 
international cooperation. Within the total firm population within China’s 
biopharmaceutical industry, DBFs established by Returnee’s account for approximately 
12% and are probably the fastest growing and most successful firms nowadays. 
DBFs established by Domestic Researchers 
The second group of Chinese DBFs comprises firms established and managed by 
Chinese scientists without overseas experience. These firms are in general up to five years 
older than the group founded by Returnees. Scientists were attracted by central and 
provincial policies introduced in the beginning of the 1990s and targeted at establishing a 
viable biotechnology industry in China. Chinese DBFs established by domestic researchers 
usually are not well disposed to of the modern scientific knowledge and experience of 
those scientists that studied abroad; nor do they have equivalent language skills (Le Bail & 
Shen, 2008). Nevertheless, their research projects and their products are not necessarily 
less innovative. In many cases it was not the lack of skills and opportunities that kept 
scientists in China, rather they were prevented from continuing their careers abroad by a 
government decision that aimed at keeping these scientists, and their unique professional 
skills, within the country. Nowadays, the domestic researchers establishing 
biopharmaceutical firms face several challenges. First, unlike Hui Gui’s, they suffer from 
reputation problems, as private entrepreneurship still enjoys only low social status in 
China’s society (Cucco, 2008; Goodman, 2008). Especially in the biopharmaceutical 
industry, with its long development cycles and severe uncertainties, the effect of this poor 
reputation discourages scientists from engaging in entrepreneurial activities which would 
mean leaving universities or public institutes where they enjoy a high social status. 
Moreover, they find it harder to establish international collaboration with foreign scientists 
and are regularly denied access to preferential policies, as most policies explicitly aim at 
attracting overseas Chinese scientists. Overall, the number of Chinese DBFs found by 
domestic scientists represents approximately 15% of the total firm population.  
Diversified Business Groups 
Finally, a few of the emerging DBFs in the Chinese biopharmaceutical industry have 
been established through investments made by diversified business groups. During the last 
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decade both central and provincial governments in China have promoted this corporate 
form (Keister, 2001). While they have declined in absolute numbers, their importance for 
China’s economic development has increased throughout the 1990s (Ma & Lu, 2005). 
These business groups are able to diversify risks by investing in unrelated industries and, 
by installing information channels that allowed them to tap into local knowledge, 
identified investment opportunities within China (Keister, 2000).  
Despite the unpromising economic performance of biopharmaceutical firms, a few 
Chinese business groups began heavily investing in the industry. They share a number of 
features. First, they usually had not previously operated in biopharmaceuticals so that 
decision makers usually lack the necessary knowledge to evaluate technologies in regards 
to their development uncertainties or market potential. Second, they rely on a very 
different set of evaluation criteria to allocate investments and to guarantee the commitment 
of their contract partners. One interview partner, for example, was required to convince his 
family to return to China in order to receive financial support from the business group. 
Third, these conglomerates have substantial financial resources at their disposal. Finally, 
by preferring to place in-group peers in decision making roles, they risk being badly 
advised (Keister, 2000; Nooteboom, 2004). Their motive to move into such a high risk 
industry seems counterintuitive. Hence, it remains uncertain how business groups will, in 
the long run, balance their need for sustainable economic return. Their share in the total 
number of firms in the Chinese biopharmaceuticals industry is assumed to account for 1%.  
Final Remarks 
As illustrated, the industry structure of China’s biopharmaceutical industry is rather 
diverse. The following Figure 4.1 illustrates the proportion of firms in each category 
describe above according to the rough estimations gathered during interviews and 
discussions with managers and industry experts in China in 2008. 
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Figure 4.1: Organizational Population in China's Biopharmaceutical Industry 
In the following section, I describe managerial challenges arising from China’s 
rapidly changing institutional environment. In particular, I discuss current developments 
within the regulatory framework, its new financial infrastructure and development within 
the Chinese education system.  
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4.2.2. China’s Regulatory Regime for Biopharmaceutical Products 
Because of their potentially harmful effects on humans, R&D, manufacturing and 
commercialization of biopharmaceutical products are governed by strict regulatory 
regimes. China first issued the Pharmaceutical Regulations in 1978, containing detailed 
rules governing research, clinical trials, test approvals, and manufacturing. These were 
updated in 1984 and substantially revised in the 2001 Drug Administration Law to 
strengthen the regulation of drugs, improve quality and safety standards, and protect the 
health, legitimate rights and interests of the people (Zhonghua Renmin Gongheguo Fagui 
Haibian [Official Decree of the PRC], 2001). Most significantly, the updated law 
contained a licensing framework similar to the one used in the U.S., Japan, and EU, issued 
new regulations for imported drugs and allocated the licensing authority from the Ministry 
of Health to the independent State Food and Drug Administration (SFDA).  
Despite the established similarity with other regulatory systems, China’s regime 
suffered substantial problems related to its enforcement (Lakhan, 2006). The SFDA is 
severely understaffed making it difficult to monitor the biopharmaceutical firms and their 
diverse activities. Further, the administration lacks the necessary scientific expertise to 
assess the validity of laboratory and clinical trial results. Most severe, however, have been 
the effects of a series of corruption scandals among public officers on the enforcement of 
China’s regulatory regime (Zhang, 2009).  
Corruption Scandals 
In 2006, a major scandal shocked China’s biopharmaceutical industry. Leading 
officials of the SFDA including the administration’s highest commissioner, Zheng Xiaoyu, 
were charged for bribery. The scandal attracted wide international attention from 
governments, media, and industry (Barboza, 2007; Jia, 2007; The Economist, 2007) and 
the unusually quick execution of the death sentence of Zheng was widely interpreted to 
reflect the damage the scandal had done to the reputation of the Chinese regulatory 
framework and its domestic products. During the following years a number of smaller 
scandals concerning milk-powder scandal or poisoned pet food scandal followed. 
The series of scandals had two immediate effects on the daily operations of the 
SFDA. First, it required re-evaluting a large number of applications that had been granted 
by the former administration. This resulted in lengthened processing times for clinical trial 
or drug market approvals. Regularly, during field research, interview partners complained 
about the slow ‘grinding mills’ of the SFDA. Second, it led to substantial uncertainties on 
the side of SFDA officers. Although some of the licensing violations had been facilitated 
by corruption, in most cases the SFDA simply did not dispose of the necessary monitoring 
capacity. SFDA officers realized that punishment would follow political motivations and 
be disproportionally severe in order to restore public confidence in the regulatory system. 
This situation discouraged administrators from cooperating with firms seeking regulatory 
approval. As one interview partner commented “..officers seem to have disappeared, and 
they certainly do not want to be seen in public with corporate representatives out of the 
fear of being charged on the grounds of bribery.” 
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Significant Improvements during the Last Years 
The scandals have led to a number of significant changes in China’s regulatory 
environment. In 2006, the government reduced the autonomy of the SFDA by merging it 
with the Ministry of Health (Chen et al., 2007). The Ministry, not the SFDA, is now 
responsible for drafting the rules and regulations and as the Ministry had previously been 
responsible for regulating hospital affairs, the reforms improve the alignment of the 
interests of hospitals with those of the biopharmaceutical industry. Shortly after the 
merger, the Ministry of Health began implementing new levels of reviews and officialdom. 
One of its first measures aimed at reducing corruption among doctors during clinical trials 
(Holden, 2008a). In addition, new GMP guidelines were introduced, facilitating the 
monitoring by increasing the number of enforcement officers and imposing joint liability 
on Chinese agents of foreign device manufacturers. Finally, an agreement between the 
Chinese and the U.S. government resulted in the establishment of three U.S. FDA offices 
in China to streamline international approval projects (Holden, 2009). 
A Regulatory Challenge: Regulate Fair or Efficient? 
The variety of firms in China’s biopharmaceutical industry continues to be a 
challenge to the monitoring and enforcement duties of the SFDA. Firms differ significantly 
in their quality of R&D, their inclination towards compliance (or non-compliance) with IP, 
their willingness to use political power or their strategies towards pricing, marketing and 
distribution. This heterogeneity poses severe challenges. Strict regulations have to be 
implemented and enforced to minimize the risk of further scandals. At the same time, 
innovative projects need to be supported by regulations that allow efficient management of 
applications and approval processes. By treating all firms equally, the authorities reduce 
the likelihood of further scandals, yet at the same time obstruct the innovative potentials of 
Chinese DBFs.  
The frequent and unpredictable changes in China’s regulatory framework pose 
significant uncertainties for biopharmaceutical firms. The introduction of stricter 
regulations has already reduced the number of traditional Chinese biopharmaceutical 
firms. With growing competition, brought about by the release of more innovative 
products, and a stronger focus of government policies upon Chinese DBFs, the survival of 
those still operating in China remains threatened. Young innovative Chinese 
biopharmaceuticals, despite their globally competitive products, face severe reputation 
problems outside China, most notably in key markets in North America, Japan and 
Western Europe. In addition, as the SFDA has no mechanisms to distinguish between 
corrupt and innovative activities in nearly any phase of the development cycle, innovative 
firms are being lumped together with all other firms and thereby suffer from ‘regulatory 
discrimination’.  
The Intellectual Property Right System in China 
The Intellectual Property Right (IPR) system in China was first introduced in 1984 
and amended in 1992 and 2000. The latest revision came into effect in 2009 containing 
important amendments such as the mandatory ‘China-first’ requirement, the mandatory 
disclosure of genetic sources when filing inventions, and the law forbidding the use, 
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production and import of patented drugs (Lam & Liu, 2009). In addition, the government 
implemented new regulations concerning counterfeit drugs, permitting prosecutors to level 
criminal charges against drug producers. However the wording of the amendment remains 
vague. For instance, prosecution is allowed when counterfeit products ‘cause substantial 
harm to human health’, a position that is far from easily established (Holden, 2008b).  
In the opinion of Western Media, the protection of IPR in China remains of concern 
(Economist, 2010). However, IPR disputes in the biopharmaceutical industry in general are 
fairly common (Slutsker, 1991) and hardly only happen in developing countries. The first 
agreement in biotechnology for instance, signed in 1982 between Genentech and Eli Lilly, 
resulted in a decade long legal dispute over the IP rights to a human growth hormone. 
IP protection in fact represents a greater or lesser threat to different sectors of the 
industry, affecting each depending on the knowledge underlying its products. For 
biopharmaceutical R&D at an early stage, patents primarily serve to secure rights on future 
earnings and attract investments. Projects at this stage are complex and dependent upon 
tacit knowledge, so that even copying results is usually not sufficient to misappropriate 
technologies. Concerns about China’s IPR system are mainly raised by foreign 
multinationals and larger domestic pharmaceuticals, especially when generating substantial 
revenues in China or when expecting to do so in the near future. More problematic 
however are illegal counterfeits of commercialized drugs. Infringements of IP lead to 
uncertainty amongst customers, both inside and outside of China, damage the reputation of 
individual products and of Chinese products in general.  
R&D activities in China, however, do not seem affected by IP enforcement problems. 
The new generation of Chinese DBFs seems to have imported global patenting norms, a 
trend interpreted as an important step for China to develop a fully functioning IPR system 
(Teh, 2007). Consequently, hardly any of the interview partners of younger 
biopharmaceutical firms were overly concerned with IP issues. Traditional domestic and 
DBFs founded by domestic researchers usually do not patent their technologies, and some 
industry experts raised concerns that this naïve patenting behaviour might pose a serious 
risk to the domestic industry in the future. Foreign firms and those found by Hui Gui’s 
tend to favour international patents. Although confidence in China’s IPR exists, many 
firms invest the time, effort and significantly higher costs to obtain patents in the U.S. or 
EU because government grants and investors evaluate the innovativeness of firms 
according to their international patent portfolios. In sum, as one interview partner in 
Shanghai commented, “IP is of concern in China, but would be a concern elsewhere in the 
world”.  
4.2.3. HR in China’s Biopharmaceutical Industry 
Success and failure in the biopharmaceutical industry is closely linked to the 
professional qualification of employees. In the early years of China’s emerging 
biopharmaceutical industry cheap labour was one of the main reasons for foreign firms to 
relocate to China (Wang et al., 2005). Nowadays, foreign firms are relocating more R&D 
activities to China; a trend is partly accounted for by improvements in China’s human 
resources.  
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China’s government has greatly increased the admission numbers for students in 
higher education. Some articles on the state of China’s universities  are both bewildered by 
and admiring of the opportunities that have come along with such rapid change (Langer, 
2007b). Others, while acknowledging the government’s efforts, are more cautious in their 
judgment. The capacity extensions at universities significantly increases demand for new 
faculty members. Young faculty however lacks research and teaching experience, 
negatively affecting the quality of education (Xin & Normile, 2008). As a result, a large 
number of less well prepared young scientists arrive in the industry. Another notable trend 
has been the decrease in employee turnover rates. Until 2007 managers complained about 
high HR turnover rates, some of which lay above 30% with employment periods of fewer 
than six months. Recently, this situation has drastically changed. The larger availability of 
employees has made it more difficult for ‘high-turnover’ candidates to find new positions. 
Newcomers on the labour market, especially, recognize the benefits of long-term 
participation in research projects. 
The increase in the universities’ capacities was initially welcomed by firms in the 
biopharmaceutical industry. However, its main transitory effect is the deterioration of the 
quality of education. The significant decrease in employee turnover rates encourages firms 
to invest more in training, since employees are more likely to remain with the organization, 
this training ultimately benefit the firms.  
4.2.4. An Emerging Financial Infrastructure 
The lack of financial resources is a chronic complaint within the biotechnology 
industry. The relatively long duration of research cycles, the above average degree of 
uncertainty, and the strict regulatory constraints, have made biopharmaceuticals, overall, 
an economically unviable industry (Pisano, 2006). In developed countries, government 
funding, public and private investors, Venture Capitalists (VC), and larger companies 
finance R&D. In China, most of these financial sources either do not exist or are emerging. 
Chinese firms, for instance, have only limited access to start-up capital provided by banks 
(Hu, 2004). China’s stock exchanges in Shanghai or Shenzhen contain high hurdles 
intended to protect investors, yet also discouraging firms from going public. Some of the 
larger Chinese biopharmaceuticals have instead been listed abroad on stock exchanges 
such as the NASDAQ or the Canadian Stock Market in Toronto. In addition, restrictions 
on exporting capital make long term investments less attractive for foreign investors (Frew 
et al., 2008). Consequently, the main financial source for most domestic biopharmaceutical 
companies remains the central and in some cases provincial governments.  
Many smaller companies – especially those found by Returnees – seek investment 
from informal networks among family and friends. These investments are by no means 
minor figures. In those cases interviewed ranged between five and $US 20 million. In 
addition, the number of foreign VC firms that attended science and research fairs in China 
has increased significantly. These firms have at least investigated China’s 
biopharmaceutical industry for attractive investment opportunities.  
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4.2.5. Industry Associations in China 
Industry associations take a mediating function between groups of firms of a certain 
industry and local and national governments. They offer a platform for firms to voice 
concerns and express criticism. At the same time, by requiring members to reach 
consensus over relevant issues, they allow governments to conceive a conjoined 
perspective on current issues within a sector (Greenwood, Suddaby, & Hinings, 2002). In 
China, industry associations due to their history in a socialist economy do not perform this 
function. Instead, they serve as a top-down information channel for the government. 
The survey results reflect this situation, yet show a more nuanced picture of the 
regulatory environment. Half of the participants disagreed with the statement that industry 
associations hold substantial practical knowledge, while 34.8% only slightly agreed, and 
none of our partners strongly agreed. At the same time, 81.4% complained about the high 
amount of policies that they had to comply with, and 55.1% argued that policies change 
frequently. More than two thirds (70.2%) did not believe they were in any way able to 
participate in the design of policies or regulations. Yet, on the other hand, interviews in 
Beijing and Shanghai revealed the formation of informal networks of DBFs functioning as 
quasi-industry associations. These are consulted by central and provincial governments 
when designing new policy instruments and are thereby taking over the function of 
industry associations.  
4.3. Conclusion 
Firms in China’s biopharmaceutical industry face the same technological and 
organizational challenges as biopharmaceutical firms elsewhere. They need to find 
mechanisms to manage the long, costly, and profoundly uncertain R&D cycles, as well as 
developing procedures that allow cumulative learning to benefit from the variety of 
available technologies. One widely acknowledged strategy to integrate various 
technological approaches is that of engaging in inter-firm relations with different 
organizations. The Chinese business environment aggravates these challenges through a 
rapidly changing institutional architecture and a variety of organizations operating in 
different manners. China’s regulatory regimes, particularly in respect to licensing, clinical 
trials, commercialization and IPR protection have undergone significant changes. These 
changes, especially the recent developments around the regulatory body responsible for 
drug approvals in all stages (the SFDA), significantly challenge biopharmaceutical 
businesses. The lack of adequate human resources can be accounted for by the unbalanced 
changes in China’s education system. This issue, in combination with the demand for 
highly skilled employees significantly challenges firms. The government pressures the 
industry as a whole to develop innovative drugs, economically motivated to develop a 
viable knowledge sector and politically forced to develop the competences to deal 
domestically with a deteriorating public health profile. As a result, China’s 
biopharmaceutical industry is expecting to begin commercializing a large number of new 
drugs within the coming years. The success of this objective is inhibited by incapacities in 
regards to logistics and marketing and the bad reputation of Chinese biopharmaceuticals in 
key markets abroad. The lack of effective representation and subsequent communication 
between policy makers and organizations in China adds to these challenges.  
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The absence of appropriate managerial techniques, the diverse range of firms 
operating in China, and the subsequent diversity in inter-firm relations make the 
biopharmaceutical industry in China a unique setting for studying management innovation 
on an inter-firm level. The hope in China’s biopharmaceutical industry to become the 
largest consumer market in the world by 2050 significantly depends on the development of 
effective organizational structures and managerial techniques. How and when management 
innovation takes place in China thus is not alone of theoretical concern but for policy 
makers and managers of significant empirical relevance as well.  
 

Empirical Study of Inter-firm Relations 
71 
5. Empirical Study in China’s Biopharmaceutical Industry 
Between 2007 and 2008, I contacted Chinese firms in the biopharmaceutical industry 
to explore how they interact with other firms and how these interactions lead to 
management innovations. I used four independent contacts to identify and approach 
Chinese biopharmaceutical firms. These initial contacts were two managers of technology 
parks focusing on biotechnology in Shanghai and Beijing, a former CEO of a large 
European multinational pharmaceutical firm who had been working in China’s 
biotechnology industry for over 15 years, and a former classmate at the China Europe 
International Business School (CEIBS) who helped me identify other alumni working in 
the industry. All four contacts were instrumental in getting access to interview partners and 
gaining their trust. Having identified local firms, I continued with a snowball sampling 
technique to locate additional interview partners. In snowball sampling, interview 
respondents are asked after the interview to recommend at least one other company for 
interviews.  
5.1. Data Collection and Measurements  
I used a mix of collection techniques to gather information. A one page summary of 
the research project was sent to potential interview partners beforehand.13 Upon a positive 
response, I conducted protocol guided interviews with senior and middle managers of 
Chinese biopharmaceutical companies.14 Interviews were conducted in English or with the 
help of Chinese translators. The interviews were facilitated by the fact that most of the 
interview partners were well educated and regularly communicated in English for 
professional reasons. The interview protocols contained both open and closed questions. In 
addition, I used a closed questionnaire which respondents filled out after the interview and 
usually returned via mail.15 The questionnaire was available in both languages. To 
guarantee accuracy in the Chinese documents, the English questions went through a 
process of back and forth translation by three professional and independent translators. The 
interview protocol and the questionnaire were used to collect background data on the 
interviewed firm, one of their cooperation partners and information on the relational, 
structural and environmental conditions under which the partnership operated.  
5.1.1. Interview Partners 
In total, I conducted 64 interviews, of which eight were eliminated because 
respondents were either unwilling or unable to disclose enough information. Three of the 
interview partners did not return the questionnaire, so that important data for the analysis 
was missing. Others claimed not to have any ties to other organizations, provided highly 
implausible information, or statements which were later falsified by their colleagues. For 
the analysis, I only considered inter-firm relations when one of the partner firms could be 
identified as a Chinese biopharmaceutical firm, i.e. a firm registered and operating within 
                                                 
13
  The project description is available in Appendix A (English) and B (Chinese). 
14
  The protocol used during the interviews is available from the author upon request. 
15
  I will occasionally refer to the closed questionnaire as survey. The document is available from the author upon 
request.  
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China, owned or managed by Chinese and engaged in the development or 
commercialization of pharmaceutical products based on biotechnology. I only interviewed 
one partner of each inter-firm relation. Although there are disadvantages associated with 
the use of single informants, I opted for this strategy in order to be able to interview a large 
number of organizations whist remaining within the constraints of both time and budget. 
Despite its disadvantages, there are certain advantages of using single informants, such as 
reducing the “… variation in informational and motivational biases across organizations 
…” (Doty et al., 1993: 1210).  
On average the interviews took one hour and twenty-six minutes and were mainly 
conducted on the company premises (in 85% of the interviews). I interviewed senior 
managers (81% of the interviewees) and middle managers with firsthand knowledge on the 
partnerships of their company. In most cases, my interview partners were the founder or a 
founding member of the company.  
For instance, a typical interview partner was Dr. Yu, who received his PhD from 
Harvard Medical School, where he continued to work for a few years after his graduation. 
In 2003, he and three Chinese scientists, who were studying and employed overseas 
established a company in Shanghai’s Zhangjiang High Tech Development Park. All 
founding members had lived abroad for many years, were educated in the U.S., some 
continued working abroad. Another, rather remarkable, interview partner was Dr. You who 
was born in the 1950s into a middle class family. During the Cultural Revolution his 
parents were accused as counterrevolutionaries so that Dr. You was prohibited from 
attending school. At the age of 15 he joined the Communist Youth Movement, working on 
an oilfield in the Northern Province of Heilongjiang. There, he prepared for the university 
entry exam and after the Cultural Revolution, when the education system was re-opened, 
he was admitted to medical studies. After his studies Dr. You was teaching at various 
universities in China. In the meantime a Canadian university accepted his application for 
enrolment in a PhD program in biochemistry. After graduation, he held various positions at 
biopharmaceutical companies in the U.S. and managed the biometric R&D department of a 
large American based telecommunications corporation. In 2003, attending an event of the 
Overseas Chinese Club, he was approached by a government official offering him a 
substantial amount of money to open a company in China. One year later, Dr. Yue returned 
to China and opened a firm developing devices for molecular diagnostics. A third partner, 
Mr. Xu, provides a contrast with the previous two interview partners, as he never left 
China. He finished a bachelor degree in biochemistry at Beijing’s Tsinghua University and 
worked for foreign pharmaceuticals, such as Astra Zeneca and Novartis in China. He also 
received an MBA from a U.S. university, through distance education. In 2004, Mr. Xu and 
two other friends, both of whom were scientists, founded a biopharmaceutical company 
developing cancer detection and diagnostics technologies in Beijing.  
As in the case of the three examples, most interview partners were predominantly 
Chinese (85%) with international experience (60.4%), holding a PhD degree in medicine 
(43.6%), chemistry (23.6%), or biology (14.5%). Only three (5%) respondents indicated 
that they were a member of the Chinese Communist Party (CCP); about 91% stated that 
they were not a member of the CCP, 4% of respondents did not say whether or not they 
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were members of the CCP. Hence, the particular political background of China does not 
play an apparent role in this industry.  
5.1.2. Interviewed Firms 
The firms they established or worked for were mainly registered in Beijing (25.0%) 
and Shanghai (56.7%) and rather young, on average 7.5 years old. They were 
predominantly private firms (68.3%), some being collectively owned (18.3%), and a few 
firms were state-owned (10.0%). Most were biopharmaceutical firms (68.3%), some 
biotechnology service firms (13.3%), and pharmaceutical firms (10.0%). As has been 
mentioned in the previous chapter, the organizational population in the Chinese 
biopharmaceutical industry is rather diverse, differing in size, origin, or ownership form. 
While it is therefore difficult to describe typical cases, the following three examples 
provide some insights into the diversity. 
WolwoPharma was founded in 2002 by two Chinese scientists who studied and 
worked in Boston for nearly a decade. In 2000, they decided to return to China and 
established WolwoPharma, located in Coahejing Hi-Tech Park, one of the older and 
smaller technology parks in Shanghai. At the time of the interview, the company employed 
around 300 employees, developing and producing allergy tests and vaccinations. Whereas 
many firms focus on a selection of product development phases, Wolwo covers the entire 
product cycle from basic research to commercialization. Its main market remains in 
mainland China, but from 2008 onwards the company began exporting products to 
countries in South-East Asia, the Middle-East, and South America. In contrast to 
WolwoPharma, OrienGene is typical of smaller and more research oriented Chinese 
biopharmaceutical firms. The company was founded in 2005 and is located in Beijing’s 
Zhongguancun Biotech Park. OrienGene’s founder, a Chinese scientist who received his 
PhD in Sweden, had already gained experience managing his own biotech company in 
England, which he sold in 2004. Returning to China, he opened his second company for 
the development of therapeutic products. At the time of the interview, the firm employed 
15 scientists and was struggling to develop a strong position both within Beijing’s high-
tech community and within China’s market for therapeutics. Lastly, Wison Biopharma is a 
division of the Wison Group, a typical Chinese business group with operations in 
engineering, chemical machinery, telecoms, and real estate. Wison’s founder had already 
ventured into drug development during the 1990s, then strongly focusing on Traditional 
Chinese Medicine (TCM). Although this venture failed, his interest in medicinal drug 
design remained. Wison’s biopharma division was established in 2004 with investments of 
US$49 million from its larger business group. It is located in Zhangjiang Hi-tech Park in 
Shanghai, China’s largest and most modern technology park and the firm develops and 
commercializes therapeutics and human vaccines.  
5.1.3. Inter-firm Relations in the Analysis 
Although most of the interviewed firms cooperated with more than one organization, 
I insisted on focusing the interviews on only one of their partnerships in order to collect 
enough in-depth information. At the beginning of each interview, I asked respondents to 
think about one ongoing inter-firm relation that they consider important for their firms’ 
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overall success. The control question in the survey showed that most interview partners 
considered the discussed partnership as very important (56.7%) or important (30.0%).  
The inter-firm relations that were discussed during the interviews existed 
predominantly between, either two biotechnology firms (19%) or a biotechnology firm and 
a biotechnology service firm (21%). With few exceptions inter-firm relations were formed 
in order to pursue scientific projects for drug or diagnostics development, or to 
commercialize products. AUAM Biotech, for instance, cooperated with a clinical trial 
hospital in Beijing to test a monoclonal antibody for cancer treatments, which required 
developing and implementing operating procedures and training modules for trial doctors. 
In other cases, young biopharmaceutical firms began cooperating to provide an array of 
research services to third parties. This strategy was commonly pursued in order to remain 
financially viable and cross-subsidize R&D activities. Inter-firm relations with foreign 
firms were regularly established to get access to technologies, or to make use of the 
significantly lower R&D costs in China. On average, the firms on which I am focusing had 
worked together for two and a half years; only 16 (28%) had a contractually agreed upon 
time limit upon their cooperation, whereas 41 (72%) did not limit the duration of their 
cooperation. About half (51%) were either initiated by a Chinese individual who had either 
studied or worked abroad for more than 5 years, or had hired an employee who had done 
so. Among the 56 inter-firm relations examined, 51% were purely domestic, i.e. between 
two Chinese firms; six had a partner outside of China but within Asia (usually in Hong 
Kong or Japan), and 22 (39%) had a partner outside of Asia, either in the U.S. or in 
Europe. Most of them met weekly (52%), about a quarter met daily (24%) and a similar 
number met only monthly (21%). The majority (82%) did not share physical facilities. 
Others used offices or laboratories jointly. For instance, the partnership between a local 
biopharmaceutical company and the research division of a large multinational 
pharmaceutical firm shared office space and production facilities on the same premises. 
The close proximity involved in this partnership served to facilitate collaboration on 
research projects.  
5.1.4. Identifying Management Innovations 
To identify and assess management innovations developed by inter-firm relations, I 
asked respondents towards the end of each interview to describe how the relation with their 
partner allowed them to cope with existing challenges or to seize opportunities. This last 
part of the interview was open, and was used as a first step towards identifying 
management innovation. This section took approximately one third of the interview’s 
duration. During this time, respondents described how they tried to deal with difficulties 
arising from China’s regulatory environment, financial pressures, R&D challenges or 
problems with employees. Furthermore, interview partners regularly illustrated new 
organizational structures and business models that had been implemented in order to take 
advantage of emerging market opportunities within China. I focused these interviews on 
management instruments that had been recently developed and introduced after the 
formation of the partnership and that would not have been possible without the 
participation of both inter-acting firms. To gain further understanding of the underlying 
motivations, logic and objectives I used non-directive questions and, after each interview, 
cross-checked observations with assistants.  
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Some of the inter-firm relations between Chinese and foreign biopharmaceuticals, for 
example, introduced HR development schemes which included video conference training 
for employees, presentations by foreign scientist, and exchange programs which allowed 
employees to visit research facilities in Europe or the U.S. These cases of management 
innovation were used to facilitate joint research between the cooperating firms, or to 
decrease HR turnover by providing employees with attractive workplaces. In other cases, 
firms in cooperation with consulting companies or VCs established ties with inefficient 
pharmaceutical companies, essentially integrating downstream activities in preparation for 
the market approval of their products. This new organizational structure required the 
implementation of various practices to connect and integrate these activities. In another 
case, triggered by the cooperation with a foreign institute, a firm implemented a 
management structure to address requests from domestic and foreign customers separately.  
5.1.5. Three Dimensional Assessment of Management Innovations 
Any empirical analysis of management innovation essentially rests on determining 
the degree of newness of a given practice, process, or structure. As has been shown in the 
literature review, there are a variety of approaches to determine the ‘newness’ of an 
innovation. Aside from disagreement regarding the appropriate unit of adoption, i.e. to 
whom, what, or where something has to be new, there are substantial cognitive aspects 
related to determining newness. Most importantly, single response and social desirability 
biases have to be reduced (Dewar et al., 1986; Kelley, 1976). To assess the newness of 
identified management innovations, I used 35 additional open-end interviews with industry 
experts, consultants, politicians, IP lawyers, university professors and managers of 
technology parks. I conducted these interviews whilst conducting my field research.  
During the expert interviews, I discussed management innovations that we had 
previously identified. Experts regularly made statements in reference to either an industrial 
context, i.e. biopharmaceutical, or to a national context, i.e. Chinese, in order to assess the 
newness of particular innovations. A common argument ran as follows: “This is fairly 
common in China but I have not seen this among biopharmaceutical firms”. For instance, 
investment practices by diversified business groups were not new to China but were newly 
introduced to the biopharmaceutical industry. It was also argued that “This is standard 
practice in the U.S., but it’s the first time I hear about it in China”. For instance, 
establishing an external scientific board was considered common in the industry but had 
not been used before within China. In addition, reference was made to a practice being 
applied in one region of China but being new to another region. These regions usually 
referred to China’s larger biopharmaceutical clusters in and around Beijing, Shanghai and 
Guangzhou. Thus, instead of using a single dimension, experts in the industry used three 
contextual dimensions to assess the newness of management innovation. These dimensions 
were not mutually exclusive. Management innovations could be new to the 
biopharmaceutical industry or new to China. They could, however, also be new to both 
contexts. To reflect this contextual diversity in assessing the newness of managerial 
innovations, I developed a three dimensional coding scheme. In this scheme the newness 
of a management innovation was determined by considering its newness in the 
biopharmaceutical industry (industrial context), its newness in China (national context), or 
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its newness in one of China’s main biotechnological regions, namely Beijing, Shanghai, or 
Guangzhou. 
Using these criteria, I presented experts with cases of management innovations and 
asked them to specify whether a given case was new to any of the three contexts. This 
process of coding management innovations was inductive, with parallel running processes 
of coding and recoding throughout the year. Additional interviews provided further 
information that corroborated or falsified previous assessments. To measure the newness 
of management innovations in China’s biopharmaceutical industry, I implied a ranking 
order between the three dimensions based on the difficulty of introduction. In particular, I 
considered introducing a new management idea to China easier than introducing a new 
management idea to the industry. The high degree of specialization of the industry and the 
large number of highly qualified returning Chinese scientists (Frew et al., 2008; Xu, 2009) 
seemed to facilitate the transfer of management innovations to China. I consequently 
prioritize the industry dimension over the country dimension.  
In sum, this multi-dimensional assessment of the newness of management innovation 
(Gupta, Tesluk, & Taylor, 2007) is empirically grounded by the fact that it considers the 
assessment of industry experts; it avoids pro-innovation biases by relying on independent 
judgments and it is strongly context dependent due to the fact that it allows a separate 
assessment of management innovations as being newly introduced to the 
biopharmaceutical industry or newly introduced to China. The following Venn diagram in 
Figure 5.1 illustrates the assessment of the newness of management innovations.  
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Figure 5.1: Calibration for Assigning Newness of Management Innovation 
Management innovations that are new to both the biopharmaceutical industry in 
general and new to China received the overall newness score of 1. Those that are neither 
new to the industry, nor to China or to one of the Chinese regions receive the score 0. The 
implied ranking allows the assignment of gradual newness scores to each management 
innovation on a scale from 0 to 1.  
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In total, I identified 72 management innovations. Within this set, 16 (22.2%) were 
coded as new to both the biopharmaceutical industry and to China. For instance, reversed 
outsourcing of R&D activities from China to the U.S., was considered new to the industry 
and new to China. Most management innovations were considered only new to the 
industry (26.4%, n=19) or new to China (33.3%, n = 24). The upstream integration of 
manufacturing capacities made available by acquiring inefficient state-owned 
pharmaceuticals for instance was considered new to the biopharmaceutical industry, yet 
was not necessarily new to China. Merely seven were new to only one of China’s regions 
(6.9%, n = 5), such as the implementation of standardized HR development systems. Table 
5.1 provides descriptive statistics for the three dimensional construct of newness. As 
should be expected, industry and country dimensions are negatively correlated, indicating 
that it is most difficult to develop and introduce management instruments that are new to 
both China and to the industry. The significantly positive correlation between the country 
and the regional dimension is explained by the natural subset relation between the two 
dimensions.  
Table 5.1: Descriptive Statistics and Cross Correlation for Newness Dimensions 
  Mean SD 1 2 
1 Industry .569 .498   
2 Country .555 .500 -.383*  
3 Cluster .708 .457 -.435* .717* 
Note: * Correlation significant at the 0.01 level (2-tailed). 
 
5.2. Calibrating Managerially Innovative Inter-firm Relations  
Based on set-theory, QCA entails the definition of gradual membership scores from 
full non membership [0.0] to full membership [1.0]. To calibrate the set of managerially 
innovative inter-firm relations, I assigned membership scores in the set of managerially 
innovative inter-firm relations according to four guidelines:16 
(1) Inter-firm relations with more than two management innovations, or partnerships 
with two management innovations of which one is new to China and the industry 
receive the full membership score [1.00] in the set of managerially innovative 
partnerships.  
                                                 
16
  Some inter-firm relations developed more management innovations than others. Computing simple weighted 
averages among all partnerships, however, would disproportionally penalize a partnership with a single highly 
innovative management tool in comparison to one with two management innovations, one highly innovative 
one and one ‘incrementally’ innovative. 
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empirical data in a high-tech industry I was not able to develop a scale for specialization. 
Most studies operationalize specialization as the percentage of professionals in the 
workforce, or as the range of professions present in an organization (Damanpour, 1996). I 
collected some of the information but nearly all employees engaged in the partnerships 
were professionals and it was not possible to meaningfully separate their educational 
background. Consequently, I could not include specialization as a facilitating condition in 
the configurational analysis. The following paragraphs list the items and explain the logics 
underlying the calibration technique for the remaining six facilitating conditions. The 
numbers in squared brackets indicate the assigned membership scores.  
5.3.1. The Set of Mutually Dependent Inter-firm Relations 
Membership in the set of mutually dependent inter-firm relations is calibrated using 
five questionnaire items that measure the level of trust existing between the two firms. 
Scores of all five items were weighted equally and normalized to represent membership in 
the set of mutually dependent inter-firm partnerships. 
Table 5.2: Items in the Set of Mutually Dependent Inter-firm Relations 
Item 
no. 
Question Answer option Membership 
score 
1 How did you identify your partnering firm? 
Prior social ties 
Third party referral 
Impersonal circumstances 
[1.0] 
[0.7] 
[0.0] 
2 Did any of you make significant investments for the partnership? 
Yes 
No 
[1.0] 
[0.0] 
3 Did the other party match that investment? Yes No 
[1.0] 
[0.0] 
4 
Age of inter-firm relation (in years): 
Membership scores assigned by 
percentiles 
5 - 8 (12%) 
3 - 4 (35%) 
2 (28%) 
0 - 1 (25%) 
[1.0] 
[0.6] 
[0.3] 
[0.0] 
5 How frequently do you meet? 
Daily (24%) 
Weekly (52%) 
Monthly (21%) 
Less frequently (3%) 
[1.0] 
[0.6] 
[0.3] 
[0.0] 
 
5.3.2. The Set of Heterogeneous Inter-firm Relations  
Membership in the set of heterogeneous inter-firm relations indicates the degree to 
which partnering firms differ in operations, organizational forms, and geographical or 
cultural origins. I used the following five items to define the set of heterogeneous inter-
firm relations. All items were weighted equally to represent membership scores ranging 
from full non membership [0.0] to full membership [1.0]. 
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Table 5.3: Items in the Set of Heterogeneous Inter-firm Relations 
Item 
No. Question Answer option Membership score 
1 Categorical distance on value chain17 
Other18 
Pharmaceutical firms 
Biotechnology Service 
Research Hospital 
Univ. labs, Research Inst. 
Biotechnology firm 
[1.0] 
[0.8] 
[0.6] 
[0.4] 
[0.2] 
[0.0] 
2 Age difference between firms (in years) 
> 40 
9-15 
4-8 
0-3 
[1.0] 
[0.6] 
[0.3] 
[0.0] 
3 Difference in ownership form 
Private & SOE 
Private & Coll./ Coll. & SOE 
Same ownership 
[1.0] 
[0.7] 
[0.0] 
4 Place of registration 
Intercontinental 
Continental (Japan/ Korea) 
Domestic, incl. HK & Taiwan 
[1.0] 
[0.7] 
[0.0] 
5 Presence of Returnees Yes No 
[1.0] 
[0.0] 
The presence of a Returnee did not make it more or less likely that firms would 
establish partnerships with foreign companies, so the two items independently accounted 
for geographical and cultural heterogeneity. Scales were equally weighted and normalized 
to range from no membership [0.0] to full membership in the set of heterogeneous 
partnerships [1.0].  
5.3.3. The Set of Decentralized Inter-firm Relations 
To measure membership in the set of decentralized partnerships, I used three 
questionnaire items. These were equally weighted and transformed linearly to indicate 
membership in the set of decentralized partnerships ranging from no membership [0.0] to 
full membership [1.0].  
Table 5.4: Items in the Set of Decentralized Inter-firm Relations 
Item 
No. Question Answer option Membership score 
1 Describe the style of decision making in the partnership 
Consensual 
Neither consensual nor 
hierarchical 
Hierarchical 
[1.0] 
[0.5] 
 
[0.0] 
2 Employees are included in the decision-
making process Seven point Likert scale
19
 
[1.0] 
[0.0] 
3 Leadership groups take most of the decisions within the partnership Seven point Likert scale 
[1.0] 
[0.0] 
                                                 
17
  I have used a standard value chain of the biopharmaceutical industry (Ernst & Young 2006; Pisano 2006). 
18
  Others include: Industry associations, technology parks, VCs and public authorities. 
19
  Throughout the closed questionnaire I used a seven point Likert scale measuring the agreement of respondents 
with statements from [0] disagree to [1] agree.  
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5.3.4. The Set of Formalized Inter-firm Relations 
Membership in the set of formalized inter-firm relations is measured by four binary 
items from the questionnaire. I have weighted all items equally and transformed the values 
to a scale ranging from 0 to 1. Inter-firm relations that had installed all four elements 
received the full membership score [1.0] in the set of formalized partnerships; those with 
three out of four formalization elements were counted as nearly full members [0.9], those 
with only two out of four alternatives received the membership score of [0.6], and those 
with only one element were counted as not quite being members in the set [0.3]. All others 
received a membership score of [0.0].  
Table 5.5: Items in the Set of Formalized Inter-firm Relations 
Item 
No. Question Answer option 
Membership 
score 
1 Existence of a contractual agreement Yes No 
[1.0] 
[0.0] 
2 Presence of a system of rules and regulations governing the activities of the inter-firm relation 
Yes 
No 
[1.0] 
[0.0] 
3 Presence of formalized training programs Yes No 
[1.0] 
[0.0] 
4 Clear division of labor between the partnering firms 
Yes 
No 
[1.0] 
[0.0] 
 
5.3.5. The Set of Vertically Differentiated Inter-firm Relations 
To measure the degree of vertical differentiation within inter-firm relations, I used 
four items in the questionnaire. Theories on administrative innovation find that 
administrative leaders have a stronger impact on management than scientific leaders 
(Chompalov et al., 2002). Therefore, I have ranked administrative leadership positions 
higher than scientific leadership positions. I have weighted the two items on the 
hierarchical structure and the form of decision-making processes equally. Given 
administrative and scientific leadership positions and hierarchical structures and decision-
making processes, partnerships receive the membership score of [1.0] in the set of 
vertically differentiated inter-firm relations. 
Table 5.6: Items in the Set of Decentralized Inter-firm Relations 
Item 
no. 
Question Answer option Membership 
score 
1 Are there designated administrative leadership positions within the partnership? 
Yes 
No 
[1.0] 
[0.0] 
2 Are there designated scientific leadership positions 
within the partnership? 
Yes 
No 
[1.0] 
[0.0] 
3 Compared to a university department, how hierarchical is your partnership organized? 
Less hierarchical 
Equally hierarchical 
More hierarchical 
[1.0] 
[0.5] 
[0.0] 
4 
To what extent are decision-making processes 
within your inter-firm relationship organized 
hierarchically? 
Seven point Likert scale [1.0] [0.0] 
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5.3.6. The Set of Inter-firm Relations Experiencing Environmental 
Uncertainties 
Membership in the set of partnerships experiencing environmental uncertainties is 
composed of three subscales measuring the degree of market uncertainty, technological 
uncertainty and regulatory uncertainty. The subscales for market, technological and 
regulatory uncertainty have been weighted equally and normalized to represent 
membership in the set of partnerships experiencing environmental uncertainties ranging 
from no membership [0.0] to full membership [1.0].  
Table 5.7: Items in the Set of Inter-firm Relations with Environmental Uncertainty 
Item 
No. Question Answer option 
Membership 
score 
Market uncertainty   
1 Is the number of competitors 
Increasing 
Stable 
Decreasing 
[1.0] 
[0.5] 
[0.0] 
2 Is the strength of competitors 
Increasing 
Stable 
Decreasing 
[1.0] 
[0.5] 
[0.0] 
Technological uncertainty   
3 How easy is it for competitors to copy your products? 
Easy 
Neither easy nor difficult 
Difficult 
[1.0] 
[0.5] 
[0.0] 
4 Preferences of customers change frequently. Seven point Likert scale 
[1.0] 
[0.0] 
5 ‘It is crucial for our collaboration to match these changes. Seven point Likert scale 
[1.0] 
[0.0] 
6 ‘Technology changes rapidly in our field.’ Seven point Likert scale 
[1.0] 
[0.0] 
7 ‘It is important for our partnership to match these changes’ Seven point Likert scale 
[1.0] 
[0.0] 
Regulatory uncertainty   
8 ‘In the biopharmaceutical industry our field 
of research is relatively labour intensive’ Seven point Likert scale 
[1.0] 
[0.0] 
9 ‘In the biopharmaceutical industry our field 
of research is relatively capital intensive’ Seven point Likert scale 
[1.0] 
[0.0] 
10 ‘There is a high amount of regulations and policies we need to comply with’ Seven point Likert scale 
[1.0] 
[0.0] 
11 ‘Regulatory requirements affecting our partnership are straightforward’ Seven point Likert scale 
[1.0] 
[0.0] 
12 ‘Policies and regulations affecting our partnership change frequently’ Seven point Likert scale 
[1.0] 
[0.0] 
13 
‘The legal mechanisms already in place 
sufficiently safeguard the interests of both 
our collaboration partners’ 
Seven point Likert scale 
[1.0] 
[0.0] 
14 
‘We are able to participate in the 
development and changes of national and 
provincial policies’ 
Seven point Likert scale 
[1.0] 
[0.0] 
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5.4. Data Analysis 
In the following section I will proceed step-by-step through the analysis, explaining 
first the function and computation of a truth table, continuing with the minimization 
procedures, and, finally, summarizing the results in a configuration chart (Ragin et al., 
2008). In some instances I repeat technical steps that have already been described in the 
introduction to QCA to facilitate the reading of the procedure. Throughout the analysis I 
used fsQCA freeware available online (Ragin, Drass, & Savey, 2006)  
The first step in fsQCA is to compute a truth table. A truth table exhibits all logically 
possible combinations of present and absent conditions (configurations). The number of 
rows in a truth table is calculated as 2k (with k denoting the number of conditions taken 
into account). For the model of management innovation, with six facilitating conditions 
(26) the number of logically possible configurations is 64. Hypothesis 1 to Hypothesis 6 
thus constitute the conceptual and methodological framework for the analysis. Each 
facilitating condition constitutes one dimension in a six dimensional property space 
(Rihoux et al., 2009).  
For each configuration, the truth table indicates the number of cases in which 
management innovation is observed or the number of cases in which management 
innovation is not observed. In addition, it specifies logical remainders. Logical remainders 
are those configurations that logically exist, but for which no empirical observation is 
made. Appendix C provides the truth table for inter-firm configurations of management 
innovation in China’s biopharmaceutical industry. There are 27 different inter-firm 
configurations in which new managerial tools have been developed and introduced. With 
64 logically possible configurations, there are 37 logical remainders.  
The truth table is then minimized in order to determine which configurations are 
considered in the analysis. For this purpose, one determines the consistency and the 
coverage threshold. The consistency threshold indicates the degree to which cases confirm 
the configurations expressed. I use a consistency threshold of 0.785 which is above the 
usually recommended minimum (Fiss, 2010; Ragin, 2006; Ragin, 2008b). Further, the 
coverage threshold determines the minimum number of cases that a configuration needs to 
exhibit. I set the solution frequency threshold at one case.  
In a second step, fsQCA uses Boolean logic to minimize configurations and 
formulate simpler statements. I compute two solutions, a parsimonious solution and an 
intermediate solution. These differ in their inclusion of logical remainders. The 
parsimonious solution extensively uses logical remainders to minimize statements without 
any evaluation of their plausibility. It thereby identifies core conditions, i.e. those that have 
to be part of any representation of the data. The intermediate solution uses logical 
remainders to reduce statements only if they are consistent with theoretical and substantive 
assumptions. It serves to identify contributing conditions (Fiss, 2007; Ragin et al., 2008). 
For the analysis, I only allow minimization if logical remainders conform to the formulated 
hypotheses: inter-firm relations are mutually dependent and heterogeneous, decentralized 
and vertically differentiated and they experience environmental pressures. Due to the 
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inconclusive evidence provided by previous research, I do not restrict the minimization 
procedure concerning the role of formalization.  
In a third step, the results from the parsimonious and intermediate solution are 
summarized in a configuration chart (Ragin et al., 2008). Core conditions are illustrated 
using large circles; contributing conditions are displayed in small circles. When the 
presence of a condition is necessary to explain management innovation, the circle is filled; 
when its absence is required, the circle is hollow. Empty spaces indicate ‘don’t cares’, i.e. 
neither the absence nor the presence of a condition is necessary to explain management 
innovation. Figure 5.3 provides the chart for the inter-firm configurations in China’s 
biopharmaceutical industry. The solution covers 66% of all cases with a consistency of 
79.2%.  
Inter-firm Configurations of Management Innovation
A1 A2 B1 B2 C D
Relational
Mutual dependence
Heterogeneity
Structural
Decentralization
Formalization
Vertical differentiation
Environment
Uncertainty
Consistency 77.71% 82.51% 82.28% 80.48% 81.64% 78.67%
Raw coverage 30.46% 35.83% 26.17% 27.76% 44.92% 44.98%
Unique coverage 5.40% 2.98% 9.53% 6.04% 9.88% 7.75%
Note:      = core causal condition present; = core causal condition absent; ͻ = contributing causal 
condition present; = contributing causal condition absent (no incidence in this empirical set)
 
Figure 5.3: Configuration Chart: Inter-firm Relations in Management Innovation 
5.5. Results  
Overall, I identify six different configurations of inter-firm relations that lead to the 
introduction of new managerial instruments. On the basis of shared core conditions, four 
equally effective inter-firm configurations can be singled out. These are referred to as first 
order equifinalities. Within these, and especially within the first two types, contributing 
conditions illustrate neutral permutations or second order equifinal types that equally 
contribute to management innovation (Fiss, 2010).  
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5.5.1. Organic Structures as Foundations of Management Innovation 
The first inter-firm configuration that leads to management innovation features two 
core conditions: decentralization and the absence of vertical differentiation. In this 
configuration, environmental uncertainties contribute to the development and introduction 
of new management instruments. As Figure 5.3 shows, there are two neutral permutations, 
these are equally effective contributing conditions that surround the core composition of 
this configuration. Management innovation is facilitated either by formalization (A1) or by 
mutual dependence (A2).  
The following case illustrates the first neutral permutation featuring formalization as 
a contributing condition. In 2005, a collectively-owned biotechnology firm based in 
Shanghai formed a partnership with a privately owned biotechnology firm in San Diego. 
The firms’ managers met at a conference in the U.S. and began loosely cooperating by 
outsourcing research projects to China. After two years, with the help of its American 
partner, the Chinese firm opened its main science division in the U.S. to circumvent 
appropriation risks in China and make use of the scientific community abroad. This 
‘reverse’ outsourcing was both new to China as well as to the industry. The partnership 
was decentralized, because decision-making power was distributed among the employees 
of joint research activities. Furthermore, they did not install hierarchical structures, which 
explains the absence of vertical differentiation. Under financial and regulatory 
uncertainties the partners formalized their cooperation via the installation of a system of 
rules and regulations and the signing of a contractual agreement. The combination of these 
four conditions explains management innovations in the cases specific to this 
configuration.  
The following case illustrates the second neutral permutation that features 
formalization instead of mutual dependence as a contributing condition. In 2006, four 
Chinese Returnees founded a biotechnology firm in Shanghai to engage in R&D and trade 
biopharmaceutical products. They formed a partnership with a pharmaceutical firm from 
Shanghai, which produced multi-vitamin supplements and dietary products. To increase 
their international competitiveness, they introduced quality control mechanisms similar to 
the ones regulating the Chinese food industry. This form of management innovation 
existed in other Chinese industries, but not in the Chinese biopharmaceutical industry. 
Additionally, there were concerns regarding IPR, brought about by these firms’ main 
international rival, who was based in Hungary. The firms decided to establish an office in 
Europe, where all of their IP would be registered. It was argued that this would improve 
the protection of their core business by facilitating access to law enforcement agencies in 
Europe. Despite the differences in size and operations between the two firms, their 
partnership was decentralized. Alongside the absence of vertical differentiation, due to the 
involvement of upper management only, the decentralization of this partnership explains 
their capacity for management innovation. Exogenous uncertainties and opportunities 
contributed to the introduction of these two new management instruments. However, as the 
partnership was originally formed via prior social ties and both partners had made 
significant investment, mutual dependence contributed to explaining management 
innovation.  
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The cases above illustrate the two neutral permutations of a configuration 
characterized by decentralization and the absence of vertical differentiation. A flat 
hierarchical structure, combined with dispersed decision-making rights, permits the use of 
external knowledge to develop and implement new management instruments within inter-
firm relations. Operating in a relatively turbulent environment contributes to these 
processes. In addition, formalization reinforces management innovation by providing for 
safeguards that allow the exchange of knowledge; a mechanisms that can be substituted in 
this particular configuration by mutual dependence. This organizational system entails 
features previously associated with organic structures of organizations (Burns et al., 1961; 
Hage et al., 1970). The findings supports the proposition of the enabling effect of 
formalization (Adler et al., 1996). Formalization, which previously has been associated 
with mechanistic structures, in fact contributes in the first neutral permutation of this 
configuration.  
5.5.2. Mechanistic Structures fostering Management Innovation 
Vertical decentralization and the absence of environmental uncertainty are necessary 
to explain management innovation in the second inter-firm configuration. Formalization 
contributes to the introduction of new managerial instruments and two neutral 
permutations indicate that, in addition, either decentralization (B1) or heterogeneity (B2) 
facilitates management innovation.  
The following case illustrates the role of decentralization as a contributing condition 
in the first neutral permutation. In 2008, a privately owned biotechnology service firm, 
specialized in marketing in rural China, formed a partnership with a large 
biopharmaceutical firm. Originally, the service firm was hired to professionalize the sales 
network of its partner. After a short period, the consulting project was modified. Instead of 
training sales representatives, both partners agreed to use the sales network as a trial 
platform for experimenting with different marketing strategies. The marketing firm was 
thereby able to offer services to other clients outside the original relationship. In return, its 
partner managed to significantly improve the efficiency of its sales network. Neither of the 
firms acted in response to environmental uncertainties. However, to systematically monitor 
the various experimentation activities, they appointed administrative leaders at different 
hierarchical levels. Decentralization contributed to management innovation because sales 
employees in the field were given enough flexibility to make decisions. Furthermore, to 
circumvent risks involved in using the sales network as a trial platform, their partnership 
formalized a contract, the rules of which governed their joint activities.  
The second neutral permutation features heterogeneity, instead of decentralization, as 
a contributing condition. This difference is illustrated by the case of a partnership between 
a large U.S. pharmaceutical and a small, privately owned Chinese biotechnology firm, 
engaged in the investigating new drugs. In 2000, the partnership was formed with the 
objective of outsourcing research activities to China in order to take advantage of the 
significantly lower labour costs. In the course of their partnership, the firms began 
introducing what the interview partner described as flexible ‘plug and play’ modules for 
training personnel in different scientific fields. Both firms were well established in their 
respective industries and their partnership was not particularly challenged by 
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environmental uncertainties. Furthermore, by appointing administrative leaders as well as 
scientific leaders and implementing strict decision-making protocols the partnership was 
vertically differentiated. The formalization of joint activities, in both contracts and rules 
and regulations, contributed to the introduction of this new HR training system. Hence, 
instead of decentralization, the heterogeneity of the firms, a consequence of their diverse 
international background, contributed by providing the necessary experience to specify the 
required type of training and to manage larger numbers of scientific staff in this case of 
management innovation.  
Vertical differentiation and the absence of environmental uncertainty are the two core 
conditions that explain management innovation emerging from partnerships in this 
configuration. In both neutral permutations formalization contributes to the development 
of new managerial instruments. In this configuration, management innovation processes 
rely predominantly on knowledge internal to the partnership. They closely resemble 
mechanistic structures which, in contrast to previous assumptions, have been assumed to 
constrain innovation (Burns et al., 1961). As in the previous configuration, a substituting 
pair can be identified. In mechanistic organizations, a decentralized structure may be 
replaced by a diverse and heterogeneous background among the cooperating firms.  
5.5.3. Formalization as Initiator of Management Innovation 
The third configuration (C) of inter-firm conditions that explains management 
innovation in China’s biopharmaceutical industry contains three core conditions: mutual 
dependence, the explicit absence of heterogeneity, i.e. homogeneity, and formalization. 
Environmental uncertainties contribute to the development of new managerial instruments. 
The following partnership, for instance, led to the introduction of a number of new 
managerial instruments. In 2006, a diversified Chinese business group, predominantly 
engaged in petrochemicals, initiated a partnership with a privately owned Chinese 
biotechnology firm. With this partnership, the owners of the business group intended to 
ensure the company’s long term survival by diversifying into a modern high-technology 
industry. Despite the difference in their operations, both firms were entirely Chinese and 
had no international background. Therefore, the inter-firm relationship was considered to 
be homogenous. The firms shared physical facilities, in the form of research laboratories 
and offices, and made significant investments into the partnership. They consequently 
showed high mutual dependence in their relationship. The financial resources, made 
available by the business group and formalized in contracts and regulations, allowed their 
biotechnology partner to introduce a number of new managerial instruments, such as 
outsourcing HR training to a professional consulting company, establishing an external 
scientific board with reputable international scientists and, most importantly, 
systematically scanning the global technology landscape to acquire IP and technologies, 
especially from North America. The market uncertainty faced by the business group, and 
the technological pressure exerted on the biotechnology firm, contributed to the 
introduction of these management innovations.  
Mutual dependence within inter-firm relations of this configuration provided the 
initial condition among homogenous partners to reciprocally access each other’s core 
competencies. The re-combination process of predominantly internal knowledge required 
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and was reinforced by formalization. Under the given relational conditions, formalization 
proves to be the decisive governance mechanism to experiment with, and introduce, new 
managerial tools. As partnerships in this configuration fall into neither organic nor 
mechanistic organizational structures, the results provide additional support for the 
enabling role of formalization in management innovation (Adler et al., 1996; Vlaar, van 
den Bosch, & Volberda, 2007).  
5.5.4. The Network Innovator: Heterogeneous Decentralization 
Finally, the last configuration (D) features heterogeneity and decentralization as core 
conditions. Introducing a vertically differentiated organization for joint activities 
contributed to partnerships developing new management innovation. The following case 
serves as an illustration. In 2005, a collectively owned biotechnology firm based in 
Shanghai and founded by Chinese Overseas formed a partnership with a privately owned 
VC from Hong Kong. A lack of access to financial resources was the most severe threat to 
the biotechnology firm. The support of the VC helped to continue the financing of research 
projects. In addition, the VC partner allowed the biotechnology firm to introduce new 
elements in its business model. As two of the firms projects went into further clinical trials, 
both partners decided to prepare for the commercialization of the products. To this end, the 
VC partners identified an old and economically unsuccessful Chinese pharmaceutical 
company. Jointly, both partners decided to acquire this company. This strategy of upstream 
integration is new to the biopharmaceutical industry. Acquired firms usually 
commercialize generic products but do not dispose of the necessary innovative capabilities 
to sustain their operations on the long run. The acquirers pursue a number of objectives. 
First, such acquisitions provide minor, yet immediate, revenues to bridge the period of 
time in the lead up to the approval of their new products. More importantly, acquirers are 
able to integrate the production and sales capabilities of the acquired company into their 
operations. In the case of the partnership described above, heterogeneity in the relationship 
provided a diverse set of knowledge and experience with which to identify and assess the 
value of the pharmaceutical firm. Also, being fairly specialized in their respective fields of 
business, they allowed different employees to participate in the decision-making processes. 
For evaluating the potential of the acquired firms both administrative and scientific leaders 
were appointed to contribute to management innovation.  
Inter-firm relations of this configuration take advantage of the heterogeneity in 
knowledge and experience among the participating firms. The presence of top management 
leadership positions complemented by distributed decision-making rights among members 
permits accessing resources external to the partnership. Such ‘network innovators’ make 
use of heterogeneous resources available in their broader environment to develop and 
introduce new management instruments.  
5.6. Discussion of Results 
The results of the configurational analysis present themselves as four equally 
effective combinations of contextual factors that allow partnerships to managerially 
innovate. The holistic approach indicates that determinants used to analyze single firms 
aptly apply to inter-firm relations as social action systems (van de Ven, 1976). Hypothesis 
1 to Hypothesis 7 as presented in Chapter 3 formulated relational, structural and 
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environmental determinants of inter-firm relations assumed to facilitate the management 
innovation processes taking place within these organizational systems. However, the 
purpose of formulating hypotheses in the context of fsQCA differs from their purpose in 
statistical methods. Instead of directly testing the proposed associations, I used the first 
seven hypotheses to define the property space for the analysis.  
The results therefore provide only limited insights into the unicausal effect of single 
determinants on management innovation. They tend to confirm previously hypothesized 
associations (Damanpour, 1991) yet allow a nuanced assessment of the complexities 
underlying management innovation. Specialization (Hypothesis 2) was not included in the 
analysis because of the particular empirical background of the study. The data did not 
allow me to develop a meaningful scale for specialization that would allow distinguishing 
between cases. Strictly speaking, all other hypotheses are rejected. Not a single 
determinant was identified that, in and by itself, explains management innovation. The 
strongest support from this study is for the role of decentralization (Hypothesis 4) in 
facilitating management innovation. In organic, as well as in network innovators, 
decentralization is a core condition. Furthermore, the results support for hypothesis that 
formalization facilitates management innovation (Hypothesis 5a), and rather 
unambiguously reject the competing hypothesis (Hypothesis H5b). The results support the 
enabling role of formalization (Adler et al., 1996) and highlight its function within inter-
firm relations for providing the necessary condition for partners to deeply interact (Vlaar et 
al., 2006). In particular, formalization has been identified as the sole governance 
mechanism in mutually dependent, homogenous partnerships reinforcing management 
innovation. It also clearly contributes to management innovation processes in mechanistic 
systems and may contribute in organic systems. The results for heterogeneity (Hypothesis 
3), vertical differentiation (Hypothesis 6), and environmental uncertainty (Hypothesis 7) 
indicate that either their presence or their absence, depending on their configurational 
context, facilitates management innovation. 
Using the hypotheses on single conditions of inter-firm relations as dimensions in a 
property space, fsQCA allows examining the complex relationships among conditions with 
management innovation. More specifically the results uncover complementarities as well 
as substitutions among facilitating conditions. Substitutions can furthermore be 
distinguished into first order equifinalities, i.e. equally effective combinations of core 
conditions, and second order equifinalities or neutral permutations, i.e. substitution pairs of 
contributing conditions within configurations. fsQCA thereby allows substantiating the 
remaining three hypotheses directed towards the more complex theoretical propositions.  
The identification of four configurations of core facilitating conditions indicates first 
order equifinality, i.e. substitutions of equally effective combinations of contextual 
conditions. Considering the satisfactory consistency score, this finding clearly supports the 
equifinality hypothesis (Hypothesis 8). Furthermore, the results allow specifying 
complementarities among core conditions within configurations. First, in case of perceived 
environmental uncertainty, inter-firm relations innovate when they establish a 
decentralized and flat, i.e. not vertically differentiated, structure. In contrast, in situations 
of environmental stability, vertical differentiated and formalized inter-firm relations 
facilitate the management innovation process. Third, partnerships among mutually 
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dependent and homogenous firms develop new management instruments when 
formalization reinforces their interactions. Finally, the set of inter-firm relations analyzed 
shows that heterogeneous inter-firm relations managerially innovated when their 
partnership is decentralized and vertically differentiated. Here, decentralization facilitates 
access to a diverse set of experience that extends beyond the boundaries of the inter-firm 
relation and benefits from the network resources available to both partners. The 
identification of configurations consisting out of two or three core conditions that are 
conceptually different supports the hypothesis on conjunctural causation in management 
innovation (Hypothesis 9).  
Last, the results reveal two substituting pairs; neutral permutations of first order 
equifinal configurations (Fiss, 2010). First, within organic structures mutual dependence 
may serve as a substitute for formalization. In light of the theorized function of 
formalization within inter-firm relations  this is particularly interesting as it shows that by 
establishing high levels of trust which consequently mitigate relational risks partnering 
firms are pressed to focus attention, articulate, deliberate and reflect, and maintain 
interaction (Vlaar et al., 2006). The primary use and exchange of external knowledge for 
the development and implementation of management instruments in organic systems is 
facilitated by mitigating relational risks either using trust or formalization. Second, within 
mechanistic structures a decentralized structure substitutes heterogeneity between firms. 
This in contrast specifies conditions for making use primarily of internal knowledge in the 
management innovation process (Carpenter & Westphal, 2001). Whereas heterogeneity 
provides for sufficient diversity in expertise and experience within the partnership, 
decentralization permits accessing diverse knowledge external to the organization. 
Partnerships may materialize on the knowledge existing within its structure or alternatively 
materialize on external knowledge by ‘activating’ the diversity of its network ties. As in 
the hypothesis on conjunctural causation – given the appropriate consistency level of the 
overall solution – the results identify substantial asymmetries among relational, structural, 
and environmental conditions that strongly support the asymmetry hypothesis (Hypothesis 
10).  
The results overall provide systematic evidence for Burns and Stalkers (1961) 
distinction between archetypical organizational systems ranging from mechanistic to 
organic structures. By identifying additional intermediate structures, the results are 
consistent with their contention that “… the two forms […] represent a polarity, not a 
dichotomy” (Burns and Stalker, 1961, p. 122). They also support the hypothesis of 
contingency theories linking organizational structure to environmental uncertainty (Child, 
1972; Donaldson, 2001). This finding supports previous theories claiming that in turbulent 
environments, organizations tend to be rather organically structured in order to swiftly 
respond to changing circumstances (Child, 1972). Processes of agenda setting, idea linking 
and idea testing are predominantly directed at developing mechanisms that help firms to 
hedge the risks of and benefit from the opportunities arising from such changing 
environments (Birkinshaw et al., 2008). However, the evidence does not support the 
proposition that organic systems foster whereas mechanistic systems constrain 
management innovation (Blau et al., 1979; Damanpour, 1996; Miller, 1983). Instead, the 
results show that mechanistic structures trigger management innovation processes as well.  
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Finally, the study in China’s biopharmaceutical industry shows how a diverse 
population of firms actively develops and implements new managerial instruments that 
address gaps or rapid changes in the institutional infrastructure. Inter-firm relations in this 
industry do not merely imitate available approaches but develop and implement new 
management practices, processes, and structures. These management innovations, as 
implicitly suggested by the management innovation literature, represent a source of 
competitive advantage by improving the overall efficiency of a firm. However, 
management innovations may also be diffused within the industry. From this perspective 
they represent prototypical arrangements of future common or best-practices. China hosts a 
young, vibrant, and viable biopharmaceutical industry that while it faces specific 
challenges exhibits a tendency to develop managerial instruments that allow coping with 
these difficulties. Some of these may eventually be adopted from developed industries in 
the West.  
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6. Implications and Conclusion  
In this thesis, I have taken a holistic, configurational perspective on inter-firm 
relations that facilitate management innovation. The review of theories in management 
innovation provided in Chapter 2 identified two broad conceptualizations. Outcome 
models offer substantial theoretical explanations for the influence of various organizational 
determinants of management innovation (Damanpour, 1991; Mol et al., 2009). However, 
theories in this field underemphasize the complex interplay between these factors and limit 
the analysis to the focal firm as the unit of analysis. Alternatively process models illustrate 
in detail how the activities between firms results in the development and introduction of 
new management instruments (Birkinshaw et al., 2008). A theoretical alternative is 
provided in the form of contingency theories of management innovation (Gopalakrishnan 
et al., 1997). Contingency theories postulate that there are different organizational systems 
that may be equally effective, suggesting that the efficiency of such systems largely 
depends on the alignment of structural and environmental factors. By incorporating the 
notions of equifinality, ‘fit’, and ideal types, contingency theory allows for a greater degree 
of complexity, while remaining sufficiently systematic to allow empirical validation (Doty 
et al., 1994; Drazin et al., 1985; Fiss, 2010).  
The review of modelling approaches in management innovation literature follows a 
similar structure. Outcome models predominantly apply regression analysis, thereby 
simplifying theoretical propositions by treating facilitating conditions as competing 
explanations. Implicit assumptions of linearity and additivity in statistical methods limit 
the insights developed by these studies (Ragin, 2008b) and might be one cause for the 
inconclusive results that are so characteristic in this field (Damanpour, 1991). Process 
approaches predominantly develop conceptual models and use single or comparative case 
study methods to explore and develop theories. They are often too complex to allow for a 
broader validation of their theoretical propositions. Contingency methods provide an 
intermediate solution by more accurately translating theoretical propositions into models. 
Contingency research predominantly uses quantitative methods. Their complexity, 
however, poses high demands on statistical techniques, as well as the quantity and quality 
of data (Longenecker et al., 1978; Schoonhoven, 1981). Due to these challenges, the 
system contingency approach has so far not been used to advance the understanding of 
management innovation.  
To address these gaps in management innovation literature, I have proposed, in 
Chapter 3, a configurational approach to management innovation. The thesis most 
generally asks what configurations of inter-firm relations facilitate management 
innovation. Acknowledging insights provided by process models, I shift the unit of 
analysis from single, focal firms, as common in outcome models, to the inter-firm relation. 
I have then formulated seven hypotheses that specify relational, structural, and 
environmental conditions of inter-firm relations facilitating management innovation. 
Further, acknowledging theoretical propositions of contingency and process theories on the 
complex antecedents of management innovation, I have developed three additional 
hypotheses. These address expectations of identifying various, equally effective 
configurations of inter-firm relations facilitating, and of uncovering conjunctural 
causations, the association of multiple variables with a given outcome, and asymmetric 
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relationships among variables (Lieberson, 1987). I have then introduced fuzzy set 
Qualitative Comparative Analysis (fsQCA). Based on set-theory, fsQCA holistically 
compares the complexity of entire cases and thereby fundamentally differs from 
conventional methods. In particular, fsQCA allows us to test for equifinality, conjunctural 
causation and asymmetric relations, and is suitable for exploring the theoretically complex 
antecedents of management innovation (Fiss, 2007; Ragin, 2008b). In addition, fsQCA 
requires researchers to calibrate measurements which are in line with the transient nature 
of management innovations. It specifically demands the development of meaningful, 
context-sensitive scales based on theoretical and substantive knowledge.  
To test these hypotheses, I have in Chapter 4 used information on 56 inter-firm 
relations in China’s biopharmaceutical industry. Due to substantial unpredictability 
regarding ultimate marketability of their products, and the industry’s complex knowledge 
domains, biopharmaceutical firms operate under high degrees of uncertainty and strongly 
rely on ties to other organizations (Nooteboom, 2004; Powell et al., 1996). In China, the 
biopharmaceutical industry is relatively young, the market for biopharmaceutical products 
is growing and the institutional framework is rapidly changing (Pisano, 2006). In addition, 
the industry contains a highly diverse population of firms. Inter-firm relations 
consequently operate under volatile conditions that require the constant development of 
new managerial instruments to address these dynamics (Frew et al., 2008). China’s 
biopharmaceutical industry therefore provides a suitable environment to improve our 
understanding of the link between relational, structural, and environmental conditions of 
inter-firm relations and management innovation.  
In Chapter 5, I provide information on the empirical study. I describe the data 
gathering process, the calibration of the set of managerially innovative inter-firm relations, 
and the sets of facilitating conditions (Fiss, 2007). I then go step-by-step through the 
analysis, beginning with the computation of the truth table and explaining the 
minimization procedures that allow the identification of core and contributing conditions. I 
then summarize the results in a configuration chart (Ragin et al., 2008).  
6.1. Summary of Findings 
The results identify four distinct configurations of inter-firm relations that facilitate 
management innovation in China’s biopharmaceutical industry. The first configuration is 
characterized by a decentralized and a flat hierarchical structure, which provides the 
context for management processes to take place. The second configuration features a 
structure highly vertically differentiated structure in the absence of environmental 
uncertainties; this second configuration also allows for the development and introduction 
of new managerial instruments. Lastly, two intermediate configurations are identified. 
Homogenous inter-firm relations with mutually dependent partnering firms, that 
specifically rely upon formalization to foster trust and enable both partners to reciprocally 
access knowledge, for the development and introduction of new management instruments. 
Another homogenous inter-firm relation that was identified consists of network innovators 
that extensively rely on external sources of knowledge, which they access via the broader 
linkages of partnering firms in their environment.  
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The results allow drawing modest conclusions in regards to the individual 
determinants of management innovation, as proposed by outcome theories: modest because 
the effects of facilitating conditions on management innovation have not been tested 
individually and independently, as in conventional quantitative studies. Instead they have 
been used to define a six-dimensional property space in order to consider the association of 
all logically possible combinations of conditions facilitating management innovations. The 
results in this respect provide support for the role of decentralization (Hypothesis 4) and 
formalization (Hypothesis 5a). They refute the idea that formalization, in ‘straight-
jacketing’ employees through an overly bureaucratic structure, acts as a coercive 
mechanism (Hypothesis 5b). Lastly, the results for heterogeneity (Hypothesis 3) and 
vertical differentiation (Hypothesis 4) provide evidence that these determinants are highly 
asymmetrically related to management innovation. In partnerships that rely on the enabling 
role of formalization, the absence of heterogeneity is an essential (core) condition to 
facilitating management innovation processes. In contrast, network innovators require 
heterogeneity between partnering firms to facilitate such processes. The role of vertical 
differentiation in management innovation is similarly asymmetric. In decentralized inter-
firm relations, and supported by environmental uncertainties, the absence of vertical 
differentiation is needed to develop new management instruments. In contrast, when there 
is no environmental uncertainty, new management tools are only introduced when inter-
firm relations are vertically differentiated. The results modestly support the hypothesized 
role of mutual dependence (Hypothesis 1) and refute the unidirectional role of 
environmental uncertainties (Hypothesis 7) in facilitating management innovation. 
Table 6.1: Overview of Results (* indicates modest implications) 
 Theoretical Factor Results 
H1 Mutual dependence Weakly supported* 
H2 Specialization Not tested 
H3 Heterogeneity Strongly asymmetric, not supported* 
H4 Decentralization Strongly supported* 
H5a Formalization (facilitates) Strongly supported* 
H5b Formalization (obstructs) Clearly rejected* 
H6 Vertical differentiation Strongly asymmetric, not supported* 
H7 Environmental uncertainty Asymmetric, not supported* 
H8 Equifinality Supported 
H9 Conjunctural causation Supported 
H10 Asymmetric associations Supported 
 
Arguably more significant is the corroboration of the remaining three hypotheses, 
directed at uncovering the complex contextual antecedents of management innovation 
processes. As already suggested above, there are four equally effective organizational 
systems that facilitate management innovation. This finding clearly speaks in favour of 
equifinality (Hypothesis 8). Moreover, all configurations are multi-dimensional 
constellations of facilitating conditions. Matching prominent contingency theories, these 
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are conceptually different, supporting the notion of conjunctural causation (Hypothesis 9). 
Finally, as has been discussed, strong asymmetric relationships have been identified in 
regards to the role of heterogeneity and vertical differentiation. The following Table 5.8 
summarizes the main findings of this thesis.  
6.2. Implications 
As a result of its holistic approach, this thesis has a range of theoretical, 
methodological and managerial implications, which are outlined in the following 
paragraphs.   
6.2.1. Theoretical Implications 
By incorporating insights provided by process models, the thesis asks for outcome 
studies to shift the focus of the analysis to the inter-firm relation as the appropriate unit of 
analysis. By identifying complex contextual antecedents of management innovation, it 
suggests that outcome studies should rather develop theories that explicate the 
interdependencies among relational, structural and environmental factors enabling 
management innovation. This seems particularly significant in light of the results 
concerning hypotheses one through seven. As the findings clearly show, the sole focus on 
single, competing explanations does not further our understanding of the antecedents of 
management innovation. In regards to process theories, it reaffirms the idea that the inter-
firm relation is the appropriate locus of innovation and provides evidence for the complex 
interplay between conditions that allow firm partnerships to develop and introduce new 
management instruments. The results of this study contribute to process theories by 
identifying four substantially different configurations of contextual conditions that 
facilitate the management innovation processes that take place between firms. Process 
theories, however, have largely neglected the role of contextual factors in the management 
innovation process. This thesis suggests that by considering relational, structural and 
environmental conditions, further insights may be generated regarding the specific role that 
these conditions play in providing internal or external knowledge to the management 
innovation process.  
Finally, the results confirm the relevance of contingency or, more appropriately, 
configurational theories in management innovation. The taxonomy that accrues from the 
analysis closely corresponds to prominent contingency theories, in particular to Burns and 
Stalker’s (1961) distinction between organic and mechanistic structures. However, the 
results do question the proposition that organic structures provide a superior context for 
management innovation processes. Instead, the findings have clearly shown that 
mechanistic structures are equally effective in developing and introducing management 
innovation. Instead of discerning between organizational systems as being more or less 
conducive to management innovation, the findings show rather that management 
innovation differs depending on the organizational system from which it emerges. 
6.2.2. Methodological Implications 
A few methodological approaches that have been applied in this thesis deserve further 
attention. While they are not all unknown within the field of research into management 
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innovation, they are crucial for future studies. First, I have used a three-dimensional 
framework to assess the newness of management innovations. According to this 
framework, novelty to the industry, to the nation and to the region has been assessed 
separately. This approach is new to management innovation studies and allows for a more 
fine-grained assessment of newness. In addition, the three-dimensional framework has 
been adapted from the pre-existing language, reasoning and understanding of experts in the 
industry. The assessment of newness thereby contextualizes management innovations and 
provides an alternative to uni-dimensional measurement approaches (Gupta et al., 2007). 
Second, I have followed earlier management innovation studies in using an independent 
group of experts to evaluate the newness of management innovations (Dewar et al., 1986; 
Kelley, 1976). This is an important aspect in innovation studies which often remains 
neglected, especially when using larger datasets that rely on standardized items and that do 
not allow for the consideration of either the transiency or the specific context of 
management innovation. This thesis calls for future management innovation studies to put 
stronger emphasis on the internal validity of datasets, and focus less on the external 
validity of observations across datasets. Finally, I have introduced fsQCA and have shown 
how the configurational analysis provides new insights into a specific aspect of 
management innovation, namely the configurations of inter-firm relations that facilitate its 
process. fsQCA provides an intriguing alternative to conventional methods. The method 
advocates a measuring technique, namely calibration, that in and by itself asks for a 
meaningful representation of the data within its substantive and theoretical context (Ragin, 
2008c). It thereby directly addresses the requirement that management innovation research 
be contextualized. Furthermore, by improving the alignment of theories with models, 
fsQCA represents a tool that both explains and reconciles inconclusive results provided by 
previous empirical studies.  
6.2.3. Managerial Implications 
By developing a taxonomy of inter-firm configurations that facilitate management 
innovation, this thesis not only draws attention towards the design and management of 
inter-firm relations, but also provides an instrument with practical managerial implications. 
By providing a limited number of equally alternative decision-making choices, taxonomies 
reduce the complexity of a perceived phenomenon to a degree that permits us to emphasise 
the most important determinants and compare possible alternative design choices (Fiss, 
2010; Martin-Pena et al., 2008). Managers that seek to develop and implement new 
management practices, processes and structures may, for instance, adjust the structural 
dimensions of existing inter-firm relations in order to facilitate management innovation 
processes. For instance, during times of environmental turbulence, the introduction of a 
decentralized structure and the abolishment of hierarchical levels in inter-firm relations are 
likely to lead to management innovation. In contrast, in the absence of environmental 
uncertainties, introducing levels of hierarchy will facilitate management innovation 
mechanisms that are supported by formalization. When interacting in a mutually dependent 
and heterogeneous partnership, the introduction of formalized rules and regulations 
encourages processes that lead to the development and introduction of new managerial 
instruments. Lastly, heterogeneous inter-firm relationships induce management innovation 
by installing a decentralized structure and facilitate these processes through vertical 
differentiation.  
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Empirically, the results show that firms in the Chinese biopharmaceutical industry do 
not merely copy existing management instruments. Instead, new management instruments 
are developed and introduced rapidly and effectively. With its grounded conceptualization 
of novelty, the study suggests that these new management instruments contain elements of 
both local and global knowledge and may serve as templates for new standards for the 
global biopharmaceutical industry as a whole. What is emerging in China is a young, 
vibrant and viable biopharmaceutical industry that, while facing specific challenges, 
exhibits a tendency to develop managerial instruments that allow firms to cope with these 
difficulties.  
6.3. Limitations  
The present study carries certain limitations that, on the one hand reflect the 
challenges of studying a complex organizational phenomenon, such as management 
innovation, and on the other are inherent to the empirical approach that has been pursued 
in the thesis. From a theoretical perspective I have not distinguished between the stages of 
development and implementation in management innovation. As management innovation 
observed in China’s biopharmaceutical industry have already been applied when 
conducting the interviews, stages in the process were not discernable. Configurations 
facilitating the processes within each of these stages, however, might well be different. For 
instance, the development of new ideas and their subsequent formulation and connection 
with other ideas might require more external knowledge. Whereas the implementation of 
management innovation into a complex organizational system might be facilitated when 
internal knowledge is introduced to the generative processes. In addition, this study does 
not specifically consider attributes of innovations; yet the four configurations identified 
might well facilitate the development of qualitatively different management innovations.  
Furthermore, the use of a medium size comparative case method challenges data 
collection and data analysis procedures and naturally limits the contributions of this study. 
In particular, it requires a careful balance between maintaining intimacy with individual 
cases, the empirical context, and the systematic collection and analysis of data. I have tried 
to include as much detailed information in order to transparently report the approach and 
findings of the study. However, the conditions under which interviews were conducted, 
variations amongst the respondents and the difficulties of documenting all of the 
information received, have led to variations occurring from interview to interview. Relying 
on single key informants to assess inter-firm conditions neglects the perspective of the 
interacting partner. Furthermore, while it is advantageous to use experts to evaluate 
newness, this assessment essentially relies on the subjective judgement of these experts. 
Also, the sampling approach taken in this study was based upon convenience rather than 
theoretical rational, due to the need to collect as much data as possible whilst being 
constrained by both time and budget. The rapidly changing environment in China’s 
biopharmaceutical industry carries biases that are specific to the country, the time, and the 
industry. Management innovation is transient by nature (Downs et al., 1976), and empirical 
research into its antecedents involves challenges. These biases are partly circumvented by 
calibrating, instead of measuring, i.e. by meaningfully representing the data within its 
empirical context (Ragin, 2008c). The three-dimensional construct which has been used to 
measure the newness of management innovation is proposed as a new and alternative 
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approach. While this measurement approach bears certain limitations, it might serve to 
revitalize discussions into how management innovation ought to be measured. This aspect 
seems particularly important considering the relevance of maintaining a high internal 
validity of datasets.  
Finally, fsQCA bears certain limitations as an analytical technique. Except for 
distinguishing core from contributing conditions, it does not estimate the relative 
importance of individual conditions of management innovation. In addition, fsQCA cannot 
directly account for omitted variables and it is difficult to perform systematic robustness 
tests for given solutions. Recent methodological developments which, for instance, allow 
us to estimate the robustness of membership scores by using type 2 fuzzy sets may 
ameliorate some of the limitations associated with fsQCA.  
6.4. Future Research 
While limitations are naturally undesirable, they do point out directions for further 
studies. Improving our understanding of how configurations change over stages in the 
innovation process will contribute to contingency and management innovation theories 
alike. Also, future research may more explicitly examine the different configurations, i.e. it 
may identify complementarities and substitutions. It has been shown that, in contrast to our 
current understanding, there are mechanistic organizational systems that develop and 
implement new managerial instruments. The different structures may in fact be connected 
to different secondary attributes of management innovations and may well generate 
qualitatively different management innovations. By substantiating these ideas, future 
research might be able to address some of the following issues of theoretical interest in 
management innovation studies. Much of the innovation literature suffers from a pro-
innovation bias. Most research implicitly assumes that innovation per se is desirable. In 
this study, I did not qualify management innovations as desirable. In fact, the empirical 
data contains new managerial instruments which are clearly undesirable, in that they are 
either illegal or economically unsound. Future research may therefore focus on developing 
better means of determining the soundness and desirability of managerial tools. This may 
also help to clarify mechanisms between management innovation and firm performance. 
Despite the fact that some research has been able to establish a positive association 
between innovation and performance (see for instance Mol & Birkinshaw 2009) the 
underlying mechanisms remain vague. Moreover, there is a need for more research 
examining the role of intentionality in management innovation. As most definitions 
maintain, management innovation ought to be intended to further organizational goals. 
Similar to the bias towards the desirability of innovation, research on management 
innovation suffers from a pro-intentionality bias. Yet, despite the fact that nearly all 
partnerships interviewed for this study were formed to pursue scientific projects, many 
also developed and introduced new managerial instruments. This suggests that 
management innovation remains an unintentional side-effect of firm interaction. 
Considering the economic and social importance that is ascribed to management 
innovation, future research may further explore the role of intentionality.  
Finally, a much neglected aspect in organizational innovation studies pertains to the 
simultaneous introduction of technological and management innovations. Since the 
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beginning of innovation studies, scholars have pointed out that the interplay and alignment 
between different types of organizations requires theoretical substantiation (Damanpour, 
1991; Sapolsky, 1967; Tichy & Sandstrom, 1974; Zeng et al., 2007). 
6.5. Conclusion 
The purpose of this thesis was to identify and test configurations of inter-firm 
relations in management innovation. The configurational approach that has been pursued is 
holistic, in terms of both theory and method. It bridges theoretical arguments from 
different conceptual camps and introduces fsQCA to the study of management innovation, 
a methodological approach that allows the systematic incorporation of a substantial 
amount of complexity into the analysis. The empirical study into China’s 
biopharmaceutical industry indicated that inter-firm relations develop and implement new 
management instruments, addressing institutional uncertainties. The results revealed four 
different configurations of inter-firm relations that facilitate management innovation. The 
findings contribute to outcome theories, process theories and contingency theories of 
management innovation. They ask for a better integration of the various theoretical 
arguments put forward in each field. On this basis, I have pointed out a number of future 
research directions with a potential to contribute to our understanding of management 
innovation.  
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Samenvatting (Dutch Summary) 
 
Het doel van deze dissertatie is te pleiten voor een holistische benadering van de 
studie van management innovatie door theorieën, methoden en empirisch onderzoek op 
één lijn te krijgen. Eerder onderzoek heeft management innovatie geconceptualiseerd als 
hetjiz de uitkomst van onafhankelijke determinanten van individuele bedrijven, dan wel 
een complex proces van samenhangende factoren tussen samenwerkende bedrijven. In 
tegenstelling tot eerdere studies probeert deze dissertatie een brug te slaan tussen uitkomst- 
en proces-georiënteerde theorieën, daarbij de complexiteit van contextuele antecedenten 
van management innovatie in acht nemende. In plaats van de specificatie van hetgeen 
actoren binnen interorganisatorische relaties doen om nieuwe management instrumenten te 
ontwikkelen en implementeren, richt deze dissertatie zich op de condities waaronder het 
management innovatie proces binnen interorganisatorische relaties plaats vindt. Met 
andere woorden, het stelt een configurationele benadering voor om interorganisatorische 
relaties die management innovatie faciliteren te bestuderen.  
De empirische analyse maakt gebruik van data van 56 interorganisatorische relaties in 
China’s biofarmaceutische industrie, welke verzameld is gedurende een extensief, een jaar 
durend veldonderzoek in China (Beijing en Shanghai) tussen 2007 en 2008. De populatie 
van bedrijven in China’s biofarmaceutische industrie is jong en bijzonder divers en is 
derhalve sterk afhankelijk van relaties met andere organisaties. Als een gevolg daarvan 
opereert de industrie onder risicovolle condities, die een constante ontwikkeling van 
nieuwe management instrumenten vereisen om de hoge onzekerheid het hoofd te bieden. 
Deze industrie is daarom een veelbelovende context om de rol van interorganisatorische 
relaties in management innovatie te bestuderen. Empirisch gezien draagt de analyse bij aan 
een beter begrip van hoe management innovatie Chinese bedrijven in de wereldwijde 
biofarmaceutische industrie integreert.  
Deze dissertatie maakt gebruik van Fuzzy Set Qualitative Comparative Analysis 
(fsQCA), en techniek die voortbouwt op settheoretische benaderingen om configuraties 
zoals deze zijn volledige context te bestuderen en te vergelijken; dit in tegenstelling tot het 
analyseren van netto effecten van individuele determinanten. fsQCA is nieuw voor de 
studie van management innovatie en is gekozen vanwege zijn mogelijkheid om complexe 
theorieën op een geschikte manier in modellen te vertalen. De verwachting is dat hierdoor 
theoretische proposities en empirische data meer op een lijn komen. Om die reden is de 
methode ook geschikt voor de bestudering van interorganisatorische configuraties die 
management innovatie faciliteren.  
De empirische resultaten wijzen op vier configuraties van interorganisatorische 
relaties. Zij verschillen in de combinaties van aanwezigheid of afwezigheid van 
relationele-, structurele- en omgevings-condities. Elk van deze combinaties is even 
effectief in het faciliteren van management innovatie, maar gebruiken interne en externe 
kennis op een verschillende manier om nieuwe management praktijken, processen en 
structuren te ontwikkelen en te implementeren. Daarmee bieden de resultaten substantiële 
empirische onderstemming voor de complexiteit tussen de contextuele antecedenten van 
management innovatie. De daarop volgende analyse van complementariteit en substitutie 
tussen deze configuraties suggereert de richting voor toekomstig onderzoek.  
De resultaten leiden tot een taxonomie van interorganisatorische configuraties die de 
essentiële condities en alternatieve organisatiemodellen voor management innovatie 
benadrukken. De taxonomie biedt een simpel en gestructureerd besluitvormingsinstrument 
om begrijpbare en praktische management strategieën te ontwikkelen. Daarnaast laat de 
empirische studie zien dat bedrijven in China’s biofarmaceutische industrie niet achteloos 
bestaande management instrumenten overnemen. In tegen deel, de nieuwe management 
instrumenten maken gebruik van zowel lokale als wereldwijde kennis en worden snel 
ontwikkeld en geïmplementeerd. Deze kunnen als voorbeeld dienen voor de wereldwijde 
biofarmaceutische industrie en suggereren dat wat in China opkomt binnenkort een 
prominente positie zal innemen in de leidende biofarmaceutische industrieën. 
  
 
 
 
 
 
 
English Summary 
 
This dissertation advocates a holistic approach to the study of management 
innovation by improving the alignment of theories, methods and empirics. Previous 
research conceptualizes management innovation as either the outcome of independent 
determinants of individual firms or a complex process of conjunctural factors between 
interacting firms. In contrast this thesis attempts to bridge outcome and process theories 
while acknowledging the complexities among contextual antecedents of management 
innovation. Instead of specifying what actors within inter-firm relations do in order to 
develop and implement new management instruments, this thesis examines the 
combinations of conditions under which the management innovation process within inter-
firm relations takes place. In other words, it proposes a configurational approach to the 
study of inter-firm relations which facilitates management innovation 
The empirical analysis builds on data from 56 inter-firm relations in China’s 
biopharmaceutical industry collected during an extensive, one year field research period in 
China (Beijing and Shanghai) between 2007 and 2008. The population of firms in China’s 
biopharmaceutical industry is young and highly diverse and strongly relies on ties to other 
organizations. As a result the industry operates under volatile conditions that require the 
constant development of new managerial instruments in order to mitigate high levels of 
uncertainty. Thus, the setting offers a promising case for examining the role of inter-firm 
relations in management innovation. On the empirical side the analysis contributes to 
understanding how management innovation integrates Chinese firms in the global 
biopharmaceutical industry.  
This thesis employs Fuzzy Set Qualitative Comparative Analysis (fsQCA), which 
builds on set theory, to examine and compare the configurations expressed in entire cases, 
instead of analyzing the net-effect of individual determinants. fsQCA is new in the study 
of management innovation and has been chosen for its ability to properly translate 
complex theories into models. It is expected to improve the alignment of theoretical 
propositions and data and is hence suitable for examining inter-firm configurations that 
facilitate management innovation.  
The empirical results identify four configurations of inter-firm relations. They differ 
in the combinations of present or absent relational, structural and environmental 
conditions. Each is equally effective in facilitating management innovation yet employs 
internal and external knowledge differently to develop and implement new management 
practices, processes or structures. Thereby the results provide substantial evidence for 
complexity among the contextual antecedents of management innovation. The subsequent 
analysis of complementarities and substitutions among these configurations points to 
future research directions. 
Further, the results lead to a taxonomy of inter-firm configurations emphasizing 
essential core conditions and alternative organizational designs for management 
innovation. The taxonomy provides a simple and well arranged decision-making tool for 
drafting intelligible and practical managerial strategies. Moreover, the empirical study 
indicates that firms in China’s biopharmaceutical industry do not merely copy existing 
management instruments. Instead, new management instruments containing both local and 
global knowledge are swiftly developed and rapidly introduced. These may serve as 
templates for the global biopharmaceutical industry and suggest that what emerges in 
China will soon take a prominent position among the leading biopharmaceutical industries 
in the world. 
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A STUDY IN CHINA’S BIOPHARMACEUTICAL INDUSTRY
This dissertation proposes a configurational approach to the study of inter-firm relations
facilitating management innovation. Previous research conceptualizes management innovation
as either the outcome of determinants of individual firms or a complex process of conjunc -
tural factors between firms. In contrast, this thesis attempts to reconcile the two camps by
examining the conditions under which the management innovation process within inter-
firm relations takes place. The empirical analysis employs data from 56 firm partnerships in
China’s biopharmaceutical industry collected during field research in 2008. The population of
firms in China’s biopharmaceutical industry is young, highly diverse and strongly relies on ties
to other organizations. Operating under volatile conditions requires constant development
of new managerial instruments. Methodologically, this dissertation employs a technique
new in the study of management innovation. Fuzzy Set Qualitative Comparative Analysis
(fsQCA) has been chosen for its ability to properly translate complex theories into models
and its suitability for configurational analyses. 
The results identify four configurations of inter-firm relations differing in their combi -
nations of relational, structural and environmental conditions. Each is equally effective in
facilitating management innovation yet employs internal and external knowledge differently
to develop and implement new management instruments. The results provide a simple and
well arranged decision-making tool for drafting intelligible managerial strategies and
indicate that firms in China’s biopharmaceutical industry swiftly develop and introduce
management instruments which soon may serve as templates for the global biopharma -
ceutical industry as a whole.
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